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Abstract 
The thesis entitled "studies on photochemical reactivity of drug molecules and 
related substances," describes photochemical studies on drug molecules and related 
substances and the study of ensuing photochemical processes and mechanisms. Certain 
drugs are able to produce phototoxicity side effects that are undesired adverse cutaneous 
reactions that appear as a consequence of the combined action of drugs and sunlight in 
the treated patients. The variety in molecular structure of phototoxic drugs is immense 
and almost all classes of drug compounds contain members with adverse 
photobiological effects. Also, photochemical degradation, by various procedures, 
including photooxidation, is likely to be an important loss and toxicity mechanism for 
many drugs and pharmaceuticals in biosystem, and this is of great significance to 
environmental photochemistry and photobiology. Natural products have served as tools 
and leads for the development of new drugs and several natural compounds from plants 
and animal kingdom are now useful drugs. Moreover, plenty of plant materials for their 
biologically active principal have proved to be of potential medicinal value. 
Singlet oxygen, a potential product of photochemical reactions of many compounds 
is a damaging agent to all living organisms, and also plays a very significant role in 
plant metabolism. Photosensitizing reactions among secondary plant products is a wide 
spread phenomenon involving ultra-violet as well as visible light. Secondary plant 
substrates of diverse biogenetic origin are capable of the photogenerating singlet 
oxygen, and they also act as quenchers of singlet oxygen, suggesting the wide spread 
use of these as potent toxic, protective and defensive agents. Tiius, photochemical 
studies on drugs and promising drug molecules is an area of vital importance in current 
medicinal chemistry, for establishing a relation to its phototoxicity. A satisfactory 
understanding of this phenomenon requires a detailed knowledge of the photochemistry 
of such molecules. In principle, photochemical reactivity of drugs can be anticipated on 
the basis of good knowledge of the possible photochemical mechanisms. To achieve 
this goal different types of studies have to be undertaken: 
(a) Photophysical studies- light absorption and emission (fluorescence, 
phosphorescence) to determine the nature of involved excited states, as well as their 
energies. Laser flash photolysis for detection of triplet states of other short-lived 
transition species that could interact with biomolecules. Singlet oxygen detection 
(steady state or time resolved near infrared emission). 
(b) Photosensitized reactions of biomolecules- photodynamic lipid peroxidation, 
pholomoditlcation of proteins (protein photocrosslinking, drug protein 
photobinding) drug photosensitizer DNA damage (strand breaks, oxidative damage 
to bases, pyrimidine dimers). 
(c) Photochemical studies- photostability, photodegradation (isolation and 
identification of drug-derived photoproducts by chromatography and spectroscopy, 
product-based elucidation of the photochemical mechanisms. 
(d) Photooxidation of drug molecules with singlet oxygen. 
HI 
In the present work we have undertaken basically two of the above aspects 'c ' and 'd' 
of the drug photochemistry, using some representative examples from established drugs 
and promising drug (biologically active molecules) class. 
Chapter 1 of the thesis includes some basic concepts of photochemistry; some 
active areas of photobiological research with an outline of their importance; 
properties, generation and reaction of singlet oxygen; some facts pertinent to 
human photobiology and a brief survey of the photochemistry and photobiology 
of drugs and some biologically active natural products. 
Second chapter of thesis describes photochemical studies on acyclovir (1) and 
phenazopyridine hydrochloride. Photodegradation of aqueous solution of acyclovir in 
phosphate buffer (pH 7) under aerobic condition was studied with light of wavelength 
>270 nm. Three major products were isolated and identified on the basis of IR, NMR 
and mass spectral studies. The products were: (2-hydroxyethoxy) methyl 
spiroiminodihydantoin (2), (2-hydroxyethoxy) methyl (amino)-2-imino-l,2-
dih\droimidazole-5-one (3), and 2,2-diamino-4-[(2-hydroxyethoxy) methyl) amino)-5-
[2H]-oxazolone (4). (Scheme I) Further the effects of: D2O as reaction medium, added 
sodium azide and the absence of oxygen on the photodegradation of acyclovir was 
checked. These observations indicated the involvement of singlet oxygen. The 
formation of products is explained by the photooxidation of acyclovir. 
In an extensive study the antiviral drug acyclovir (1) was treated with triplet 
excited ketone, generated by thermal decomposition of 3-(hydroxymethyl)-3,4,4-
IV 
liimethyl-L2-dioxetane (HTMD), in the dark. Three major photo-oxidation products 
were isokitcd and characterized by spectroscopic studies. The products were (2-
hydroxyetlioxy) methyl spiroiminodihydantoin (2), (2-hydroxyethoxy) methyl (amino)-
2-imino-l.2-dihydroimidazoie-5-one (3), and 2,2-diamino-4-[(2-hydroxyethoxy) 
methyl) amino)-5-[2H]-oxazolone (4). The HTMD-induced reaction was found to occur 
by two photooxidation mechanisms, at almost equal pace: type I leading to 3 and 4 and 
type 11 giving 2. The findings are based upon determination of the exact yields of 
products in a comparative study with the established photosensitizers, riboflavin (type I) 
and rose Bengal (type II) (Scheme 2). 
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Photochemistry of phenazopyridine hydrochloride (5) was studied in different 
reaction media including the drug adsorbed on silica gel. This resulted in photochemical 
cyclodehydrogenation, reductive photodegradation and rearrangement of the drug 
molecule. Four major products were isolated and identified on the basis of IR, NMR 
and mass spectral studies. The products were: pyrido[3,4-c]cinnoline-2,4-diamine (6), 
N'-phenylpyridine-2,3.4,6-tetraamine (7). pyridine-2,3,6-triamine (8), 2,6-diamino-l-
(4-aniiiiophcnyl)pyridin-4(lH)-one (9) (Scheme 3). 
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Chapter 3 of the thesis records the photochemistry of two anti-inflammatory 
drugs desonide (10) and clobetasol propionate (14) was studied in aerobic as well as in 
anaerobic conditions with different irradiation wavelengths (254 nm and 310 nm) in 
acetonitrile and 2-propanol. The photoproducts were characterized on the basis of their 
IR. H-NMR, 'C-NMR, mass spectral and elemental analysis studies. The products 
from the photolysis of desonide were; 11(3, 21-dihydroxy-16a, 17a-(l-
methylethylidenedioxy)-l,5-cyclopregn-3-ene-2,20-dione 11, 1 lp-hydroxy-16a, 17a-
(l-methylethylidenedioxy) androsta-l,4-diene-3-one 12, 17p-hydroperoxy-ll(3-
hydroxy-16a, 17a- (1-methylethylidenedioxy) androsta-l,4-diene-3-one 13 (Scheme 
4). From the photolysis of clobetasol (14) products were: 21-chloro-9-fluoro-l 1-
hydroxy-16-methyl-17(l-oxopropoxy)-l,5-cyclopregn-3-ene-2,20-dione 15 (254 nm), 
VII 
21 -chloro-9-tluoro-11 -hydroxy-16-methy I-17(1 -oxopropoxy)-! 8,20-cyclopregn-l ,4-
dienc-3-one 16, 9-fluoro-17-liydroperoxy-16-methyl-17(1-oxopropoxy) androsta-1,4-
diene-3-one 17 (Scheme 5). 
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The chapter 4 records our investigation on the photoreactivity of anti-cancer 
drug lliitamide (18, FM) adsorbed on siHca on the silica gel TLC plates. The results 
were consistent with the formation of nitroso derivative 19 as the sole stable 
photoproduct, formation of which was realized by the structural changes of flutamide 
occurring upon its compartmentalization in the silica gel intermolecular cavities 
(Scheme 6). 
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IX 
The photostability of three flutamide oral dosage formulations (tablets 
available in India) were studied using indirect sunlight (daylight) and continuous 
artificial light. The extent of photodecomposition of FM was determined using a 
specific reversed phase high performance liquid chromatography (HPLC) method. The 
effectiveness of artificial and natural sunlight on FM photodegradation was also 
determined using both pure FM powder as well as a methanolic FM solution for 
comparison to tablet form. All the tested FM formulations were likely to be photostable 
up to at least 12 weeks of continuous artificial and natural day light exposure, compared 
with pure FM powder and methanolic solution. Photodegradation of FM powder and 
methanolic solution exposed to indirect sunlight was faster than the artificial light. 
Chapter 5 of the thesis describes photooxygeiiation reaction of two plant-derived 
terpenoids tinosponone (20) and furanoeremophilanc (24). The reaction of tinosponone 
with singlet oxygen was studied by using different combinations of photosensitizers 
(i.e. rose bengal, methylene blue, riboflavin and benzophcnone), solvents (i.e. benzene, 
chloroform, acetone, acetonitrile and methanol) and singlet oxygen scavengers (i.e. 
DABCO and sodium azide). Two major products: (3S,4aS,4bS,8R,8aR,10aR)-8-
hydroxy-3-(5'-hydroxy-2'-oxo-2',5'-dihydrofuran-3'-yl)-4a,8a-dimethyl-3,4,8, 
8a,9,10-hexahydro-10aH-benzo[f]isochromene-l,5 (4aH,4bH)-dione (21) and 
(3S,4aS,4bS,8R,8aR,10aR)-8-hydroxy-4a,8a-dimethyl-3-((l'R)-3'-oxo-4',6'-
dioxa-bicyclo[3.1.0]hexan-r-yl)-3,4,8,8a,9,10-hexahydro-l OaH-benzo[f] 
isochromene-l,5(4aH,4bH)-dione (22) were isolated in all the solvents except 
methanol. In methanol a single product (3S,4aS,4bS,8R,8aR,10aR)-8-hydroxy-3-
(5'-hvdroperoxy-2'-methoxy-2',5'-dihydrofuran-3'-yl)-4a,8a-dimethyl-
3.4,H.8a.9J0-hexahydro-10aH-benzo[fl isochromene-l,5(4aH,4bH)-dione (23) 
was obtained (Scheme 7). All products were characterized on the basis of IR, ' H - N M R , 
'C-NMR, mass spectral and elemental analysis studies. The formation of products was 
explained by photooxidation of tinosponone. Effect of different solvents with the 
variation of added singlet oxygen sensitizers and singlet oxygen scavengers was 
observed on the yields of photooxidation products and was correlated to the rate of 
singlet oxygen formation. 
The photochemical oxygenation reaction of 2p-angeloyloxy-10(3-H-
furanoercmophilane (24), a sesquiterpene, was studied in benzene and methanol. Three 
pholoproducts were isolated and characterized by IR ' H - N M R , ' ^ C - N M R and mass 
spectral studies. Sesquiterpene itself was found to be singlet oxygen ( O2) sensitizer. 
Addition of rose bengal increased the rate of photooxidation whereas as DABCO was 
found to decrease the rate of photolysis proving the involvement of O2 in these 
photoreactions. 2p-angeloyloxy-8-hydroxy -lOP-H-eremophilanolide (25) and 2p-
angeloyloxy-7,8-epoxy-I0P-H-eremophilanolide (26) were obtained as products in 
ben/xNie. Photolysis in methanol gave a single product 2p-angeloyloxy-10p-H-8-
melhox\-l2-hydroxy-7,1 1-dihydro-eremophilanolide (27). Reaction was also carried 
out by adsorbing compound (24) on silica gel bound rose bengal which yielded the 
products 25 and 26 with an increase in the rate of reaction (Scheme 8). 
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Chapter 1 
General Introduction 
Liulit is a ubiquitous element of our environment with a tremendous impact 
on life. Witjiout light, life, as we know it would not exist. Plants harvest 
solar energy by photosynthesis, and provide energy to other organisms 
through the food chain. Humans and animals depend on light through vision 
and other photoresponses. Biological effects of artificial light are the basis 
of a variety of medical treatments and diagnostic techniques. Light can also 
l',a\e deleterious effects. For example, ozone in the atmosphere protects 
living things from damage by ultraviolet radiation. Increases in the amount 
of ultraviolet light reaching the earth's surface as a result of changes in the 
ozone layer may result in increased rates of skin cancer and skin aging as 
well as undesirable effects on agriculture, oceanic plankton and the aquatic 
food chain. Recognition of the importance of light in biology has led to the 
development of the science of photobiology: the study of the myriad effects 
of light on life. 
There is growing awareness of the influence of light (both beneficial and 
liarniful) on living organisms. Some active areas of photobiological 
research and an outline of their importance to society is highlighted in the 
following section. 
Photosynthesis 
Photosynthesis is one of the most important biological processes on earth. 
By consuming carbon dioxide and liberating oxygen, it has transformed the 
world into the hospitable environment we know today. Directly or indirectly, 
photosynthesis fills all of our food requirements and many of our needs for 
fiber and building materials. The energy stored in petroleum, natural gas and 
coal all came from the sun via photosynthesis, as does the energy in 
tirevvood. which is a major fuel in many parts of the world. This being the 
case, scientific research into photosynthesis is extremely important. If we 
can understand and control the intricacies of the photosynthetic process, we 
can learn how to increase crop yields of food, fiber, wood, and fuel, and how 
to use our lands more benignly. The energy-harvesting secrets of plants can 
be adapted to synthetic systems, which will provide new, efficient ways to 
collect and use solar energy. Because photosynthesis helps control the 
makeup of our atmosphere, understanding photosynthesis is crucial to 
understanding how carbon dioxide and other 'greenhouse gases' affect the 
global climate. 
Photomedicine 
To avoid the sun, would be to exist without one of the great pleasures of 
life. But as with most enjoyable things, indiscriminate exposure and lack of 
understanding of the possible unpleasant consequences can result in 
unhappiness and even serious aftereffects. There are over 25 diseases that 
are caused or aggravated by sunlight. The field of photomedicine includes 
the study of such diseases and their treatments. 
Harmful effecis of lighl - Sunlight is implicated in several skin diseases, 
including premature aging of the skin and skin cancer. Skin sensitivity to 
sunlight is controlled by the genetic ability of an individual to produce 
melanin, the pigment that helps protect the skin from light-induced injury. 
Genetic variations in the capacity to form melanin, proximity to the equator, 
and personal habits of sun exposure determine the susceptibility of an 
individual to skin aging and cancer of the skin. Deficiencies in cellular 
capacity to repair sun-induced damage of DNA, as in the inherited disorder 
called xeroderma pigmentosum, are responsible for the early onset of sun 
sensitivity and freckling, which can lead to sunlight-induced skin cancer. 
Certain drugs or chemicals also augment skin reactivity to solar radiation, 
and lead to transient phototoxic effects or chronic photoallergic reactions, in 
the synthesis of hemoglobin, the substance that gives the red color to human 
blood and carries oxygen, genetic deficiencies of certain enzymes lead to 
metabolic overproduction of hemoglobin precursors called porphyrins. These 
porphyrins absorb light and cause severe, disabling photosensitivity. 
Beneficial effects of light- Photomedicine is also concerned with the 
beneficial effects of light. For example, phototherapy is useful for treating 
jainidice in premature babies, and light-based therapies can be effective in 
treating psoriasis. The light-based techniques are used to treat tumors and to 
inactivate the human iinmunodeficiency virus that causes AIDS and other 
viruses present. Phototherapies for several other diseases exist or are under 
development by the photomedical community. 
Photuprotection. Both topical and systemic sunscreen agents prevent the 
acute and chronic effects of sunlight. They enable people to work outdoors 
and enjoy outdoor activities with reduced risk of sun-induced injury. The 
damage that absorbed light creates in the skin, such as the changes 
recognized as aging of the skin, is preventable by using new types of water-
and sweat- resistant sunscreens. 
Fhotoimnninology. Light exposure can affect the immune system. For 
example, irradiation of mice with ultraviolet light not only produces skin 
tumors at the site of exposure, but also alters the entire immune system, 
allowing transplantation of the tumors to areas not exposed to light. Studies 
of these effects may ultimately help explain the molecular basis for skin 
cancer in humans. This and other effects of light on the immune system are 
cunenily under active investigation in many photobiology laboratories. 
Environmental Photobiology 
Environmental photobiology is a new, multidisciplinary research area. It is 
concerned with the effects of artificial light on the human environment, the 
effects of sunlight on ecosystems, and human influences on the quality of 
sunlight reaching the earth's surface. The role of artificial light on the 
human environment has only begun to receive serious attention, and is an 
exciting challenge for the future. 
Phoiosensitization phenomenon occurs not only in humans, as described in 
the section on photomedicine, but also in other organisms. For example, 
some plants contain potent photosensitizing chemicals. When cattle, sheep 
or other animals eat these plants they become light sensitive and may even 
die if they remain in the sunlight. Grazing animals with liver dysfunctions 
also become light sensitive due to the accumulation of chlorophyll 
metabolites that are photosensitizers. Even foodstuffs can suffer from 
pholodamage. Some snack foods such as potato and corn chips develop an 
olT flavor when exposed to light. This apparently results from the 
photooxidation of unsaturated oils that remain in the chips after cooking. 
Photobiologists working with ultraviolet radiation are concerned with 
identifying the photochemical changes that are produced in living tissue by 
the absorption of ultraviolet light and determining the biochemical and 
physiological responses of cells to this damage. 
Photochemistry 
At the turn of twentieth century, photochemistry was barely developed as a 
science. Although many photoreactions were known due to accidental or 
intentional exposure of substrate to (sun) light," the underlying principles 
were poorly understood. The "first law of photochemistry" had been 
recognized by Grotthus (1817) and Draper (1843), but the quantum nature of 
light and its consequences for photochemistry were yet to be discovered. 
A little more than two decades ago a vigorous interest in the photoreactions 
of organic molecules began to develop. That initial interest was followed by 
tremendous research effort in the area of photochemical mechanism and was 
paralleled by remarkable and rapid technological breakthroughs in 
generation and control of light, especially in the area of pulsed excitation, 
which allow the study of dynamic processes with duration as short as lO"'" 
second. The new respectability, which resulted from the development of a 
mechanistic framework for photoreactions encouraged further research and 
early breakthroughs in exploratory photochemistry and underlying physical 
principles led to new diverse, yet inter-related area of research. Two types of 
developments, one based on techniques and one based on new theories and 
concepts have been vital for the growth of photochemistry. These 
developments are well recorded in the many fine books of photochemistry. ' 
Thus in the 20" century, photochemistry blossomed from a poorly defined to 
a highly sophisticated science, and these days it is considered a thrust area 
of research activity worldwide for its diverse scope in chemical and 
biological sciences. 
Photochemical changes are responsible for biological responses to light, and 
can have important effects on the environment of all organisms, including 
humans. Understanding and control of any photobiological process requires 
knowledge of the underlying photochemistry, and hence photochemistry is 
becoming increasingly important as a tool in biological research. For 
example, the understanding of many complex photobiological processes can 
be enhanced through the preparation and study of synthetic photochemical 
models. Photochemistry can also be used to study the spatial relationships 
of molecules in complex biological structures. In this approach, light is used 
lo induce chemical bonds between adjacent molecules. Subsequent 
identification of these attachments indicates the spatial relationship of the 
molecules in the native biological structure. 
Many important industrial and manufacturing processes are based on 
photochemistry. Photocopying, photography and photolithography are just a 
few examples. Also, natural and synthetic chemicals (e.g., medications, 
industrial chemicals, herbicides and pesticides ) can sometimes be altered by 
sunlight 10 produce compounds toxic to humans and other organisms or 
harmful lo the environment.'^ For example, the action of sunlight on 
automobile exhaust contributes to smog. 
Thus the importance of photochemical reactions to mani<;ind is tremendous. 
Although the same kind of reactions are found in photochemistry as in 
thermochemistry, the reactivity of a molecule in its ground state and in its 
excited state mostly differ from each other, not only qualitatively but also 
quantitatively. Some examples serve to illustrate the point: 
I. Thcrmochemically (A) the chloramphenicol is very stable in aqueous 
solution; e.g. at 25"C and pH 7 it has a half-life of more than 2 years. '" 
The major cause of chloramphenicol degradation under these conditions 
can be attributed to the hydrolytic cleavage of the amide bond (Fig. 1.1). 
In contrast, homolysis occurs photochemically (hv) at the carbon atom 
adjacent to the aromatic ring. During exposure to sunlight of moderate 
intensity (I = 14 W m' ' at 360 nm) for 45 min at room temperature, more 
than 80% of initial chloramphenicol (10 mg 1"' in 0.05 M phosphate, pH 7.0) 
proved to be decomposed. In addition to 20% unconverted material. 25% p-
nitrobenzaldehyde, 1 5%/7-nitrobenzoic acid and 36%/7-nitrosobenzoic acid 
were found." Formation of these reactive photoproducts can have 
toxicological implications, if only because the concentration in the aqueous 
humour of the eye after topical and systemic application of the drug is 
approximately 5-15 mg 1"' and 5-30 mg I"' respectively " for some hours. 
OoN 
OH NHCOCHCI2 
C—C—CHoOH 
H H 
?H NH, 
I 
C—C—CH2OH 
H H 
HOOCCHCU 
O J N ^ Q V C H O + O J N ^ Q V C O O H + O N ^ Q V C H O 
Fig. 1.1 Thermochemical (A) hydrolysis and pholohomolysis (/;v) of 
chloramphenicol in aqueous medium. 
The tranquillizer chlordiazepoxide (1 mg mP': pH 7) decomposes very 
slowly into demoxepam upon standing in. the dark at room temperature 
(to.5 = 2 h at 80°C).'^ Demoxepam is one of the main metabolites of 
chlordiazepoxide in man. 
When the same solution is exposed to UV radiation (Xn,ax = 350 nm: 1 = 
20 W m'^ intensity comparable to that on a sunny May day in Holland) 
the half-life is only 40 s. However, in contrast to the thermochemical (A) 
reaction where hydrolysis occurs, chlordiazepoxide isomerizes into an 
oxaziridinc (Fig. 1.2). This photo-isomerization (hv) into a very reactive 
oxaziridine has been shown to be responsible for the phototoxic and 
photoallergic properties of chlordiazepoxide and other imino-N-oxides. 
Fig. 1.2 Thermochemical (A) hydrolysis of chlordiazepoxide (A) into 
dcmoxepam (B) and photoisomerization (hv) into its oxaziridine (C). 
Hecause a photochemical reaction only take place with molecule in an 
excited state, a knowledge of the formation of excited states, its kind, and 
the processes they undergo apart from chemical reaction is essential to 
iinJersland ihe pholochemislry of an organic molecule or biologically active 
substrate such as drugs. The electronic arrangements in molecular orbitals 
during electronic transition leads to singlet and triplet states differing in spin 
multiplicities. A state can be specified by its spin multiplicity (2S+1) (Table 
I . ] ) . 
No. of unpaired 
l^lcctrons 
0 
1 
2 
T J 
S 
s=o 
S= 1/2 
S= 1 
S=3/2 
Multiplicity 
2S+1 = 1 
2S+1 =2 
2S+1 =3 
2S+1 =4 
State 
singlet 
doublet 
triplet 
quartet 
Table 1.1 
For any molecule there is a series of excited states obtained by different 
electronic transitions designated as: excited singlet state (S | , ST ) and 
excited triplet state (Ti, TT, T3 ). A triplet state always has a lower energy 
than singlet state (due to Hund's rule). Triplets are rarely obtained directly 
by photon excitations; they are obtained indirectly by singlets or by energy 
U'ansfer. 
S4 
S3 
S2 
I4 
I3 
^ 
T2 
T , 
Fig. 1.3 Some electronic energy stales of a normal organic molecule 
represented in a .lablonski diagram. Subscript 0 indicates tlie ground state, 
while ihe higher subscripts point to singlet (S) and triplet (1") excited states. 
The other point of significance is the formation of excited states and the 
physical deactivation processes they can undergo apart from chemical 
reaction: 
//? Ihe absence of surrounding molecules: Absorption of energy, UV-
radiation or visible light, by a molecule only occurs in discrete quantities, 
photons. If a photon is absorbed then its energy corresponds to the 
difference in energy between the excited state involved and the ground state. 
During excitation of the So to one of the T„ states both the orbital and the 
spin of the electron must change. However, absorption takes place in only 
10" ' s and this makes such a simultaneous change of both orbital and spin of 
the electron involved highly improbable. An importance consequence of this 
is that with organic molecules, which normally have singlet ground state 
(So), absorption of light exclusively produces singlet excited states and not 
triplets. 
The lifetime of excited singlet states other than Sj, is usually smaller than 
10" s; too short for a photochemical reaction. Within this short time, 
molecules in higher excited singlet states tumble down to lowest vibrational 
level of their Si state. In fact the energy gap between the higher excited 
stales and Si state is much smaller than that between the Si and the ground 
state S(). This facilitates the rapid decay of highly excited states to the 
Sistate. The larger energy gap between the S| a,Ki So states results in a longer 
lifetime of the molecule in the S| state: 10''''-10"''. 
Important consequences of this are: 
1, Although absorption of light is an essential condition for 
photochemistry, the nature of photochemical reaction is independent 
of the wavelength of the radiation used. This is due to the sequence: 
hv : So " Sn 
A : S n - * — • —• —• Si — • reaction 
2. The extinction coefficient (s) is a measure of the efficiency with 
which light of a given wavelength ultimately produces the first 
excited singlet state. A consequence of (1) and (2) is that the rate of 
photoreaction is a function of s. 
From the foregoing it follows that it is a misconception to believe that light 
of shorter wavelength is more detrimental to chemicals than light of longer 
wavelengths. For example protoporphyrin is 50 times more photoreactive 
wilh visible light of 410 nm than with the same intensity of UV-radiation of 
330 nm. The reason for this is that 84IO~50XE33O. 
Because of the vast majority of organic molecules, light absorption 
ultimately leads to an S| state, it is important to know what kind of processes 
can take place from that excited state. 
There are radiative and non-radiative ways to lose the excitation energy 
ii-i5.M|. Tiic non-radiative piocesses, a and i iiiiiiallv m 1 
loss of energy; a high vibrational level is reached of either the Si or the T; 
stale, followed by a rapid cascade to the lowest vibrational level. Both 
processes are probable because only the orbital of electron (a) or its spin (b) 
is changed. Process (a) is called internal conversion (IC) and (b) intersystem 
crossing (ISC). 
The most important consequence of process (b) is that the triplet excited 
stale, which is almost not formed upon light absorption, can often easily be 
obtained via the probable processes S,->T| (ISC). The other non-radiative 
process, from the triplet T| to a high vibrational level of the ground state So 
is improbable because the orbital and the spin of the excited electron should 
be simultaneously changed. 
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Fig. 1.4 Ph)sical deaciivalion processes from the first excited state without 
surrminJing molecules being present (electronic and vibrational levels are 
represented), (a) Si^So + vibrational and rotational energy; (b) S1-+T1 + 
vibrational and rotational energy; (c) Si^So + hv (fluorescence); (d) T|—•So+ hv 
(phosphorescnce); (e) T|—>So+ vibrational and rotational energy 
Radiative processes are (c) from the S] and (d) from the Ti, called 
fluorescence and phosphorescence respectively. With (c) only the orbital and 
with (d) both the orbital and the spin should changed, making (c) a probable 
;md (d) an improbable process. 
The important consequences of the fact that processes (a), (b) and (c) from 
the S| state are probable and (d) and (e), from the T| state, are improbable 
processes, is that the lifetime of the molecule in the triplet excited state is 
far longer than that in the singlet excited state. The intrinsic lifetime, 
without surrounding molecules, is 10" -10 s for the Ti state and 10' -10' s 
for the S| state. Because the intrinsic lifetime of a molecule in its T| state is 
much longer, the change of colliding with a reaction partner is far greater 
than when it is in the Si state. This is the reason that the T| state is so 
important to photochemistry. 
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In addition to the pliysical relaxation processes mentioned (Fig 1.4) 
competing photochemical reactions can take place in which surrounding 
molecule are not necessarily involved (unimolecular reaction). Thus 
isomerization, rearrangement and radical formation are examples of 
reactions that a molecule in the excited Si or Tj state can undergo. Because 
imimolecular reactions can proceed very rapidly, the change that a molecule 
in its singlet excited state will undergo this kind of reaction should be taken 
in to account. 
//; ilic presence of .surroimding molecules (in particular energy transfer). 
In the presence of other molecules (X) formation of excited states and 
subsequent deactivation processes are essentially the same as described in 
the previous section. A number of processes can occur, some of which are 
rather trivial: 
Si (orTi) + X — • So + X + Kinetic energy 
S-i (orTi) + X — " Reaction products 
The fii'st process is called collisional deactivation to which, evidently, the T] 
siaic with Its longer intrinsic lifetime is more susceptible. The same holds 
for the formation of reaction products. (However, one should be careful 
when considering the Ti state as a prerequisite for photochemical reaction. 
Especially when reactants are very near, as for the complexation of drugs 
with bio-molecules, the Si state can considerably contribute to product 
formation. 
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Apart from the trivial processes mentioned, the presence of other molecules 
can produce another effect, called energy transfer, which complicates the 
photochemical activity of drugs. This involves transfer of excitation energy 
from an electronically excited molecule (D = Donor) to the ground state of 
another molecule (A = acceptor) resulting the deactivation of D and 
excitation of A. Excited D involves either the S| or T| state. Light 
absorption, followed by radiation less deactivation of excited singlet states 
with n>l , produces the S| state. The Ti state results from intersystem 
crossing (ISC): 
hv.DiSo) •D(Sn) 
A: D ( S , ) ^ ^ ^ ^ D(Si) 
ISC : D{Si) —• D(Ti) 
Between organic molecules, of which the ground state usually is a singlet, 
two modes of energy transfer, (a) and (b), are possible (the arrows in 
parentheses represent the electron spins of the outer two electrons; subscript 
s or t means singlet or triplet). 
D s ( | t ) + A,{\\) " D s ( | t ) + A s d t ) 
DT(t f )+ A3 ( I t ) • D 3 ( | t ) + AT(tt) 
Oxygen, which often plays a role in photochemical processes of bio-
molecules, is a triplet in its ground state. In connection with energy transfer, 
route (c) in which A = O2 is also important. Singlet has a longer lifetime. 
The reason is that the transition to the triplet ground state is improbable 
because the orbital and the spin orbital should be simultaneously changed. 
DT(ft)+ Ayd j ) " D3 ( | t )+ Axdt ) 
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In processes (a), (b) and (c), both D and A undergo an electronic transition. 
Consequently, this would mean that (a) would be the only probable process. 
The reason is that both with (b) and (c) simultaneous change of spin of the 
electrons involved in the excitation of A and in the deactivation of D also 
occurs. However, (b) and (c) can still occur by the virtue of exchange 
interaction between D and A. This means that the molecular collision or near 
collision between D and A should take place, such that the electron clouds 
of the donor and acceptor overlap. In the region of overlap, the excited 
electron of D and outer electron of A are indistinguishable and can 
exchanged without their spin being changed. 
Although for route (a) to produce a collision between D and A is not 
necessary and the distance between the two can as much as 5 nm, the So -^ 
S| part of the absorption spectrum of the acceptor should partly overlap the 
fluorescence spectrum (S\ -^ So) of the donor: the energy difference between 
S,i -^ Si and S| -^ So should not be too large. Because a (near) collision 
between donor and acceptor is a condition for the occurrence of both (b) and 
(c), it is understandable that a long lifetime of the excited D as a triplet will 
favour the occurrence of processes (b) and (c). Another condition for both 
(a), (b) and (c) to proceed, is that in each case the energy for deactivation 
for excited D exceeds that for excitation of ground state A; e.g., process (b): 
E ( D T ^ D , ) > E ( A , ^ AT) . 
Whether conditions of overlap of spectra, lifetime of excited state and 
difference in deactivation and excitation energy are fulfilled in a given case 
can be concluded from the study of the electronic spectra (absorption, 
fkiorescence and phosphorescence) of D and A. Whereas absorption spectra 
mostly consist of more bands, the fluorescence and phosphorescence spectra 
have one band only. The reason is that the higher excited singlet states, 
formed upon absorption, live too briefly and tumble down in a non-radiative 
process to the lowest vibrational level of the Si slate. From the latter energy 
level, fluorescence can take place, which brings the molecule into one of the 
vibrational levels of its ground state, So. In the same way, phosphorescence 
occurs i>om the lowest vibrational level of the Ti state, reached from the S| 
slate by ISC. As a result of the latter, both fluorescence and phosphores-
cence bands of a given compound are at the long wavelength side of its 
absorption spectrum. Further, the fluorescence spectrum (S| -^ So) is often a 
mirror-image of the long wavelength absorption band (So -^ S|). 
Energy transfer from an excited donor to a ground state acceptor mostly 
proceeds very efficiently. This holds for the processes (b) and (c), and not 
only for (a) in which a collision is not even necessary (distance effect). A 
frequently observed situation is that the donor itself does not react during 
the process of photosensitization. If this is the case, the donor can repeat the 
transfer of absorbed energy numerous times per second and act as a catalyst. 
The consequence is that the donor, also called photosensitizer, can be 
present in a very low concentration. 
Oxygen is also an ubiquitous element of our environment with a 
tremendous impact on animal and plant life. Atmospheric oxygen has been 
recognized for more then 100 years as the principal agent responsible for the 
deterioration of organic materials exposed to air. The parallel role of 
oxygen, a molecule essential for many forms of life, as a destructive (toxic) 
agent for living tissues lias been discovered mucJi more recently.''' Oxygen 
is not only fundamentally essential for energy metabolism and respiration, 
bin it has been implicated in many diseases and degenerative conditions. A 
common element in such diverse human disorders as ageing, arthritis, 
cancer, Lou Gehrig's disease and many others is the involvement of partially 
reduced forms of oxygen. 
Atmospheric oxygen in its ground-state is distinctive among the gaseous 
elements because it is a triplet biradical, or in other words it has two 
unpaired electrons with parallel spins. This feature makes oxygen 
paiamagnetic; it also makes oxygen very unlikely to participate in reactions 
with organic molecules unless it is "activated". According to Pauli's 
exclusion principle, this precludes reactions with a divalent reductant, unless 
this redtictant also has two unpaired electrons with parallel spin opposite to 
that of the oxygen, which is a very rare occurrence. Hence, oxygen is 
usually non-reactive to organic molecules, which have paired electrons with 
opposite spins. Activation of oxygen may occur by two different 
mechanisms: absorption of sufficient energy to reverse the spin on one of 
the unpaired electrons, or monovalent reduction. If triplet oxygen absorbs 
sufficient energy to reverse the spin of one of its unpaired electrons, it will 
loim the singlet state, in which the two electrons have opposite spins. This 
activation overcomes the spin restriction and singlet oxygen can 
consequently participate in reactions involving the simultaneous transfer of 
two electrons (divalent reduction). Since paired electrons are common in 
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organic molecules, singlet oxygen, a metastable higher energy state 
molecular oxygen species, is much more reactive towards organic molecules 
than its triplet counterpart. 
Singlet oxygen a potential product of photochemical reactions of many 
compoLinds is a damaging agent to all living organisms and so it also places 
a very significant role in plant metabolism.'^ Photosensitizing reactions 
among secondary plant products is a wide spread phenomenon involving 
ultra-violet as well as visible light. Secondary plant substrates of diverse 
biogenetic origin are capable of the photogeneration of singlet oxygen and 
they act as quenchers of singlet oxygen, suggesting the wide spread use of 
these potent toxic and as protective and defensive agents. Oxygen plays an 
important role in aging, damage to materials in the environment, cellular 
pathology (for example, the damage following stroke or heart attack) and 
many other areas. The details of the chemical reactions underlying these 
processes are poorly understood. 
Singlet oxygen ( O2) was first observed in 1924 and then defined as a more 
reactive form of oxygen. In 1931, Kautsky"' first proposed that 'O2 might be 
a reaction intermediate in dye-sensitized photooxygenation. Following this 
suggestion, many studies have showed that 'O2 is an important intermediate 
species in the detrimental oxidation of biomolecules. Singlet oxygen is very 
toxic to organisms because it reacts with important biological molecules 
such as unsaturated lipids, ' oxidizable amino acids," '" and nucleic 
acids. ' '^^ particularly guanosine derivatives."' The resulting reactions cause 
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destruction of membranes, enzyme inactivation, and mutations, all of which 
can lead to cell death. 
Since oxygen is ubiquitous and efficiently quenches electronically excited 
states, O2 is likely to be formed following irradiation in countless situations 
and involved in various chemical and biological processes as well as in 
several disease processes. Reactive intermediates include^* singlet oxygen 
( O2). a metastable excited state of molecular oxygen), superoxide ion, and 
other oxygen species. 'O2 O2 HO' HO'2 RO'2 
Elech-onic slrucliire and the lifetime of singlet oxygen 
Molecular orbital theory can explain the electronic structure of molecular 
oxygen. The lowest electronic state of oxygen is a triplet ground state (^Eg") 
with two unpaired electrons distributed in the highest occupied orbitals. 
Rearrangement of the electron spins within these two degenerate orbitals 
results in two possible singlet excited states. The 'Ag state has an energy 
only 23 kcal above that of the ground state; both electrons are paired in a 
single orbital, leaving the other vacant. This state might be expected to 
undergo two-electron reactions. The higher singlet state ( Eg') comes from 
ihe spin pairing electrons in different orbitals and might be expected to 
undergo one-electron free-radical reactions. Because there are no unpaired 
electrons, neither 'Ag nor 'Sg" are radicals. In both forms of 'O2, the spin 
restriction is removed so that the oxidizing ability is greatly increased. The 
'Eg' state has a much shorter lifetime than 'Ag state because 'Eg^ is more 
reactive than the 'Ag form, it decays to 'Ag state before a chemical reactions 
can occur. 
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Genera/ion of singlet oxygen 
Both physical and chemical methods are used to generate singlet oxygen. 
I'hvsiccil Dicthods: These are based on photosensitization and proceed by two 
different processes called Type I and Type 11'^ (Fig. 1.5). Usually the direct 
radical mediated reactions are called as Type 1 reactions where as singlet 
o.xygen mediated reactions are considered as Type II reactions. 
Sensitizer 
hv 
Radicals or 
radical ions 
O, 
Products of 
oxidation 
Type I 
substrate 
or solvent 
Type II 
Sensitizer* 
O, 
Sensitizer + O2 (oxidised) 
^0 , 
substrate 
Products of 
oxidation 
Fig. 1.5 
The most common method of generating singlet oxygen in organic solvents 
has been the use of dyes in solution with the reagents."^ The irradiation of 
the solution excites the dyes to a higher singlet state, which then undergoes 
intersystem crossing to the longer lived triplet state (Fig. 1.6). This state 
transfers its energy to form singlet oxygen from the triplet ground state. 
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Type I chemical reactions Q 
free radical, redox '' ^ 
I 
2D0 kJ ;• 47,8 kca 
siDsorbance 
superoxicie 
150 y . ' 2 5 . 8 ^ 1 
S,= 1,-1 Type J 
95 y ; 22 J kcal cheiiiical reactions 
Fig . 1.6. Photosensilizer mechanism 
Commonly used dyes include Rose bengal (1), methylene blue (2) and 
tetraphenylporphyrin (3) shown in Figure 1.7. The choice of dye is based on 
high absorbance in the visible region, the half-life and energy of the triplet 
state, and the efficiency at exciting oxygen in the reaction solvent. Although 
the dyes are catalytic, they are slowly degraded by singlet oxygen in a 
photobleaching process and longer photooxygenation require higher dye 
loading to be efficient. As a result, this technique is not amenable to large-
scale reactions and alternative photooxidations methods have been 
investigated. 
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Nd£G02 
Fig. 1.7 Dye structures 
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The useful photosensitizers" for singlet oxygenation are given in table... 
Sensitizer 
Methylene blue 
Tetraphenyl porphyrin 
Hematoporphyrin 
Rose bengal 
Eosin 
Benzophenone 
Triplet energy 
K.1 mol"' 
142.2-142.3 
142.3 
155.7 
164.1-176.6 
180.8-192.5 
287.2-289.2 
Kcal moP' 
33.5 
34.0 
37.2 
39.2-42.2 
43.2-46.0 
68.6-69.1 
Table 1.2 
hrechel has reported the use of dendrimers as catalysts for singlet oxygen 
reactions.'" The dendrimer structure shown in Figure 1.8 contains a 
hydrophobic core with a photosensitizing moiety. Nonpolar reagents diffuse 
into the reaction core while polar products diffuse back into solution. This 
method would be expected to work best when there is a large polarity 
difference between product and reactant. Benaglia and coworkers have fixed 
5,10,15,20-tetrakis(4-hydroxyphenyl)porphyrin onto polyethylene glycol 
resins to generate a catalyst that is soluble in methylene chloride.^ Upon 
reaction completion, the catalyst may be precipitated with the addition of 
diethyl ether, filtered and recycled up to six times without activity loss. 
Polymer-bound photosensitizers show higher stability toward 
photobleaching and minimize dye decomposition and solution 
contamination. Free and polymer-bound dyes exhibit the same product 
selectivity and comparable yields. 
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H.V^. 
HO 
o^'yCoH 
OH 
Fig. 1.8. Polymer supported dye and dendrimer for photooxygenation. 
Alternatively, singlet oxygen can be "stored" for several weeks in the form 
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of calcium peroxide diperoxohydrate (Ca02.2H702) at -80 C. ~ 
(Ca02.2H202) can be made by reacting H2O2 with CaCh or Ca02.8H20. The 
\ icld of 'O2 from the calcium salt upon thermolysis at 50 C is observed to 
be 25 % by titration with a reactive cyclic diene, a-terpinene. This method is 
most efficient for compounds that readily undergo photooxygenation. 
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However, when physical and chemical quenching becomes important, longer 
reaction times and higher calcium peroxide diperoxohydrate loading are 
required. 
Chemical methods 
Some chemical methods ' '' used to generate 'O2 are: 
a) Murray Method: thermal decomposition of ozone-phosphite adducts 
Ph0^f\ i OPh 
PhO PhO^-OPh PhO 
cO , O 
-78-25" C Y^OPh -0P(0Ph)3 
PhO—^P. • ^ 2 
*OPh 
O -0 
b) Thermal decomposition of aromatic endoperoxides 
Ph Ph Ph 
PhH, reflux 
substrate 
Ph Ph Ph 
c) Decomposition of hydrogen peroxide with bleach 
+ ^0 , 
H2O2 + OCI •^ HO2+HOCI • H0"+H00CI • H2O + CIOO 
CIOO 
-* 01 + ^02 
This is one of the biologically significant reactions because OCI can be 
formed by the enzyme myeloperoxidase during phagocytosis 35 
Generalion of Singlet oxygen in biological systems: 
Singlet oxygen in biological systems can be generated in two different 
ways;" '^ by Might reaction' due to photoexcitation and by 'dark reaction' due 
to chemi-excitation. A major route for the process is by the type II 
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photosensitization reaction resulting in an energy transfer from triplet state 
of pholosensitizer to groimd state molecular oxygen. 
Many cellular constituents such as flavins, porphyrins, cytochromes etc. 
have the ability to generate 'O2 under illumination. The dark reactions that 
generate O2 include enzymatic reaction catalyzed by dioxygenases, 
lactoperoxidases, myeloperoxidases, cytochromes, tryptophan, pyrrolase and 
lipooxygenases. There are evidences for O2 production obtained using a 
number of purified enzyme system. Metabolic generation of 'O2 has been 
shown to occur in stimulated neutrophils. Some studies show that 'O2 can be 
derived from spontaneous rather than enzymatic decomposition of super 
oxide, llence superoxide dismutase indirectly protects from 'O2. This 
species has also been found to be generated from other reactions of 
biological relevance such as lipid peroxidation and reaction of 
hydroperoxides with peroxynitrite. 
The formation of O2 by these mechanisms is likely to be increased under the 
influence of certain xenobiotics capable of inducing oxidative stress. In the 
mammalian tissues, one of the main candidates for the production of 'O2 is 
activated polymorphonuclear leukocytes. The primary function of these cells 
is to destroy invading microbes, in response to such stimuli, the cells 
generate superoxide, hydrogen peroxide and hypohalous acid during a 
process known as "respiratory burst". Fairly large and toxic quantities of O2 
are produced during respiratory burst via reactions catalyzed by lysosomal 
myeloperoxidase. The generation of 'O2 by polymorphonuclear neutrophils 
or myeloperoxidase during bactericidal action, photosensitization and during 
lactoperoxidase activity was proved. This provided evidence showing 
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microbactericida! activity is related to 'O2 generation. Human saliva, in 
presence of low amounts of hydrogen peroxide can also generate 'O2. 
Generalion in Chloroplasl: 
The condition which favour 'O2 production, i.e., triplet excited molecules 
and ubiquitous oxygen, are likely to be found with in the active chloroplast. 
The close proximity of excited chlorophyll and an oxygen evolving system 
is thus potentially hazardous as is also an active electron transport system 
with the potential for electron donation to oxygen to yield superoxide anion. 
Superoxide is probably dismutated via a linked series of enzymes involving 
superoxide dismutase, ascorbate peroxidase and glutathione reductase.^^ 
When a chlorophyll molecule absorbs a quantum of light energy it enters in 
excited singlet state. Singlet chlorophyll has a lifetime of approximately 10"^ 
sec. The triplet state is not only potentially damaging itself in a type 1 
reactions but also by virtue of triplet-triplet interaction with ground state 
oxygen it may generate O2. Isolated chloroplast thylakoid membranes when 
incubated in absence of electron acceptors and thus likely to favour 'O2 
generation, have been shown to undergo pigment and lipid breakdown. 
These reactions were enhanced by conditions, which promoted O2 
generation and lifetime, such as high light and oxygen. 
'Oi generalion in stress conditions ,• 
A number of conditions may promote photodestruction in plants and these 
could involve generalion and action of 'O2 e.g. chlorophyll formation under 
high light conditions,'" during the incubation of leaves in the absence of 
carbon dioxide,''" under chilling conditions "' and in presence of 
photosynthetic electron transport inhibitor herbicides.'*'' Approximately half 
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of all currently utilized herbicides operate by inhibiting photosynthetic 
electron flow''^ and the inhibition of electron flow promotes the generation 
of 'Chi and hence 'O?, 
Other plant products are also reported having potential to generate 'O2 e.g. 
hypericin. Isolated from the glandular trichomes of the calyx of Hypericium 
liii-.siiiiim, is capable of generation of O2, Furanocoumarins are also 
capable of pholodynamic reactions involving the activation of oxygen. The 
phologeneration of 'O2 by furanocoumarins have now been thoroughly 
documented and indicates that they may be responsible for the direct 
disruption of membranes and enzymatic deactivation.'" 
Delection of singlet oxygen 
The techniques of O2 detection and measurement depend on the generating 
system. Some of the prevalent methods are listed below. Moreover the 
search for more sensitive and accurate procedure continues. 
1. Scavengers: Scavengers can inhibit a reaction dependent of 'O2.'"* For 
example, azide acting as a physical scavenger reacts with 'O2 to give a 
reactive azide radical, N3- + 'O^-^ Ns* + O2. Other scavengers including 
DABCO, carotene, ascorbate, thiols and histidine act as chemical 
scavengers. 
2. D2O: ChO can be used to detect 'O2 presence because the lifetime of 'O2 
is 10- fold longer in D2O than in H2O.'''' So, if a reaction in aqueous 
solution is dependant on singlet oxygen, carrying it out in D2O instead 
should greatly potentate the reaction. 
3. I.Liminescence: As O2 decays back to the ground state, some of the energy 
is emitted as light. The light from singlet oxygen appears in the infrared 
as 1268 nm.^" O2 (lAg) ^ O2 (^S- g) + hv(l268 nm) 
Other detection methods include ESR, calorimetry, photo-ionization and 
mass spectrometry. 
Chemical reactions of singlet oxygen 
Singlet oxygen is an electrophilic species and isoelectronic with ethylene. 
Functionally 'O2 seems to behave like an analogue of ethylene. Indeed, each 
of the three characteristic (fig. 1.9 and 1.9a) modes^'' '" in which 'O2 adds to 
olefins finds precedent in one of the reaction pathways of ethylene. 
1,4-cycloaddition 0 
(Diesls-Alder reaction) g endoperoxide 
1,2-cycloaddition OMe 
OMe 
^02 - -• / -I I 
0 - 0 
1,2-dioxetane 
Fig. 1.9 
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Op 
Schenk ene 
reaction 
/ \ 
concerted 
mechanism 
/ \ 
stepwise 
mechanism 
o 
. 0 . 
•0'°-^ 
J-" 
OOH 
H 
/ ^ 
allylic hydroperoxide 
0—H 
H -„,^^„ 
Hydroperoxide 
Fig. 1.9a 
The addition of 'O2 to dienes generating endoperoxides may be viewed as Diels-
Alder reaction with 'O2 as dienophile. In the 'O2 "ene" reaction, olefins containing 
allylic hydrogens are oxidized to corresponding allylic hydroperoxides accompanied 
by a K2-shift of the double bond, in 1,2-cycloaddition, the 'O2 oxygenation of 
certain C=C double bonds to yield dioxetanes is analogous to the production of 
cvclobutanes by a 2s + 2a) cycloaddition of two ethylenes. 
Oiicnching of single/ oxygen 
The quenching of singlet oxygen involves the deactivation of the excited 
state of molecule. Deactivation can be accomplished by either physical or 
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chemical quenching. Physical quenching leads only to the deactivation of 
singlet oxygen to its ground state with no oxygen consumption or product 
formation. In chemical quenching, by contrast, singlet oxygen reacts with 
quencher R to produce RO2. Two major mechanisms of O2 quenching are 
known, namely energy transfer and charge transfer quenching. 
1. Ener^^y Iransfer quenching 
I his mechanisni of quenching is the reverse of reaction by which singlet 
oxygen is formed."^ It involves formation of triplet quencher and ground 
state oxygen ('O2 + Q ^ ^Oz + 'Q) . 
2. Charge transfer quenching 
This mechanism involves the interaction between the electron-deficient O2 
molecule and electron donors to form a charge transfer complex. 
Intersystem crossing restrictions are relaxed in the complex which can then 
dissociate into donor and ground state oxygen. 
Evolution of life is the consequence of continual response to an ever-
changing environment. In the evolution only those organisms survive which 
can respond adequately. Every living being is forced to respond to the 
pressure of environment and, as a result of this, it is shaped by these 
responses. Thus, responses from an integrated part of an organism, in other 
word each animal and plant is a reflection of its environment. A delicate 
balance exists between the organisms and their environment. Interfering in 
this balance poses new problems leading to new responses; the latter may be 
damaging or profitable for the functioning of an organism. 
I^i'filtt and oxygen are ubiquitous element of our environment with a 
Ireinendous impact on life. The human body is exposed to wide array of 
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xenobiotics in one's lifetime, from food components to environmental toxins 
to pharmaceuticals and pesticides. The treatment of disease requires 
occasionally the use of either systemic or topical medication during certain 
period of time and now a days drugs have become an integral part of human 
life. The photobiological effects of drug, as pronounced in its photostability, 
photochemistry, phototoxicity and photodynamic therapy have become 
highly significant. Pharmaceuticals and personal care products are a class of 
chemicals that are continuously released into the environment through 
human activities."'One potential loss process for pharmaceuticals and 
personal care products is photodegradation. The potential environmental 
impact of these chemicals should be detected by their persistence in the 
environment and the biological activity of any degradation products. 
The use of pest control chemicals to protect the crops from damage is 
unavoidable; as we need the maximum yield possible to meet our sharply 
increasing demand of food grains. As we know, all pesticidal molecules after 
application are exposed to various biotic and abiotic components of the 
environment and are thus subjected to various physical, chemical and 
biological transformation processes. It has been demonstrated over the past 
few years that photochemical reactions play a key role in the environmental 
degradation or detoxification of various anthropogenic chemicals including 
pesticides that contain organic chromophores or metal organic complexes 
capable of absorbing light energy directly. Indirect photolysis or 
photosensitization is important especially for the pesticidal molecules 
having no chromophoric groups. Sensitization processes may be catalytic in 
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nature when the chromophore in the sensitizer molecule is regenerated by 
ihe processes of energy transfer and cyclic redox reaction. 
It is therefore important to study the photoreactivity of all common 
chemicals that may be exposed to sunlight. In the present study emphasis 
has been placed on drugs and biologically active plant metabolites. 
The molecular mechanism of biological photosensitization by drugs is 
receiving increasing attention. The interest in this subject is promoted by the 
serious toxic reaction (mainly disease of epidermis and dermis) produced by 
many pharmacologically important chemicals under sunlight irradiation. 
Photoallergic effects, generally associated to cell mediated immunity 
response, and photomutagenic effects are also of current concern. 
Intermediates and stable photoproducts generated upon light absorption by 
the drugs interact with the cell components and lead to cell degeneration or 
death. Control of the drug photoreactivity in practical situations and 
preparation of protectiv.e strategies against the light-induced damage 
requires the understanding of the structural and environmental factors 
determining the photoreactivity of the various classes of drugs and of their 
major photoproducts, the identification of the transient species formed by 
photoexcitation and the study of the reactivity of these transients with the 
biological substrates. Information on the location and the mode of 
interaction of the drugs in the biological environment is also a key point. 
Photobiology studies the interaction of light with living organisms. This 
application encompasses a number of areas including environmental 
photobiology, photomedicine, and UV photobiology, which is the study of 
the effects of ultraviolet radiation on plants, animals and humans. The 
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interest in human photobiology is currently growing for a number of 
reasons. First, sunlight is beneficial to health but overexposure as a result of 
increased outdoor activities can cause skin cancer^^ and accelerated aging of 
vital organ." Further, artificial light sources, such as fluorescent tubes and 
the new and increasingly popular high intensity lamps are now used world 
wide for lighting of large public shopping areas, factory-buildings, offices 
and private houses. As a large part of population spends much of its time in 
these artificially illuminated places, in which light intensity and spectral 
distribution differ considerably from those found outdoors, there is a 
concern about the consequences for human health. Thus, it is not only 
because of lamps used for sunbathing that the role of artificial light in 
human health and diseases has begun to receive serious at tention." Second, 
spectral distribution and intensity of daylight will change if ozone layer in 
the stratosphere, which filters out much of the short wavelength UV 
radiation.' is deteriorated by gases from, e.g., spray cans and supersonic 
aircraft. A change in the spectral distribution and intensity of daylight is 
expected to have serious consequences for human health. Third, drugs can 
also interfere in the balance between light and the human body. The effects 
may be beneficial and thus the combination of light and drug can be used as 
therapeutics. Often however, the effects are unintended and uncontrolled and 
damage of organ functions occurs. 
Spectral composition of sunlight; Subdivision of the UV radiation: 
The discovery of UV radiation and its effects on living organism was a 
gradual process that involved contribution from chemists, physicists and 
biologists. The cumulative evidence to the data indicates that UV radiation 
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has both beneficial and harmful effects depending on the type of the 
organism, wavelength of radiation and irradiation dose. Extraterrestrial solar 
radiation (200-800 nm) is essentially continuous, lacking only certain 
narrow wavelength bands because of the absorption by the sun's atmosphere. 
At midday, maximal intensity is in the region of 450-500 nm. Although there 
is little change in the spectral composition of sunlight as such, the intensity 
as a function of wavelength to which man is exposed can vary greatly 
depending, for example, on season, distance from the equator and height 
above the sea level. 
The subdivision of ultraviolet radiation (UVR) into three regions*""'^' dates 
back to early observations by photodermatologists. UVA (320-400 nm) was 
considered as innoxious and responsible for pigmentation, UVB (290-320 
nm) as a cause of sunburn and photocarcinogenicity and UVC (200-290 nm) 
as radiation, which, although photobiologically active because of its 
mutagenic and antimicrobial activity, is not relevant to human health 
provided that it is effectively absorbed by the ozone layer. 
More recent research has modified this picture; e.g., both UVB and a part of 
UVA are carcinogenic. More photobiological effects have now been 
discovered which are important for the functioning of the human body and 
whose action spectra do not fit one of these UV-regions, e.g., influence of 
the UV radiation on the immune system.*"" That UVC would not be relevant 
to human photobiology because of the above mentioned reason is a 
conclusion often drawn but incorrect because it is based upon a 
misconception of the process of light absorption. It follows fro equations 
describing radiation absorption, that a certain portion is always transmitted. 
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Whether a small amount of the UVC transmitted by the ozone layer is 
important or not, should be assessed from its photobiological effects. In this 
connection, it is of interest to know the essential biomacromolecules have 
their maximal absorption in the UVC region, e.g., proteins at c. 280 nm and 
DNA at c. 260 nm (for comparison, current knowledge of human 
photobiology would not validate the conclusion that UVR is less important 
than visible light because UVR is only a few per cent of the electromagnetic 
radiation of (200-800 nm). Althougii as shown above, tiie subdivision into 
UVA. UVB and UVC has limited value and is inevitably dated, it is 
frequently used in the literature. 
I'lioioioxic versus pholotherapeutic Xenobiotics (Drugs): 
Absorption of light by an endogenous compound or a xenobiotic in the skin 
or eyes can provoke a biological effect as a result of the following molecular 
processes. As far as the molecular processes underlying the occurrence of 
photobiological effects are concerned, there is no essential difference 
between the phototherapeutics and phototoxicons as a group; the same 
processes, a, b and c occur. One speaks of a phototherapeutic if the 
photoreaction is intentional and controlled. The later concerns not only the 
site in the body where it occurs but also the dose of the drug and the light 
(wavelength region, intensity and exposure time) applied. 
With both phototherapeutics and phototoxicons, the sequence of events, this 
eventually leads to the biological effects, starts with the absorption of a 
photon of UV-radiation or visible light. In a biological system a 
photoexcited drug or other xenobiotic can undergo a number of primary 
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reactions (Fig. 1.10). The detailed photobiological effects of an excited drug 
are indicated in Fig. 1.11. 
Biological Effect 
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M J21^ M* — ^ 
(c) 
Rection with 
endogenous compound 
Product formation by 
a unimolecular reaction 
Energy transfer to 
endogenous compounds 
Biological effect 
Biological Effects 
Fig. 1.10 
(a) Photochemical reaction of the compound as such, a unimolecular 
reaction, e.g., rearrangement, isomerization or decomposition. The 
reaction products or their metabolites can display their biological activity 
by interaction with a receptor. At present there are no reports of 
phototherapeutic or phototoxic compounds acting in this way. Yet this 
can be considered as a possibility; certainly if one takes into account that 
that interaction of a photometabolite with a receptor is an essential part 
of a normal endogenous photobiological processes in man. This process 
concerns the UVB induced rearrangement of 7- dehydrocholesterol into 
previtamin D3 and subsequent steps. The vitamin D process is also 
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important to research of the photobiological activity of the drugs, 
because it demonstrates that in the light-exposed slcin, compounds can be 
formed in an extremely low concentration, which exerts their biological 
activity in parts of the body far away from the skin. 
Unstable photoproducts can react with endogenous molecules resulting in 
a biological effect. If the half-life of such a photoproduct is long, it can 
react in inner organs after having been formed in the skin. For example, 
phototoxic imino ~N-oxides isomerizes in the UVA exposed skin into an 
oxaziridine. " The latter can irreversibly bind to biomacromolecules.^'' 
Decomposition can also involve formation of radicals,'^ '"^ which, whether 
or not coupled to oxygen, can damage biomacromolecule. For instance 
chlorpromazine photodecompose with UVA into the phenothiazine 
radical, this, in vivo, covalently binds to lipids and to proteins.^'' 
(b) Phaloreaction with endogenous molecules. An example of this is the 
irreversible binding of photoexcited psoralens to DNA as a result of 
UVA absorption in the skin. What is considered to play an important role 
in the so-called PUVA-therapy.""^° 
Photoexcited M can also abstract an electron or an H-atom for example; 
endogenous glutathione and so formed M-derived radicals can damage 
biomacromolecules such as DNA, proteins and lipids as constituents of 
membranes. 
(c) Energy transfer to endogenous compounds. This is exemplified by 
singlet oxygen formation from ^O?, which is supposed to play an 
important role in dye /visible light therapy of cancer.''''^^ Phototoxic 
compounds of quite different molecular structure can also produce 
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singlet oxygen by energy transfer, e.g., phenylpropionic acid derivatives 
used as anti-inflammatory drugs and tetracyclines. 
Bach of the essential bio(macro)molecules can be damaged by primary 
photoreactions (a), (b) and (c) fig. 1.10. Damage to DNA can lead to cell 
death but also to mutation. If DNA repair enzymes (protein) are also 
inactivated for instance by a simultaneously occurring primary 
photoreactions, mutation can be transferred and tumor formation can result. 
Photoreaction with proteins, or with lipids as constituents of membranes, 
can lead to cell death, but it can also trigger an immune response, which 
cveniually can lead to allergy, in addition to biomacromolecules such as 
DNA. proteins and membrane constituents, small endogenous molecules, 
such as glutathione, which is important to the cellular defense, are targets to 
primary photoreactions. 
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l^he biological effects which can be observed with a given phototherapeutic 
or phototoxicon depends on a variety of factors, such as: 
(1) The extent to which each of the primary photoreactions a, b and c 
occurs. 
(2) The extent to which each of the essential bio(macro)molecules is 
damaged. 
(3) The bioavailability of the given photoactive compounds and its 
metabolites, not only in the organs exposed to light but also at cellular 
level. 
For example, singlet molecular oxygen is a mutagenic species. However, 
although dyes are efficient singlet oxygen producers by energy transfer (c), 
mutagenesis is not an expected problem with the dye/visible light therapy.'"" 
'' The fact is that the dyes commonly used in this therapy accumulate in the 
lipid material of the membranes and remain outside the cellular nucleus. 
A comparable situation was found with furocoumarins: photobinding to 
DNA got by far the most attention. However, it has been demonstrated that 
8-methoxypsoralen, frequently used in PUVA therapy, photobinds in vivo 
not only to DNA but to a high extent also to proteins and lipid material of 
the epidermal cells. 
Xenobiotics are extensively used in, for example, drugs, cosmetics, food and 
agricultural chemicals. Although very useful and almost indispensable they 
can produce adverse biological (toxic) effects. // is commonly assumed that 
phololoxicity of drugs and other xenobiotics remains restricted to the organs 
exposed 10 light, namely the skin and eyes. However, there are natural 
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pholohiological processes in man by M'hich the eventual effects occurs in a 
purl of the body far from the sunlight exposed organ in M'hich 
photoexcitation of an endogenous compound took place. 
Insight into tiie molecular processes which a given phototoxicon undergo in 
vivo after absorption of UV or visible light, is a prerequisite for the 
identification of that part of molecular structure which causes the unwanted 
photobioiogicai effect. Only after this identification will it be possible to 
alter the molecular structure of the xenobiotic in such a way that the 
phototoxicity diminishes whereas desired properties remain conserved. It has 
been indicated by Beijersbergen van Henegouwen^''' that this research aim can 
be achieved by combining data from in vitro and in vivo investigations. The 
in vivo system is too complicated and without continuous help from in vitro 
research, the investigation of this cannot provide much insight. 
Photoreactivity of the phototoxic xenobiotic and structural analogues should 
be studied: 
1. In vitro, weather or not in the presence of essential bio (macro) 
molecules. 
2. In microbiological test systems (e.g., bacteria and yeast) and in cells, 
whether or not in culture. 
3. In experimental animals or human volunteers. 
Both with (1), (2) and (3), attention should be paid to the identification of 
photoproducts and to the possibility that photobinding to and damage of 
biomacromolecules has occurred. These data can provide insight into the formation 
of reactive intermediates and into the reaction mechanism occurring in vivo. The in 
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vivo system is too complicated and witiiout continuous help from in vitro research, 
the investigation of this can not provide much insight. For this reason, the above 
mentioned research lines (1), (2) and (3) should be performed in continuous 
inleraction with each other. 
The photochemical studies in the present work is an attempt to address in 
vitro photoreactivity of drugs and biologically active plant metabolites. On 
the basis of photochemical principles the many photochemical reactions now 
known have been rationalized. This is shown in many fine books of 
photochemistry,•'"'' which demonstrate both the dramatic development of this 
science in last decades and high degree of rationalization that has been 
reached. The photoreactions of drugs^^ obviously can be discussed in the 
same way. It is therefore generally possible to predict the photochemical 
behavior of a new drug, as of any other molecule, or at least to point out the 
most likely alternatives. More exactly, as it has been pointed out by 
Grenhill, ' it is possible to indicate some molecular features that are likely 
to make a molecule liable to photodecomposition, even if it is difficult to 
predict the exact photochemical behaviour of a specific molecule. 
At any rate, several chemical functions are expected to introduce 
photoreactivity (Scheme 1.1). These are: 
(a) The carbonyl group. This behaves as an electrophilic radical in the nn* 
excited state. Typical reactions are reduction via intermolecular 
hydrogen abstraction and fragmentation either via a-cleavage (Norrish 
Type 1) or via intramolecular y-hydrogen abstraction followed by Ca-Cp 
Cleavage (Norrish Type 11). 
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(b) The nitroaromatic group, also behaving as a radical, and undergoing 
interrnoiecular hydrogen abstraction or rearrangement to nitrite ester. 
(c) The N-oxide function. This rearranges easily to an oxaziridine and the 
final products often result from further reaction of this intermediate. 
(d)The C=C double bond, liable to E/Z isomerization as well as to 
oxidation. 
(e) The aryl chloride, liable to homolytic and/or to heterolytic 
dechlorination. 
(f) Products containing a weak C-H bond, e.g., at a benzylic position or a to 
an amine nitrogen. These compounds often undergo photoinduced 
fragmentation via hydrogen transfer or eJectron proton transfer. 
(g) Sulphides, alkenes, polyenes and phenols, are highly reactive with 
singlet oxygen, formed through photosensitization from the relatively 
harmless ground state oxygen. 
Such functions are present in a very large fraction, if not the majority, of 
commonly used drugs. Thus many drug substances, and possibly most of 
them, are expected to react when absorbing light. 
OH 
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Thus photochemical studies on drugs and promising drug molecules is an 
vital area of importance in current medicinal chemistry, for establishing a 
relation lo its phototoxicity. A satisfactory understanding of this 
phenomenon requires a detailed knowledge of the photochemistry of such 
molecules. In principle, photochemical reactions can only be anticipated on 
the basis of good knowledge of the possible photochemical mechanisms. To 
achieve this goal different types of study have to be undertaken: 
(a) Photophysical studies- light absorption and emission (fluorescence, 
phosphorescence) to determine the nature of involved excited states, as 
well as their energies. Laser flash photolysis for detection of triplet states 
of olher short-lived transition species that could interact with 
biomolecules. Singlet oxygen detection (steady state or time resolved 
near infrared emission). 
49 
(b) Photosensitized reactions of biomolecules- piiotodynamic lipid 
peroxidation, piiotomodification of proteins (protein photocrosslini<.ing, 
drug protein photobinding) drug piiotosensitized DNA damage (strand 
breaks, oxidative damage to bases, pyrimidine dimers). 
(c) Photochemical studies- photostability, photodegradation (isolation and 
identification of drug-derived photoproducts by chromatography and 
spectroscopy) and product-based elucidation of the photochemical 
mechanisms. 
(d) Photooxidation of drug molecules with singlet oxygen. 
In the present work we have undertaken two of the above aspects ' c ' and 'd ' 
of the drug photochemistry using some representative examples from 
established drugs and promising drug (biologically active molecules) class. 
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A collection of literature is presented here which illustrate the various in 
vilro photoreactions of the various drugs and related substances. 
Anli-histaminic and Immunosuppressant drugs: 
Among drugs with anti-histaminic action are thiazine derivative 
promethazine (1), which upon irradiation gets, N-deaikylated to 
phenothiazine (2) which in turn is oxidized to the sulfone (3) and to the 3H-
phenothiazine-3-one (4) (Scheme 1.2). Antihistaminic drug terefenadine 
(5) undergoes oxidation (main process) and dehydration at the benzylic 
position lo give products (6) and (7), respectively, upon irradiation in 
aqueous solution (Scheme 1.3). 
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The immunosuppressant drug azathioprene (8) undergoes fragmentation of 
the C-S bond to give 6-mercaptopurine (9) and 1-methyi-4-nitro-5-
h_vdro.\\ imidazole (10) as well as cyclization reaction to give (11)**" (Scheme 
1.4). 
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Scheme 1.4 
/VV>/7 steroidal anti-inflammatory drugs: 
A variety of 2-aryl propionic acid derivatives are used as anti-inflammatory 
drugs. Most of these are photoreactive and have some phototoxic action. As 
a consequence, their photochemistry has been intensively investigated. 
The main process in aqueous solution is decarboxylation to yield a benzyl 
radical, a general reaction with a-arylcarboxylic acids.^'' Under anaerobic 
conditions, benzyl radical undergo dimerization or reduction (and in an 
organic solvents abstracts hydrogen).'^ In presence of oxygen, addition to 
give hydroperoxy radical and the corresponding alcohol and ketone. 
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The results from the irradiation of naproxen (12) in water are shown in 
Scheme 1.5, and a related chemical course is followed with several drugs 
pertaining to this group, such as ibuprofen, butibufen, flurbiprofen, 
kcioprofen,^''"'"' suprofen,'^' benoxaprofen, ' " tiaprofenic acid and 
ketorolac tromethamine (16)'^'' (Scheme 1.6). 
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For Indomethacin (18) in methanol decarboxylation is the main process,^^''^ 
when mercury lamps are used, while day light irradiation leads to products 
conserving the carboxyl group which have been rationalized as arising via 
the acyl radical (Scheme 1.7) ''. In case of the related drug diclofenac (19), 
on the other hand, dechlorination as stated above is the dominant process. 
Sequential loss of both chlorine atoms is followed by ring closure, 
reasonably via radical addition, to yield the carbazole-1-acetic acid (20) and 
(21) as main products (scheme 1.8).'^ '* The anti-inflammatory agent 
mcclofenamic acid (22) likewise undergoes dechlorination and ring closure 
to the carbazoles (23) and (24) (Scheme 1.9).'^ '^  
Photoreactivity has been reported also for some anti-inflammatory and 
analgesic drugs different from aryl acetic acid. 
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G lucoc or ti CO steroids: 
The photoreactivity of glucocorticosteroids have been explored both in 
solution as well as in solid state and it is well known that they have to be 
protected from light. Hydrocortisone (25), cortisone (27) and their acetates 
(26, 28) undergo photooxidation in the solid state. The main process 
involves loss of the side chain at C-17 to give androstendione and trione 
derivatives respectively (Scheme 1.10).'°^ Molecular packing has an 
important role in determining the photostability in the solid. As an example 
irradiation of crystalline hydrocortisone tert- butylacetate leads to the 
photooxidation of two over five of the polymorphs investigated. This fact 
has been correlated with the possibility of oxygen to penetrate in the crystal 
in such structure 104 
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Cross conjugated glucocorticosteroids such as prednisolone (29), prednisone 
(30), betamethasone (31), triamacinolone (32) and others are quite 
' ' ' * „ • ' : - ' ' ' 
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photoreactive, as one may expect, since the efficient piiotorearrangement of 
cycloliexadienones to bicyclo[3.1.0] iiexanones is well known. '° ' This 
rearrangement has been observed for dexamethasone, prednisolone, 
prednisone, betamethasone and some of their acetates (Scheme 1.11).""''"'^ 
The primary photoproducts may undergo further transformation with 
cleavage of the three membered rings resulting in re-aromatization or 
cleavage of ring A or in expansion of ring B. 
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Drug acting on central nervous system: 
5,5-Alkyl derivatives of barbituric acid (33) are used as hypnotic and 
tranquillizers. These compounds undergo two types of photochemical 
reactions (Scheme 1.12). In first type of reactions cleavage of the C(4)-C(5) 
bonds takes place which leads to the formation of an intermediate isocyanate 
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(path a), which in turn adds nucleophiJic solvents to give an amide (34) in 
water and urethane (35) in ethanol. The positive evidence for the formation 
of isocyanate has been obtained by irradiation in the solid state.""* Barton et 
al. studied similar type of reaction pattern in case of barbital (36, R, 
R"=Et, R"=H) and its methyl derivative (37, R, R'=Et, R"=Me) . The second 
one involves cleavage of second C-C bond with the elimination of CO (path 
b). Barton et al. ' obtained similar reaction pattern with mephobarbital 
(38, R=Et, R'=Me, R"=H) which leads to hydantoin (39) as product. 
Different process occurs for the acidic forms of cyclobarbital (40), which is 
photooxidized to ketone (41) rather than cleaved (Scheme 1.13). 
CHRR' NHCOOH 
I 
R" 
(44) 
CHRR' NHCOOEt 
CHRR' NH2 
O' 
R"orK™. 
I 
R" 
I 
R" 
(34) 
Scheme 1.12 
For the tranquillizer proxibarbital (42) it was suggested that a nucleophilic 
group in the side chain intervenes in the process via intermolecular addition 
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and gives the tetrahydrofuran (43) (Scheme 1.14)."'^ Monoalkylbarbiturates 
(44) undergo hydroxylation at position 5."^ 2-Thio analogue of 
i^henobaibital (45) gives (46) by selective reduction of the thiocarbonyl 
function by irradiation in alcohols (Scheme 1.15). 
hv 
Scheme 1.13 
M 
^ 
e 
O"' 
0 
y ^ N H 
1 
R" 
(42) 
hv 
HpNOCHNOC 
(43) 
Scheme 1.14 
Ph 
J 
0 
1 
H 
(45) 
hv 
i-PrOH 
0 
1 
H 
(46) 
Scheme 1.15 
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Benzodiazepines: 
They are generally photolabile, but the path followed in the degradation 
depends on the structure of each derivative and on the reaction condition. 
Moore et al. ' obtained benzophenone (48) as main product by the 
irradiation of diazepam (47) at 300 nm in iVleOH-H20 through the cleavage 
of heterocyclic ring, and dihydroquinazoiine (49) by irradiation at 254 nm in 
methanol. This compound then slowly isomerizes to (50) as well as to (51) 
and (52) through dechlorination and oxidation (Scheme 1.16). 
hv, 254 nm 
Ph 
MeOH/HjO 48 + 
Me 
(47) 
N-
/ O 
hv, 320 nm 
MeOH/HjO (51)R=H,(52)R=CI 
CU pH-7.4 ' ' ^ ^ ^ COPh 
NHMe 
(48) 
Scheme 1.16 
I 16 ,1 17 Andersin et al. ' studied intravenous anaesthetic midazolam (53) which 
undergo ring restriction to quinazoline (54) as well as oxidation to 5-
fluorophenyi moiety to give (55) and (56) (Scheme 1.17). Roth et al. 
obtained different reaction pattern in case of nitrazepam (57) because of the 
insertion of nitro subsistent, this abstracts hydrogen and reduced to azoxy, 
azo and amino function by irradiation in organic solvents under nitrogen. 
The hypnotic flunitrazepam (58) undergoes a multi step reduction finally 
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leading to the 7-amino derivative under anaerobic conditions.' While it 
is N-deinethyiated to give (59) in presence of oxygen (Scheme 1.18) 
' ^ ' ^ . 
o 
NH 
K 
N' Me 
(56) 
Scheme 1.17 
Ar 
0,N hv a N=N Ar 
N 
R' ° 
(57) A r = P h , R= H 
(58) Ar = 2 - F - C 5 H 4 , R = Me 
(59) A r = 2 - F - C 6 H 4 , R = H 
' 0 
Scheme 1.18 
Chlorodiazepoxide (60) in which photochemically active moiety N-oxide is 
present rearranges to oxaziridine (61) and further reacts to give compound 
(62) and (63) through ring contraction and ring expansion respectively. " ' 
The solid state photochemistry of chlordizepoxide'"'^ gave quinazoline (62) 
and ring opened product (65) and (66). Cornelissen'^'' also studied same 
compound in presence of reducing agent such as glutathione where the main 
observed process is N-deoxygenation to (64) (Scheme 1.19). 
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O Ph 
NHMe ^ ' V ^ ^ ^ ' • 
NHMe 
(65) (66) 
Scheme 1.19 
AnHhyperlensives: 
4-nitrophenyldihydropyridines are widely used as vasodilators and due to 
presence of hydrogen abstracting nitro group and easily abstracting benzylic 
hydrogen these drugs are considered to be quite photoreactive. Reduction of 
nilro (o nilroso group of heterocyclic ring and re-oxidation of nitroso group 
in the presence of oxygen are mainly observed reaction paths (Scheme 1.20). 
Nifedipine (67), the 4-nitrophenyldihydropyridine derivative, shows similar 
type of reaction pattern.'"^''^'' Other nitrophenyldihydropyridine derivative 
62 
such as nicardipine (68),'^^ furnidipine (69)'^'* and nimodipine (70)'^° also 
photoreact in tlie similar manner. 
R'OOC 
Me N Me 
I 
H 
or solid 
NO, 
COOR hi/ R ' O O C ^ v , /COOR O2 . R'OOC 
solution | ( ^ 
Me N Me 
(67) R,R' = Me, 2-NO2 
(68) R= Me, R' =[(N-methyl-N-benzyl)-2-aminoethyl] 
(69) R,R' =Et, 2-tetrahydrofurylmethyl 
(7(D) R, R' =/so-propyl, 2-methoxyethyltetrahydrofurylmethyl 
Scheme 1.20 
Diltiazem is stable in solid state'^' but on irradiation of aqueous solution at 
different pH it gets deacetylated. Karlicek et al., " on irradiation of aqueous 
solution of ergotamine under nitrogen atmosphere, obtained product due to 
hydration of double bond at 9,10 position. Reserpine (71) photoreacts both 
in aqueous solution and in chloroform and the process occurring are 
epimerization at C-3 and stepwise dehydration of the tetrahydro carboline 
skeleton'"''^''(Scheme 1.21). 
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MeO 
MeO OMe 
Scheme 1.21 
Antibaclerials: 
Golpashin et al.'^'' studied several N-substituted sulfanilamide derivative 
and reported that yields of products changes with the structure. The main 
process takes place is the cleavage of C-S and S-N bonds with the 
elimination of SO2 and formation of aniline (72) and appropriate amine (73) 
(Scheme 1.22). Chiang et al.'^ *^ observed that methylation of amino group 
take place on irradiation of sulfadimetoxine in methanol. Irradiation of 
sulfacetamide (74) in water yielded deacetylated product sulfanilamide (75), 
which undergoes oxidation of the amino group to give the azo (76) and the 
nitro (77) derivative,'"''' when irradiated in water. In ethanol'"^^ the formation 
of 2-methylquinoline-6-sulfonamide (78) accompanies the above process 
(Scheme (.23). 
R = C-NHBu —C-NH2 ^ 
NH 
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hi/ 
NH, 
+ RNH2 
(72) (73) 
Scheme 1.22 
OMe 
OMe 
hv 
H,0 
SO2NHAC 
(74) 
H2O2NS. O ^ Toioi <'"^ '°"^  
N Me 
SO2NH2 
(77) (78) 
Scheme 1.23 
Darvis at al.' and Moore et al. carried out irradiation of aqueous 
solution of tetracycline (79) under aerobic condition where homolytic 
deamination with the addition of oxygen, resulted in the formation of 
quinine (80) (Scheme 1.24). Chlorotetracycline on irradiation in aqueous 
buffer solution at pH 7.4 undergo homolytic dechloroniation. '*' 
NMej 06 O HO ,Me H 
OH h\/ 
OHll 
OH 0 OH 0 
(79) 
CONH, °2 
OH 
CONHo 
OH 
CONH. 
Scheme 1.24 
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Aqueous solution of chloramphenicol (81) gives 4-nitrobenzaldehyde (82), 
glycolic aldehyde (83) and dichloroacetamide (84) by the homolytic 
cleavage of C-C bond. The resulting product 4-nitrobenzaldehyde undergoes 
secondary photoreaction and leads to amino and nitro benzoic acid as well as 
aniinobenzaldehyde oxime'''""''''' (Scheme 1.25). 
,—^ OHNHCOCHCI2 / — \ CHO 
0 2 N ^ Q ^ C H C H C H 2 0 H '^ ^ . O z N - ^ ^ Q ^ C H O + ^ ^ Q ^ + CHCI2CONH2 
(81) (82) (83) (84) 
Scheme 1.25 
The urinary anti-bacteria) nitrofurantoin (85) is cleaved to nitrofuran 
carboxaldehyde upon UV irradiation. Furazolidone (86) is cleaved and 
h}drolyzed to nitrofuran carboxaldehyde (Scheme 1.26). '''^  
O 
0 2 N - . ^ C H = N - N ^ J _ M ^ _ 0 , N . ^ C H O ^ NO,CH20CH,CH=NNHCONH, 
(85), X = NH, Y = CO 
(86), X = 0, Y = CH2 
Scheme 1.26 
Among five membered heterocycles metronidazole (87) and related 
antibacterials show typical nitro group photoreactions.''**'''' This is initiated 
by typical nitro-nitrite rearrangement to give (88) followed by shift of NO 
group to vicinal position. Hydrolytic ring opening-ring closure from oxime 
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leads to 1,2,4-oxadiol-3-carboxamide (89) which finally hydrolyzed to 
oxaldiamides (90) (Scheme 1.27). A different photochemistry of 
metronidazole was observed in presence of citrate. '"^ Irradiation of six 
membered heterocyclic drug isoniazid (91) in ethanol caused oxidation of 
ethanol to acetaldehyde which is trapped by substrate to yield hydrazone 
(92) which again reacts with a molecule of ethanol to give (93)'^° (Scheme 
1.28). Trimethoprim'^ (94) undergoes oxidation at benzylic position and 
hydrolysis of amino group in pyrimidine ring to yield (95) and (96) (Scheme 
1.2Q). 
R 
(87) 
/7V 
R 
I 
M e ^ ^ N ONO 
(88) 
RHN 
Me. 
O 
(90) 
R 
I 
OH 
NO 
NH2 y^y 
Me- .0., N 
^ N H R 
O 
(89) 
R 
M e ^ ' ^ ' N j ^ O 
N-
NOH 
H2O 
RN 
M e ^ NH-<\ 
N-OH 
Scheme 1.27 
CONHNH, 
LQ 
N 
(91) 
hy 
EtOH 
CONHN=CHMe 
o 
N 
(92) 
OH 
CONHNHCHCHMe 
Me 
(93) 
Scheme 1.28 
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OMe 
MeO^ J^ ^N^ ,NH2 
MeO' N 
NH2 
(94) 
hv 
OMe 
MeO" ~"^ ^ i ^ N ^ ^ MeO 
OMe 
^N OH 
(96) 
Scheme 1.29 
Fluoroquinolones: 
Quinolone antibiotics bearing fluorine substituent, such as norfloxacin (96a) are 
commonly called tluoroquinolones. The photobehaviour of fluoroquinolone 
antibiotics has recently been the object of increasing interest due to the finding of 
their photosensitizing properties. '~ The main result obtained for a series of 
structurally related, representative fluoroquinolone drugs is reviewed.'^ ^ Both 
activation of oxygen and various degradation pathways have been identified and the 
effects of medium and structure have been rationalized. The results can help in the 
understanding of the photochemistry occurring in biological environments and in the 
assessing of the correlation between structural characteristics and biological 
photodamage. 
Aiiliprolo'zoul drugs: 
Photochemistry of antiprotozoal drug quinine occurring in citric acid 
solution has been extensively studied'^'' and this drug is well known to be 
photolabile.'" Photochemical oxidative degradation of alkyl amino chain is 
the main reaction path observed in the majority of this class drug. 6-
Alkylamino derivative primaquine (97) 156,157 4-alkylamino derivative 
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amodiaquine,'^^ hydroxychloroquine (98)'^' and chloroquine (99)"^0""'2 
undergo degradation of alicylamino side chain (Scheme 1.30, 1.31 and 1.32). 
Tonnesen and Grislingaas"'^ found that mefloquine (100), on irradiation in 
methanol produces (101) and (102) (Scheme 1.33). 
Me 
NHCH(CH2)3NHMe 
Me 
NHCHX 
MeO. ^ ^ ^ / k 
(97) 
hv MeO. 
H2O, pH=7.4 
X = CHzCOCHzNHMe, 
COCHjCHgNHMe, 
COCH + CHNHMe, 
CH2COCH + CH2, 
Scheme 1.30 
Me 
NHCH(CH2)3N' 
,CH2CH20H 
Et 
hv 
H,0 
Me 
NHCH(CH2)3X 
+ Further Products 
X = NHEt, NHCH2CH2OH, H 
Scheme 1.31 
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Me 
NHCH(CH2)3NEt2 
hv 
(99) 
Me 
NHCH(CH2)2X 
cr ^ ^ N 
X = CHzNHEt, CH2NAC, OH Y = NH2, 0-i-Pr, Et 
Scheme 1.32 
hv 
MeOH 
(101) X = COOMe 
(102) X = CH20H 
Scheme 1.33 
Antineoplastic drugs: 
Morton et al.'^ "* observed that irradiation of dacarbazine (103) in solution 
causes dimethylamine elimination to yield diazo derivative (104), which is 
further hydrolyzed to give hydroxyimidazole (105). This hydroxyimidazole 
in turn couple with diazo derivative (104) to give azo derivative (106). 
Alternatively (104) cyclize to give 2-azahypoxanthine (107) (Scheme 1.34). 
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(107) 
C0NH2 
(105) 
^CONHp 
Scheme 1.34 
An investigation of photochemistry of anti-tumor antibiotics, hedamycin and 
l<idamycin has been reported."'^ 6-Mercaptopurine (108) is oxidized when 
irradiated in oxygen equilibrated aqueous solution by near U.V light giving 
sulfinate (109) as the primary product, which is finally oxidized to sulfonate 
(110) (Scheme 1.35)."''' Several other anti-neoplastic drugs as alkaloid 
vinblastine sulphate, carmustine, tauromustine and mitonaftide were found 
to be photochemically unstable. 
SH 
(108) 
hv 
O2, H2O 
SOOH 
(109) 
SO3H 
N' N 
H 
(110) 
Scheme 1.35 
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The neuroleptic drug levomepromazine is pJTotolabile under UV-A and UV-
B liglit in aerobic conditions. Irradiation of a methanol solution of this drug 
produces one photoproduct, resulting from the oxidation of 
levomepromazine. It is demonstrated that photodegradation occurs via type 
II mechanism involving irreversible trapping of self-photogenerated singlet 
molecular oxygen. 
The photoreactivity of phototoxic anti-cancer drug flutamide has also been 
studied in homogenous media, cyclodextrin cavity and liposomes.'^^'"'^ 
Gonadotropic steroid and synthetic estrogens: 
Synthetic estrogens are generally the stilbene derivatives. They undergo fast 
R-Z photoisomerization, and trans fused dihydrophenanthrene is formed by 
the conrotatory electrocyclic ring closure of the Z-isomer, which in turn gets 
aromatized in presence of oxidants such as atmospheric oxygen. Thus 
clomiphene ( I l i a ) , when irradiated in chloroform solution gives 
phenanthrenes (112) and (113)'^° (Scheme 1.36). Cyclization is also 
observed with temoxifen (111b) . ' " Dihydroxy substituted stilbenes such as 
dienoestrol (114) and stilboestrol (115) are like wise cyclized'' '""''" (Scheme 
1.37 and 1.38). 
Ph R 
hv 
EtjNiHjCjjO 
(111a), R=CI 
(111b), R=Et 
CHCI3 
Et2N(H2C)20 
(112) 
Scheme 1.36 
Et2N(H2C)20 (113) 
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(114) 
Scheme 1.37 
Et Et 
Scheme 1.38 
The pheiKDiic ring present in the estrogens maizes them quite labile to 
photooxidation. The reaction can be conveniently carried out by 
photosensitization, under conditions where singlet oxygen is produced 
avoiding direct irradiation of the substrate. Sedee and co-worker''^ observed 
that photosensitized reaction of estradiol (116) involve singlet oxygen 
addition to electron rich phenolic ring to yield ketohydroperoxide (117). 
Similar reaction pattern was obtained in case of estrone (118) (Scheme 
1.39). 
»0H 
(116) X = C, 
C^CH 
(118) X= C = 0 
hv 
O, 
Scheme 1.39 
(117) 
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When photolysis is carried out in solid state different reaction paths are observed. 
Reisch et al.'^^'^^ have reported that testosterone (119) yielded androstenedione 
(121) and androstanedione (122), while 17- methyltestosterone (120) gives seco-
derivative (123) (Scheme 1.40). Levonorgestrol and ethisterone are photodimerized 
1 70 1 R(l 
in solid state under nitrogen atmosphere. ' Testosterone propionate (124) gives 
dimer (125) when irradiated in solid state (scheme 1.41) 181 
(119)F^ = H 
(120) R = Me 
R = Me 
R = H 
(123) 
Scheme 1.40 
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(124) 
hv 
Solid 
EtOCO' 
Me .OCOEt 
Scheme 1.41 
Anti-diuretic Drugs 
The phototoxic diuretic drug furosemide (126) is photoiabiie under aerobic 
and anaerobic conditions. Irradiation of methanoiic solution of furosemide 
under oxygen atmosphere gave photoproducts 127, 128a, 128b and 129, 
while under argon atmosphere the photoproduct 127 and 128a were 
isolated ~ (Scheme 1.42). A peroxidic unstable product was also detected 
during the photolysis under oxygen atmosphere. Furthermore, a 
photocycloaddition of singlet oxygen to furan group of furosemide was also 
detected. 
GOGH 
GOGH 
H,N0-,S 
NHGH; Ar 
H2NO2S C; NHGH: ,\ // + 128a 
(127) 
Gl 
(126) 
127 
H2NO2S 
NHGH; GGOH 0 
Gl H2NO2S 
(128a), R=H 
(128b), R=GH 
Gl 
(129) 
Scheme 1.42 
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The phototoxic diuretic drug chlorthalidone (130) is photolabile under 
aerobic conditions and UVB light.'^"''^^ Irradiation of this drug under 
oxygen atmosphere produces photoproducts 131, 132, 133 and singlet 
oxygen (Scheme 1.43). 
NHOH 
(133) 
Scheme 1.43 
The phototoxic antidiabetes drug glipizide, a benzosulfonamide derivative, 
was also photolabile under aerobic conditions and UVB light.'^'' 
1 QC 
Hydrochlorothiazide (134) dimerized upon irradiation with a medium 
pressure Hg arc lamp through a glass filter in deaerated aqueous or alcohol 
solution to give (135) (Scheme 1.44). 
H2NO2S 
CI 
O 0 
~NH 
(134) 
Scheme 1.44 
Photooxidation of troglitazone, an antidiabetic drug, gave the quinone and quinone 
epoxide as the major products.'^ "^ Photooxidation of the ophthalmic drugs pindolol 
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and timolol in water was reported to involve singlet oxygen.'**^ Photooxidative 
degradation of papaverine '^ ^ and clomipramine'^'has also been reported. 
Plant derived natural products 
The neem triterpenoid nimbin (136) on photo-oxidation produced two 
isomeric products (137, 138) containing a hydroxybutenolide moiety, formed 
by the reaction of singlet oxygen with the furan ring."" (Scheme 1.45). 
HO'^  
HO o 
o 
OH 
(137) 
Scheme 1.45 
(138) 
Latifolin (139), the major constituent of D. latifolia on photolysis gave 
iraiis-] -(2,4-dimethoxy-3-hydroxyphenyl)-2-(2-hydroxyphenyl) 
cyclopropane (140) as the sole photo di-H-methane rearrangement product. 
In contrast, its analogues, 3-(2,4,5-trimethoxyphenyl)-3-phenyl-prop-]-ene 
(141) and 3-(2,4-dimethoxyphenyl)-3-phenyl-prop-]-ene (142), gave a 1:1 
mixture of c/.v- and //•an.y-cyclopropanes. Dye-sensitized photooxidation of 
latifolin and dihydrolatifolin (143) gave novel xanthan derivatives (144) and 
(145) involving a crucial step of photooxidative demethylation followed by 
cyclization. Similar reaction of the closely related propenyl compound 146 
gave, interestingly the benzofuran (147). The propane (148), lacking free 
hydroxyl or double bond, gave only the quinone (149), indicating that 
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quinones are intermediates in tiie above oxidations. The cinnamyl alcohol 
(150), having similar feature, undergoes oxidation to the corresponding 
aldehyde (151) and the benzophenone (152) but not to a quinone''^' (Scheme 
1.46). 
H j C O ^ / ^ , /OCH3 
(139), Ri=R2=0H 
(141), Ri=0CH3, R2=H 
(142), Ri=R2=H 
H,CO 
(144), R= CH=CH2 
(145), R= CH2CH3 
H,CO, 
(149) 
(140) 
OCH, 
(146) 
.OCH, 
(143), Ri=R2=0H 
(148), Ri=OH, R2=H 
H,CO 
(147) 
(150), Ri=R3=H, R2=0H, R4=CH20H (152), Ri=R3=H, R2=0H, 
(151), Ri=R3=H, R2=0H, R4=CH0 
Scheme 1.46 
3-.Substituted cholesterols (153) and 7-substituted pseudocholesterols (153a) 
undergo a facile photooxygenation sensitized by 9, 10-dicyanoanthracene 
(DCA) and lumiflavin (LF) to give similar, oppositely-positioned enol 
derivatives (154, 155) (Scheme 1.47). Both steroids showed the same 
^ 
64/-© _ 1 ' 
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reaction pattern associated with tlie endocyciic 5- and 4-olefin units, 
respectively. Tlie reaction was proposed to proceed via tiie ene reaction of 
singlet oxygen and subsequent rearrangement of tlie initially formed 5a-
hydi'operoxides. 
PsHi? 
(153) 
R= H, CH3, CH3CO DCA or LF 
k 
or hv/Oz 
CRHI7 
Scheme 1.47 
Photosensitized oxygenation of 3-hydroxyflavones 156a and 156b in the 
presence of rose bengal, gave corresponding depsides 157a and 157b, carbon 
193 
monoxide, or carbon dioxide (Scheme 1.48) 
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(156a), R=OMe; R'= H 
(156b), R=R'= H 
hv, O2 
Rose bengal 
R OH 
-CO 
O 
COOH 
(157a), R=OMe 
(157b), R= H 
O 
CO-COOH 
Scheme 1.48 
Pliotooxidation of 4-amorphen-l l-ol (158), one of the major sesquiterpene 
natural products from the medicinal plant Fabiana imbricala, results in three 
allylic hydroperoxides""* (159, 160 and 161), which are expected from the 
"ene-type" reaction of molecular oxygen with the tri-substituted double bond 
in 158. The tertiary allylic hydroperoxide 159 undergoes carbon-carbon 
bond cleavage and a second autoxidation reaction to yield the more highly 
oxygenated .seco-amorphane 162 under mild conditions (Scheme 1.49). 
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1_ HOO, 
Scheme 1.49 
The key step in the synthesis of spongianolide A (164), an antitumoral 
natural sesquiterpenoid, involved the photooxygenation of 
trimethylsilylfuran''^"^ (163) as shown in Scheme 1.50. 
(163) 
OiJPP.hv, CH2CI2 
•78°C,30min 
Scheme 1.50 
A stereoselective synthesis of zoantiiamine (165), potent anti-inflammatory 
alkaloid, was accomplished by a strategy involving photosensitized 
oxidation of furan derivative in the key step"^ (Scheme 1.51). 
TMS 1 ^02, hv, 0°C 
RB, CH2CI2 
2, sat. NH4CI aq 
3. TMSCHN2 
CH2Cl2-MeOH 
^Q CHOOMe 
(165) 
Scheme 1.51 
Sometimes dioxetanes are the primarily detected as photooxygenation 
adducts in the reaction of benzofurans, naphthofurans, naphthodifurans, 
furonaphthopyrones as (166), which finally leads to characteristic cleavage 
products (Scheme 1.52). An anomalous behaviour has been observed in the 
photooxygenation of furanopyrone (167). Indeed differently from 166 which 
give the corresponding dicarbonyl compound, 167 lead to stable 
hydroperoxide (168) by an ene-type reaction (Scheme 1.53). 
H,C 
,0 H3C O. 
O2, TPP, hv fl 
— " O 
(166) 
Scheme 1.52 
CHO 
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H,C 
HX 
(167) 
HOO. 
H,C 
H,C 
(168) 
Scheme 1.53 
The most significant application of tJTe photooxygenation of indole 
derivatives is in the synthesis of ali<:aloids."°" The photooxygenation of 
1,2,3,4-tetrahydrocarbazole is the starting step in the synthesis of spiro 
derivatives, which would be used as a starting material for the synthesis of 
spiro analogues of the ergot alkaloid (Scheme 1.54). 
CK 
_,H00 _ ^ 
polymer ^^^^^^Kf~~^ 
supported 
RB 
10% v = ^ •)^^ 
N 
10°/ 
Scheme 1.54 
The pholooxidative double bond cleavage has been usefully adopted for the 
construction of large heterocyclic rings containing a carbonyl group. 
Utilizing this type of reaction the quinine alkaloid camptothecin has been 
synthesized by quinoline, obtained via photooxygenation of indole (169), 
followed by the basic treatment of the resulting keto-amide (170)^°' (Scheme 
1.55). 
H 
'COOMe 
COOt-Bu 
Scheme 1.55 
Tryptophan (171) on reaction with oxygen molecule in the presence of 
riboflavin or methylene blue as a photosensitizer yields N-formylkynurenine 
(172) and its derivatives." "•' The hydroxide (173) has also been found by 
reduction of the crude oxygenation mixture, it gives oxytryptophan (174) 
under acidic conditions" (Scheme 1.56). 
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Scheme 1.56 
The variety in molecular structure of the phototoxic drugs is immense, and almost 
all classes of drug compounds contain members with adverse photobiological 
effects. A knowledge of the part of the molecular structure which is responsible for 
the phototoxicity of a particular drug can provide the opportunity to alter a 
phototoxicon in such a way that the adverse photobiological effects diminish while 
the desired ones remain conserved. This aim can be reached more efficiently by 
combining photoreactivity data from both in viiro and in vivo investigations. The in 
vivo system is too complicated and without continuous help from in vitro research, 
the investigation of this cannot provide much insight. Therefore, we have carried out 
in vitro photochemical studies on certain synthetic drugs and biologically active 
natural products, as described in the following chapters. 
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Chapter 2 
Photochemical Studies on Acyclovir and 
Phenazopyridine Hydrochloride 
86 
Introduct ion 
The treatment of disease requires the use of either systemic or topical 
medication during certain period of time. Frequently the treatment coincides 
with exposure to electromagnetic radiations, coming from different types of 
sources (sunlight in works made outdoor and intense artificial radiation used in 
specific works etc.). This coincidence may lead to photobiological effects such 
as drug photosensitization, phototoxicity, photodegradation etc. The molecular 
mechanism of biological photosensitization induced by drugs and their phototoxicity is 
receiving increasing attention. '^  With regard to the mechanistic pathways, it is accepted 
basically the four paths as main routes for phototoxic reactions,^ namely singlet oxygen 
formation and its reaction with drug, radical formation, covalent photobinding to 
hiomolcculcs andphotoproducts in decomposition reaction. 
Studies on both, the drug induced singlet oxygen formation and its reaction with drug 
and photodegradation of drugs are relevant to drug development process, because the 
photoproducts may have biological effects different from those of parent compounds. 
These studies are of high significance in current medicinal chemistry as this may 
explain, at least partially, phototoxicity mechanism. 
With this interest herein we have investigated: 
I A]. I. Photooxidation of acyclovir in aqueous solution. 
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[A].2. Photooxidation of acyclovir by thermally generated triplet excited ketone 
from 1,2-dioxetane and its comparison with type 1 and type 11 
photosensitizers. 
[B] Photochemistry of Phenazopyridine hydrochloride. 
Section [A] 
Photooxidation Studies on Acyclovir 
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|A]. 1. Photooxidation of acyclovir in aqueous solution 
Acyclovir (9-[(2-hydroxyethoxy) methyl] guanine) (Ac, 1) is an antiviral drug 
used for the treatment of herpes encephalitis caused by herpes simplex virus or 
varicella zoster infections. Acyclovir is mainly used to treat chickenpox, 
shingles, and the symptoms of herpes virus infections of the genitals, lips, 
mouth, skin, and brain. The medicine does not cure the infections, but it 
relieves the discomfort and speeds healing of sores, when they are present.^ 
Although acyclovir has a large therapeutic index and usually well-tolerated, 
acute renal failure and neurotoxicity are two important potential adverse effect 
of this drug.^'^ It is metabolized, probably by alcohol dehydrogenase and 
aldehyde dehydrogenase, to 9-carboxymethoxymethyl guanine and to a smaller 
extent to 8-hydroxy-9-(2-hydroxyethoxymethyl) guanine (8-OH-Acyclovir).'' 
Acyclovir is structurally related to deoxyguanosine and with photoactivatable 
chromophores and electron rich heterocyclic ring it is prone to photochemical 
transformation, including reaction with the electrophilic singlet oxygen. 
Exper imenta l 
Chemicals 
All chemicals used were of analytical grade. Acyclovir was extracted, from the 
commercial medicament Acivir (Cipla Limited, Mumbai, India) with a soxhlet 
extractor using methanol as the solvent and recrystallized from the same 
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solvent. Melting point, ' H - N M R and co-TLC with the authentic pure sample 
determined the purity of acyclovir. 
Appunilus 
Irradiations were carried out in a photoreactor equipped with medium pressure 
mercury vapour lamp (Philips, 450 W) inserted in a water-cooled immersion 
well with continuous supply of water. The incident photon flux of the 
irradiation setup was 9.78 x 10"''einstein/min as determined by using 
ferrioxalate actinometry.' IR spectra were recorded as KBr discs on a Perkin 
Elmer model spectrum RXl. ' H - N M R and '"'C-NMR spectra were recorded on a 
Bruker DRX-300 spectrometer using SiMe4 as internal standard. ElMS and 
FAB-mass spectra were recorded on VG-ZAB-HS and Jeol SX 102/DA-6000 
mass spectrometers at 10 KV accelerating voltage spectrometer using m-
nitrobenzyl alcohol (NBA) matrix and argon as FAB gas, respectively. High 
resolution mass spectra were determined with a VG-ZAB-BEQ9 spectrometer at 
70 eV ionization voltage. 
Pitotooxidation procedure 
Irradiation of an aqueous solution of Ac (5 mM) in 50 mM phosphate buffer 
(pFl 7) was carried out in, the absence and in presence of rose bengal (O.lmM) 
as sensitizer, with medium pressure mercury vapour lamp. The solution was 
continuously stirred during photolysis and the temperature of the solution was 
kept at 15°C during irradiation by cooling with a water streamer immersed in 
the solution. A corex filter transmitting above 270 nm was used for photolysis 
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of Ac. Progress of the reaction was monitored by tiiin layer chromatography. 
Ai'ler 6 h of irradiation, removal of solvent in a rotary evaporator (30°C) and 
silica gel column chromatography (chloroform : methanol) of the photolysate 
yielded compounds 2, 3 and 4 as products. The above photoreaction was also 
examined in deuterium oxide and in the additive presence of sodium azide (1.0 
mM). for establishing the involvement of singlet oxygen in this photoreaction. 
Polci.ssiiim Ferrioxalale Actinometry 
The amount of ferrous produced is measured via spectrophotometric 
determination of its 1, lO-phenanthroline complex at 510 nm. Ferric apparently 
forms only a weak complex with 1, 10-phenanthroline, and this complex is 
transparent at 510 nm. 
2Fe^+ + 0 2 0 4 2 - - ^ 2Fe2+ + 2CO2 
Preparalion of Actinometer solution 
1. Fe2(S04)3 solution (0.2 mol/L) was titrated with standardized EDTA 
using 0.2 gm salicylic acid/100 mL solution as indicator and buffered 
with 0.3 gm glycine/100 mL solution, to a pH of 3-4. 
2. A 100 mL solution of K2C2O4 was prepared in such a way that its 
molarity is six times that of the Fe2(S04)3 solution (approximately 
1.2 mol/L K2C2O4). 
3. When actinometer solution was needed, 5mL of Fe2(S04)3 solution 
and 5 mL of K2C2O4 solution was pipetted into a 100 mL volume 
flask and diluted to the mark with water. 
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Intensity Measurement 
a) A volume of K3Fe(C204)3 solution equal to that of the samples to 
be irradiated was pipetted into the reaction vessel. 
b) Irradiated for an appropriate period of time. 
c) Irradiated solution was mixed thoroughly and an aliquot (ImL) of 
the actinometer was pipetted into a 10 mL volumetric flask. 
d) 2 mL of 0.2 % 1,10-phenanthroline solution was added to this. 
e) A volume of buffer equal to one half of the aliquot of the 
actinometer taken was added and diluted to the mark with water. 
f) A blank was prepared by following the steps c-e with a non 
irradiated volume of actinometer equal to the aliquot of irradiated 
sample withdrawn. 
g) The absorbances of the solutions ' e ' and ' f were measured vs. 
water at 5 1 0 nm and difference was taken. 
Calculation of light intensity: using the absorbance obtained the light intensity 
was calculated from the following formula. 
AV2V3 
/ (einsteins/min) = 
sdtpxtVi 
Where 
A Absorbance (at 510 nm) of the irradiated actinometer solution corrected 
for absorption of blank. (0.83 1) 
d Path length of the absorption cell used in measurement of A (1cm). 
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£ Extinction coefficient of ferrous 1, 10-phenanthroline complex at 510 nm 
(1.1 |x]O^L/mol/cm). 
cp). Quantum yield of ferrous production at wavelength of light used. (1.03) 
V| Volume (in milliliters) of irradiated actinometer solution withdrawn. 
VT Volume (in liters) of actinometer irradiated. (0.20 L) 
V', Volume (in milliliters) of volumetric flask used for dilution of irradiated 
aliquot (10 mL). 
t irradiated time (150 min). 
Chuiacleriztition of products 
(2-Hydroxyethoxy) methyl spiroiminodUiydantion (2): yield: 85.50 mg (38%); 
HRMS calcd. for (M"") CgNsOsH,, 257.2054, found 257.2057; IR (KBr) : 3490, 
3475. 3365, 3320, 1800, 1760, 1735, 1700, 1150 cm"'; ' H - N M R ( D M S O , 5, 
ppm): 8.43, 8.38, 8.35, 8.27 (4H, NH), 5.24 (d, 2H), 3.71 (t, 2H), 3.56 (t, 2H); 
'T-NMR (DMSO, 5, ppm) : 181.9 (C-8), 172.5 (C-4), 171.3 (C-6), 165.8 (C-2), 
85.1 (C-5), 69.7, 67.9, 61.1; FAB-MS m/z: 258 [C8H,|N505+H]^ 184 
4-f(2-Hydroxyethoxy) methyl ammo]-2-imino-l,2-dihydroimidazole-5-one (3): 
yield: 20.25 mg (9%); HRMS calcd. for (M^) C6H10N4O3 186.1700, found 
186.1698; IR (KBr): 3240, 1734, 1645, 1528, 1155 cm"'; ' H - N M R (DMSO, 5, 
ppm): 9.08 (2-NH), 8.90 (3-NH), 9.31 (5-NH), 4.73 (d, 2H), 3.70 (t, 2H), 3.56 
(t. 2H); "C-NMR (DMSO, 5, ppm) : 184.8 (C-2), 176.7 (C-4), 166.5 (C-5), 
69.8. 69.2. 61.1; FAB-MS m/z: 187 [C6H|oN403+H]^ 113 [C3H4N40+H]^ 
94 
2,2-Di(imino-4-[(2-hydroxyethoxy)methyl) amino]-5-[2H]-oxazolone (4): 
yield: 24.75 mg (11%); HRMS calcd. For (M^) C6H12N4O4 204.1840, found, 
204.1845; IR (KBr) : 3350, 2945, 1780, 1735, 1659, 1490, 1160 cm"'; ' H - N M R 
(DMSO, 5, ppm): 7.58 (NH2, 4H), 8.20 (4-NH), 4.73 (d, 2H), 3.70 (t, 2H), 3.56 
(t, 2H); ' 'C-NMR (DMSO, 5, ppm) : 166.3 (C-2), 156.1 (C-4), 160.1 (C-5), 
69.9, 69.8, 61.1; FAB-MS m/z: 205 [C6H,2N404+H]^ 131 [C3H6N402+H]^ 161 
[C6H|2N404-C02+H]^ , 87 [C3H6N402-C02+H]^ 
Results and discussion 
Irradiation of air saturated aqueous solution of Ac (1) in pH 7 phosphate buffer 
with corex filtered light followed by purification of crude product by silica gel 
column chromatography, afforded three major products, which were identified 
by their spectral studies as: (2-hydroxyethoxy) methyl spiroiminodihydantion 
(2), 4-[(2-hydroxyethoxy) methyl amino]-2-imino-l,2-dihydroimidazole-5-one 
(3), and 2,2-diamino-4-[(2-hydroxyethoxy)methyl) amino]-5-[2H]-oxazolone 
(4) (Scheme 2A.1). The study was supplemented by irradiation in the presence 
of rose bengal, whereby same products were obtained, with considerably 
greater conversion in a much shorter time. When rose bengal was replaced with 
silica bound rose bengal" the rate of photooxidation of Ac was slower but it 
contributed to a clean workup. 
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Scheme 2A.1 
A brown colouration was observed for compound 4 after spraying the silica gel 
TLC plates with the hydroxylamine iron (III) chloride, suggesting the presence 
of lactone moiety in compound 4. The photomediated transformation of Ac 
involves singlet oxygen as evidenced from following observations: (1) No loss 
of substrate was observed when oxygen was excluded from medium; (2) 
Destruction of substrate was quenched in presence of sodium azide, a singlet 
oxygen quencher; (3) Loss of substrate was accelerated in D2O, a well known 
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singlet oxygen life time promoter; (4) The enhanced degradation in D2O was 
also inhibited by sodium azide. 
A comparison of ' H - N M R and '^C-NMR spectra of Ac and those of 
photoproducts 2, 3 and 4 did not show any significant change in the chemical 
shifts of protons and carbon atoms of side chain. The slight up field shift 
observed for methylene protons of side chain with respect to Ac may be 
explained by loss of aromaticity of heterocyclic ring. The lack of H-8 resonance 
signal (5 8.05) in the low field region of the ' H - N M R spectrum indicates that 
purine ring of the substrate has been modified. In the '^C-NMR spectrum of 
compound 2 signal at 5 181.9 was assigned to imine type carbon C-8 and 
signals at 5 165.8, 172.5 and 171.3 ppm were attributed to carbonyl carbon at 
C-2, C-4 and C-6 respectively. A significant feature of '^C-NMR spectrum is 
the appearance of a new resonance signal at 5 85.1 ppm, which was assigned to 
ihc quaternary carbon in the spiro ring in comparison with the spectra of related 
spirohydantoins.''^'"' The presence of hydantoin ring in product 2 is evidenced 
from its infrared spectrum, which showed a sharp absorption band at 1800 cm"' 
along with three intense absorption bands in the region 1780-1700 cm"'.'' ' 
1 -I 
Inspection of the low field region of the C-NMR spectra of both the 
photoproducts, 3 and 4, revealed the loss of two carbon atoms in the starting 
compound. Resonance signals at 6 8.20 for 4 and 5 9.31 for 3, exchangeable 
with D2O, were assigned to those of 4-NH for 4 and 5-NH for 3, respectively. 
This observation is consistent with opening of imidazole ring of Ac. In case of 
product 3 two other exchangeable protons observed at 5 9.08 and 8.90 were 
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assigned to 2-NH and 3-NH respectively. In the spectrum of 4, a broad signal at 
5 7.58 equivalents to four exchangeable protons of two amino groups on sp"' 
carbon C-2. 
The structure of three products identified in this study is also well supported 
from their mass spectra. Base peak at m/z 258 corresponds to [CsHnNsOs +H)]"^ 
ion of the oxidation product 2 and peak at m/z 184 corresponds to protonated 
spiroiminodihydantoin, the expected consequence of fragmentation involving 
the loss of (hydroxyethoxy)methyl unit. The spectrum of compound 3 exhibits a 
major peak corresponding to protonated molecule [C6H 101^ 403+!^ ]"*" at m/z 187 
and other peak at m/z 1 13 [C3H4N40+H]'^ arising from loss of (hydroxyethoxy) 
methyl unit followed by protonation. The mass spectrum of compound 4 
recorded the presence of molecular ion [C6Hi2N404+H]^ at m/z 205 and 
fragmentation ion [C3H6N402+H]^ at m/z 131, arising from splitting of side 
chain. The two other fragments [C6H|2N404-C02+H]^ at m/z 161 and 
|C3H6N402-C02+H]'^ at m/z 87 may be rationalized by the release of CO2 from 
the molecular and fragment ion, respectively. A similar mass fragmentation 
pattern has already been described for imidazolone-2'-deoxyribonucleoside and 
oxazolone-2'-deoxyribonucleoside.'^'^' The three products which were 
identified in this study as, spiroiminodihydantoin (2), imidazolone (3) and 
oxazolone (4) are analogous in structure to the products described in 
photooxidation of deoxyguanosine (dGuo) and its related derivatives. 
The formation of photoproducts 2, 3 and 4 has been realized as depicted in 
scheme 2A.2. The reaction of dienophilic 'O2 with guanine moiety of Ac (1) by 
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a Diels-Alder [4+2] reaction involving C-4 and C-8 carbons of the purine ring 
results in the formation of 4,8-purine endoperoxide ( la) which isomerizes to 8-
hydroperoxyderivative (5). This resulting hydroperoxide may undergo 
dehydration followed by hydrolytic cleavage to form spiroiminodihydantoin 2 
(Scheme 2A.2). Additionally, the hydroperoxide 5 in its reduced form 6 
undergoes further [2+2] cycloaddition to produce an unstable dioxetane, which 
on subsequent decomposition gives imidazole 3 as product (Scheme 2A.3). The 
sequential formation of imidazolone from unstable dioxetane has its precedence 
in similar singlet oxygen photooxidation of nucleosides.^ ' ' The initially 
generated photoproduct, namely the imidazolone (3), on hydrolysis leads to the 
I'ovmation of oxazolone derivative 4 (Scheme 2A.4). 
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[A|. 2. Photoox idat ion of acyclovir by thermal ly generated tr iplet 
exci ted ketone from 1,2-dioxetane and its c o m p a r i s o n with 
type I and type II photosens i t izers 
Biological photosensitization reactions are generally considered as belonging to either 
the type 1 (radical mediated) or type II (singlet oxygen mediated)?^ There are many 
exogenous photosensitizers which impart differential sensitization mechanisms e.g. 
riboflavin, benzophenone are predominantly type I photosensitizer and rose bengal and 
methylene blue are type II,^ "'• '^' whereas 3-hydroxymethyl-3,4,4-trimethyl-I,2-dioxetane 
(HTMD) is neither a typical type 1 nor a characteristic type II photosensitizer.^^ Hence, 
in an extensive study, photooxidation of acyclovir was investigated by thermally 
generated triplet-excited ketone from HTMD for its comparison with type I and type II 
photosensitizers. The triplet excited ketones are important class of photooxidative 
sensitizers of biological interest since they may be generated in cellular systems upon 
exposure of endogenous chromophores to UV radiation or by dark reactions.^ *" 
Thermal decomposition of HTMD, which is a convenient chemical source of triplet-
excited ketone,'^ is accompanied by infrared photoemission at 1270 nm, characteristic 
for singlet oxygen monomolecular emission,^^ and thus HTMD are known to generate 
singlet oxygen in sequence, and can operate as type I or type II photooxidants. 
The photooxidation of Ac was conducted in presence of thermally generated triplet 
excited ketone. The distribution of the products was compared with those of sensitized 
photooxidation of Ac by riboflavin (type 1) and rose bengal (type II). 
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Exper imenta l 
Reaction procedure 
28N For the HTN4D(prepared as per literature ) mediated oxidation of Ac, a 0.5 mM 
solution of Ac in 10 mM sodium cacodylate buffer (pH 7.0) and 10 vol% of 
dioxetane solution in acetonitrile was kept at 50 C for 18 h in absence of light. 
The photosensitized oxidation of phosphate buffered solution of Ac (0.5 mM) 
was carried out in the presence of photosensitizer riboflavin or rose bengal for 
2.5 h by irradiation with a 150 W sodium lamp. The lamp was placed at 15 cm 
below the bottom of an ice filled beaker, in which a round bottom flask having 
reaction mixture was placed. After the given time period the amount of 
photoproducts formed and the remaining amount of Ac was determined by 
isolation and purification of the reaction mixture using silica gel column 
chromatography. 
Relative \'ields of the products was determined on the basis of consumed Ac 
and the mean value of at least 3 independent run, and a comparison of the 
results with the different sensitizers is presented in Table 2A.1. The 
concentration and time profile for HTMD induced oxidation of Ac (0.5 mM) at 
50" C was also determined by using 10 mM sodium cacodylate buffer (pH 7) as 
a reaction medium with 10 vol% of acetonitrile as co-solvent. Effect of D2O on 
the yield of Sp in HTMD-induced photooxidation was also observed to confirm 
the involvement of singlet oxygen. 
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Results and discuss ion 
On the thermal treatment of Ac with HTMD at 50° C, three major products 
were obtained. The products were identified as (2-hydroxyethoxy)methyl 
spiroiminodihydantoin (2), (2-hydroxyethoxy)methyl (amino)-2-imino-l,2-
dihydroimidazole-5-one (3), and 2,2-diamino-4-[(2-hydroxyethoxy)methyl) 
amino)-5-[2H]-oxazolone (4) (Scheme 2A.5). The photoproducts were 
identified by comparing their spectral data with that of singlet oxygen mediated 
Ac photooxidation products spiroiminodihydantoin (Sp) imidazolone (Im) and 
oxazolone (Ox). Similar products pattern was obtained when Ac was irradiated 
in an aerated aqueous solution containing riboflavin or rose bengal, but 
different yields of products were obtained depending upon the photosensitizer 
used. (Table 2A.1) In the type 11 sensitized photooxidation by rose bengal, 
spiroiminodihydantoin was detected as the major product whereas the type 1 
photosensitizer riboflavin gave imidazolone and oxazolone as major product. 
For HTMD, which entails both photooxidation modes, the yields of type 1 and 
type II products were close to each other. The Sp/Im+Ox product ratio 
indicating the relative predominance of photooxidation products was taken as 
mechanistic probe to assess the extent of type I and type II photosensitized 
oxidation. For example in riboflavin sensitized photooxidation the product ratio 
lies below 1 while for rose bengal sensitized oxidation it is above 3. For HTMD 
the product ratio is 1.3. Also for the product balance, the HTMD oxidation lies 
between the type I (40%, entries 2) and type II (57%, entries 3) process. 
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Furthermore, the relative yield of Sp in HTMD-induced oxidation (30%) is 
significantly higher (15%) than that of riboflavin sensitized oxidation and 
smaller (15%) than that in the rose bengal sensitization. In contrast the yields of 
the type 1 products in HTMD-induced oxidation (23%) are comparable with 
those of type 1 sensitizer (25%) and significantly higher than those in type II 
photooxidation (12%). 
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Entry 
1 
2 
3 
Concentration 
(^iM) 
10000 
10 
10 
Product yield 
Oxidant 
HTMD/ 50 C 
Riboflavin 
Rose bengal 
s(%f 
Sp 
(type II) 
30±3 
15±2 
45±1 
Im+Ox 
(type I) 
23±2 
25±3 
12±2 
Product 
balance 
53±3 
40±3 
57±2 
Table 2A.1 Product balance of Ac oxidation by dioxetane HTMD and by 
riboflavin and rose bengal photosensitizers. ^ Relative yields based on 
consumed Ac; mean value of three independent runs. 
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This difference in products distribution may be accounted for by the fact that 
rose bengal produce singlet oxygen in large amount by a type 11 mechanism, 
whereas riboflavin, which acts mainly by type I photosensitized oxidation, do 
nol produce significant amount of singlet oxygen. On the other hand HTMD is 
neither a typical type I nor a characteristic type II photooxidant; in particular 
both photooxidation modes occur quite efficiently. 
As shown in Figure 2A.1, when Ac was thermally treated with HTMD at 50° C 
for 15 h, a linearly dependent degradation of Ac was observed with increasing 
HTMD concentration. The absolute yield, based on initial amount of Ac, of 
characteristic type I photooxidation products. Ox and Im was 15%, while type 
II product Sp was formed in up to 22% absolute yield at 25 mM HTMD 
concentration. In these reactions the sum of quantified products, relative to 
consumed Ac, amounted to be 56±4 % and was independent of the HTMD 
concentration. Figure 2A.2 shows the time profile for thermally HTMD induced 
photooxidation of Ac, which revealed a gradual increase of all oxidation 
products with time and product balance of 53±3 % at 25 mM HTMD. Also in 
this case the product balance was independent of the reaction time. 
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Figure 2A.1 Concentration profile for the thermally HTMD-induced 
photooxidation of Ac, yields derived from the mean values of three independent 
runs, (•) conversion of Ac, (A) Yields of Ox and Im, (•) yields of Sp. 
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Figure 2A.2 Time profile for the thermally HTMD-induced 
photooxidation of Ac, yields derived from the mean values of three 
independent runs, (•) conversion of Ac, (A) Yields of Ox and Im, (•) 
yields of Sp. 
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The linear increase of Ac conversion with increasing HTMD concentration 
suggested that the HTMD oxidation of Ac is directly proportional to the amount 
of iriplet-excited ketone formed by the thermal decomposition of the dioxetane. 
i'he time profile for photooxidation of Ac exhibited a decrease of Ac 
concentration with time. This reflects that the Ac is consumed in parallel with 
the generation of triplet-excited ketone. 
Proof for the involvement of singlet oxygen in HTMD-induced oxidation came 
from the substantial effect of D2O on the formation of Sp. Higher yields of Sp 
in D2O compared to those of H2O indicated that singlet oxygen is involved in 
HTMD mediated photooxidation. Singlet oxygen quenchers such as DABCO, 
sodium azide etc. could not be used to confirm the involvement of singlet 
oxygen in HTMD mediated photooxidation as they are known to react with 
dioxetane. 
Our present investigation revealed that triplet excited ketone generated in the 
thermal decomposition of HTMD oxidizes Ac efficiently to the Sp, by a type 11 
photooxidation mechanism, and to the Ox and Im by a type I mechanism. In 
addition, in the riboflavin sensitized type I oxidative modification of Acyclovir 
Ox and Im were obtained as major products, whereas Sp was characterized as a 
major type II photooxidation product of rose bengal sensitized oxidation of Ac. 
The HTMD-induced photooxidation of Ac may have an implication to the in 
vivo photobiological transformation in dark and of significance to 
•photobiology without light'.^''"'^ 
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Section [B] 
Photochemistry of Phenazopyridine 
Hydrochloride 
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|B | Photochemistry of Phenazopyridine hydrochloride. 
Phenazopyiidine hydrochloride (2,6-diamino-3-pheylazopyridine) (PhPy, 8) is the 
generic name for an azo dye, which has been used for 40 years as an analgesic drug to 
reduce pain, associated with urinary tract infection.^^ Phenazopyridine with an azo 
chromophore is expected to be photolabile and a probable photosensitizer of biological 
substrates. Moreover, several drugs with phenylazo moiety are known to biometabolize 
to arencdiazonium ion, which is known to behave as photosensitizer.^'* Interest in the 
photoreactivity of phenazopyridine arises from the clinical and pharmacological reports 
of loxic effects^ ^ '^^ ' associated with the use of this drug. 2,3,6-Triaminopyridine (11), a 
metabolite of phenazopyridine, is known to cause muscle necrosis and renal damage in 
rats,'^ and it is reasonably anticipated to be human carcinogen,^ based on sufficient 
evidence of carcinogenicity in experimental animals.^ ' 
In the present study we have investigated the photolysis of phenazopyridine in different 
reaction medium, including the drug adsorbed on silica gel, as a biological mimic of 
situation in liposomes.'*' The results of photolyses are outlined in Scheme 2B.I. The 
photoreactivity of phenazopyridine was enhanced in the organized medium of silica gel. 
The various products of photolysis were fully characterized by IR, 'H-NMR, 'X-NMR 
and mass spectrometric studies. Formation of 2,3,6-triaminopyridine (11) is probably 
indicative of phototoxicity of drug, as it is identical with the known toxic metabolite of 
the dru"."' 
Experimental 
Apparatus 
Same as in section [A]. 1. 
Chemicals 
All chemical used were of analytical grade. Phenazopyridine hydrochloride (8), was 
extracted from commercial medicament Pyridium (Parke Davis, India). The purity of 
drug extracted, was checked by TLC. 
Irradiation of phenazopyridine hydrochloride in methanol 
Phpy (8) 2 gm (0.009 mole) was dissolved in 100 mi methanol and irradiated in a 
pholoreaclor equipped with a 450 W medium pressure mercury vapour lamp inserted in 
a water cooled quartz fitted immersion well with continuous circulation of water. As the 
reaction progressed, solution becomes brighter. The progress of the reaction was 
monitored by TLC using a solvent system of chloroform-methanol (80:20) mixture. 
After irradiation of the mixture for 12 hours the solvent was removed in a rotary 
evaporator and crude product was subjected to silica gel column chromatography. 
Elution with chloroform-petrol gave 9,10,11 and 12 as products. 
Pyrido/3,4-cJcinnoline-2,4-diamine (9): Yield: 35%; UV A,max(MeOH)252 and 368 nm; 
IIRMS calcd. for (M") C11N5H9 211.0880, found 211.0860; IR(KBr) : 3500, 3200, 
1570. 1200 cm"'; ' H - N M R (CDCI3) 5 4.0 (brs, 4H, exch., aromatic C-NH), 5.92 (s, IH, 
H-l), 7.57 (m, 3H, H-8, H-9, H-10), 8.30 (d, J=6.5 Hz, IH, H-7); '^C-NMR (CDCI3) 5 
98.3 (C-1), 123.4, 129.6, 131.0, 138.3, 140.5, 146.1, 150 (cinnoline), 151.6 (C-4), 158.1 
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(C-2); MS m/z (rel. int.) M+1: 212 (100), 214 (12.1), 213 (54.7), 184 (4.9), 183 (5.7) 
136(29.6). 
N^-Phenylpyridine-2,3,4,6-tetraamine (10): Yield: 15%; HRMS calcd. for (M^) 
CiiNsH,:, 215.1218, found 215.1215; IR(KBr) : 3510, 3400, 1590, 1410 c m - ' ; ' H - N M R 
(CDCI3) 5 4.0 (brs, 7H, exch., aromatic C-NH), 5.20 (s, IH, H-5), 6.46 (d, J=2.5 Hz, 
2H. phenyl), 6.62 (m, IH, phenyl), 7.01 (m, 2H, phenyl); '^C-NMR (CDCI3) 5 85.4 (C-
5), 106.0 (C-3), 116.3, 118.8, 129.6, 143.1 (phenyl), 145.7 (C-4), 148.2 (C-6), 149.2 (C-
2); MS: m/z (rel int.) M+1: 216 (7), 215 (45.1), 214 (100.0), 186 (3.9), 185 (6.7), 137 
(27.1). 110(12.7). 109(9.14), 108(3.1). 
Pyndine-2,3,6-tnamine (11): Yield: 12%; HRMS calcd. for (M^) C5N4H8 124.0904, 
found 124.0901; IR(KBr): 2925, 1460, 1377, 1320, 763 cm"'; ' H - N M R (CDCI3) 5 4.0 
(brs. 6H, exch.. aromatic C-NH), 5.94 (d, J = 8 Hz, IH, H-5), 6.64 (d, J = 8 Hz, IH, H-
4); ' ' C - N M R (CDCI3) 5 100.2 (C-5), 122.0 (C-3), 125.2 (C-4), 147.3 (C-6), 148.3 (C-
2): MS: m/z (rel int.) M+1: 125(70), 108(63), 81 (30), 54 (100). 
2,6-Diamino-l-(4-aminophenyl)pyridin-4(lH)-one (12): Yield: 5%; HRMS calcd. for 
(M') C11N4OH12 216.1169, found 216.1171; IR(KBr) : 3500, 3430, 1700, 1665 cm"'; 
' H-NMR (CDCI3) 5 2.0 (brs, 4H, exch., -NH2), 4.0 (brs, 2H, exch., aromatic C-NH), 
4.42 (s, 2H, dienone protons), 6.21 (s, 4H, aromatic protons); '^C-NMR (CDCI3) 5 82.6 
(C-3 and C-5), 117.1 (C-2', 3', 5', 6'), 131.3 (C-1'), 138.4 (C-4'); MS: m/z (rel. int.) 
M+l:217(31.5), 189(5.3), 140(2.3), 139(28.1), 112(8.1), 110(100.0). 
Irradiation ofPlipy (8) adsorbed on silica gel 
The drug was dissolved in methanol and mixed with aqueous slurry of silica gel. TLC 
plates were prepared and photolyzed as such with a 450 W medium pressure mercury 
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lamp. The plate appeared as yellow chromatogram, which turned dark yellow within 15 
min. Photolysis was continued up to 4 hours for complete decomposition of the drug. 
The progress of the reaction was monitored by withdrawing a scratch of irradiated silica 
gel and its co-TLC with the drug. Complete scratch from the plate was dissolved in 
acetone, filtered and evaporated in a rotary evaporator followed by chromatography on 
silica gel yielded 9,10,11 and 12 as products. 
Results and discussion 
Irradiation of methanol solution of Phpy (8) with medium pressure mercury vapour 
lamp in a immersion well type photoreactor gave pyrido[3,4-c]cinnoline-2,4-diamine 
(9), N'-phenylpyridine-2,3,4,6-tetraamine (10), pyridine-2,3,6-triamine (11) and 2,6-
diamino-l-(4-aminophenyl)pyridin-4(lH)-one (12) as photoproducts (Scheme 2B.1), 
which were characterized from their spectral studies. 
None of these products showed IR band at 1600 cm" typical for free azo group, 
however a band at 1570 cm' in the IR of 9 could be assigned to -N=N- in cinnoline. 
Photoproduct 9 showed a broad singlet at 5 3.95 ppm equivalent to two -NH2 group 
protons. A sharp singlet at S 5.92 ppm was assigned to the only proton present in the 
diamine substituted pyridine ring. NMR signals for the aromatic ring amounting to only 
four protons along with characteristic UV bands at 252 and 368 nm supported for a 
benzo[c]cinnoline'*^ structure. 
Product 10 showed a broad singlet at 5 4.0 ppm due to protons of aromatic -NH2 group. 
A sharp singlet at 5 5.2 ppm, logically upfield to the benzene ring protons, was assigned 
to a single proton flanked by two amino groups in the pyridine ring. This is further 
supported by the '^C-NMR value of 5 85.4 ppm for the only unsubstituted carbon to 
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which this hydrogen is attached. The NMR spectrum of product 11, with a six proton 
broad singlet at 8 4.0 ppm for aromatic amino group and a pair of ortho coupled 
doublets at 8 5.94 and 6.64 ppm for aromatic protons, along with its mass spectrum 
established 2,3,6-triaminopyridine structure for it. 
H2Ns^N NH2 
(8) 
HCI 
hv 
CH3OH 
orHsO 
or drug adsorbd on 
silica gel 
]> (11) 
NH, 
NHo 
NH, 
(12) 
Scheme 2B.1 
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The photoproduct 12 showed two types of-NH2 signals: at 5 4.0 for two protons and at 
8 2.0 for four protons. A sharp singlet for four protons at 5 6.21 ppm indicated that 
aromatic ring is para-disubstituted. A p,P'-diaminodienone structure for it was 
supported by proton signal at 5 4.42 ppm for dienone protons and '"'C-signal at 5 185.8 
ppm for carbonyl carbon and additionally by IR frequency at 1700 and 1665 cm"' 
(C=0). 
The probable course of formation of products is described in scheme 2B.2 and 2B.3. 
The product 9 results from photochemical cyclodehydrogenation of phenazopyridine, 
whereby a reduced molecule of the drug (8a) also produced.'*^ Phenhydrazopyridine 
(8a) undergoes reductive degradation to 2,3,6-triaminopyridine (11) and in an 
alternative course rearranges to N^-phenylpyridine-2,3,4,6-tetraamine (10). The 
reductive degradation of 8a probably co-generates phenylnitrenium ion (Scheme 2B.2), 
as traces of/j-methoxyaniline was detected on TLC. Arylnitrenium ions are known 
intermediates in physiological DNA-damaging reactions, which are responsible for 
carcinogenesis.''^ 2,6-Diamino-l-4(4-aminophenyl)pyridine-4-(IH)-one (12) was 
proposed to be derived from 10 in a sequence shown in Scheme 28.3. 
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H 2 N . / N ^ ^ N H 
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H H 
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N-H 
NH, 
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NH, 
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NH, 
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OCH, 
Scheme 2B.2 
NH, 
HjN - N H - ^ 
NH, 
(10) 
HoN 
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Chapter 3 
Photochemistry of Bischromophoric Steroidal 
Anti-inflammatory Drugs (Desonide and 
Clobetasol propionate) 
126 
Introduction 
Polyfunctional molecules in which different photochemically reactive chromophores are 
connected by rigid hydrocarbon framework are a subject of fascinating 
photochemistry. ' ' The intramolecular energy transfer (both singlet-singlet and triplet-
triplet) may occur from an 'antenna' group to other chromophore leading to chemistry 
different from that observed by direct excitation of that chromophore.'^"' In the 
photochemistry of such multichromophoric molecules the evaluation of interaction 
between the chromophores, the mode and extent of local reaction at any chromophore 
after electronic excitation and possible role of energy transfer is of high mechanistic 
significance. 
Morrison established, through a series of elegant papers, " that intramolecular energy 
transfer (both singlet-singlet and triplet-triplet) occurred from the phenyl 'antenna' to 
C]7 kelo group in the steroids (Scheme 3.1) by the way of through-bond mechanism. 
This lead to a different photochemistry observed by the direct excitation of ketone 
chromophore. Albini et al. ' have demonstrated non-communicating reaction paths in 
some pregna-l,4-diene-3,20-dione. Since many steroidal drugs are commonly used and 
several reports on their phototoxic effects have been reported,'°"'^ it was of interest to 
extensively study the aspect of competition between chemical reactions of the separated 
excited moieties incorporated in the rigid skeleton of the steroids. It was expected that 
such photochemical mechanisms might have some relevance for the mechanism of 
phototoxicity. 
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Glucocorticosteroids are natural hormones with a steroidal structure derived from 5a-
pregnane. These steroidal hormones with powerful anti-inflammatory effects are 
secreted by the cortex of adrenal gland. Semisynthetic derivatives of these hormones are 
widely used as drugs to treat inflammatory illness, including arthritis and asthma, and 
many of them are effective by topical use in dermatoses and other dermatological 
disease. 
With this interest, herein we have investigated the photochemistry of desonide (De, 1) 
and clobetasol propionate (6) under different combinations of solvents and irradiation 
wavelengths. 
X = CO, CHOH; R =0H, OAc 
0 . 
CH2R 
Z = CHOAc, COCH2CH2O; R = H,OAC 
Scheme 3.1 
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|A] Photochemical Studies on desonide 
Desonide (De, 1) is a synthetic nonfluorinated corticosteroid for topical dermatoiogical 
use. it is used to treat inflammation caused by a number of conditions such as allergic 
reactions, asthma and psoriasis.'"*'^ Desonide is very interesting from photochemical 
point of view because it bear two spatially separated chromophores i.e. cross conjugated 
dienone moiety in ring A and an isolated ketone at C20. A number of photochemical 
studies have been carried out on steroidal ketones, both in solution and in solid state."'" 
The photochemistry of cross-conjugated cyclohexadienone has been intensively 
studied because of their facile and fascinatingly complex photochemical reactions. 
William et al. ^ carried out photolysis of prednisolone, a molecule structurally related to 
De. at 254 nm and observed that only photoprocess occurring in dioxane solution was 
the "lumiketone" rearrangement of the cyclohexadienone moiety. 
Experimental 
Chemicals and Instrumentation 
All chemicals used were of analytical grade and were used as such without any further 
purification. Pure desonide and clobetasol propionate were obtained from Galderma 
Pvt. Ltd. (Mumbai, India) and ZYG Pharma (Mumbai, India) respectively. Irradiation at 
254 nm were carried out in an immersion well type photoreactor (quartz) equipped with 
20 W low-pressure mercury arc lamp. For irradiations at 310 nm the solutions were 
irradiated with two 15 W phosphor coated lamps. IR spectra were recorded as KBr discs 
on a Perkin Elmer model spectrum RXI. ' H - N M R and '^C-NMR spectra were recorded 
on a Bruker DRX-300 spectrometer using SiMe4 as internal standard and CDCI3 as 
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solvent. Circular dichroism spectra were measured on a Jasco-J 41A spectropolarimeter. 
High-resolution mass spectra were determined with a VG-ZAB-BEQ9 spectrometer at 
70 eV ionization voltage. Merck silica gel 60 F254 plates were used for analytical TLC; 
column chromatography was performed on Merck silica gel 60 (70-230 mesh). 
General photoinadiation procedure 
A solution of desonide or clobetasol (in acetonitrile or 2-propanol) was stirred and 
flushed with argon or oxygen (as desired) for 1 h before irradiation and was kept 
bubbling during the irradiations. The course of reaction was monitored by thin layer 
chromatography on pre-coated silica gel TLC plates using chloroform-acetone (9:1) 
mixture. After the completion of reaction (when desired conversions have reached) the 
solvent was removed in a rotary evaporator and products were purified by silica gel 
column chromatography. 
Irradiation ofDe in argon- saturated acetonitrile 
A solution of De (210 mg, 0.5 mM) in argon-saturated acetonitrile (400 ml) was 
irradiated for 2.5 h at 254 nm. After following the steps described in general 
photoirradiation procedure, compound 2 was obtained as product. 
Iip,21-Dihydroxy-16a,17a-(l-methylethylidenedioxy)-l,5-cyclopregn-3-ene-2,20-
dione (2): Yield: 115 mg (55%); HRMS calcd. for (M"*") C24H32O6 416.5073, found 
416.5065; IR (KBr) 3410,1680 (C=0), 1565 (C=C), 1355, 1160, 1022 cm "' 
(cyclopropyl): ' H - N M R (DMSO-ds) 5 7.24 (d,IH, J=6Hz, H-4), 5.98 (d, IH, J=6Hz, H-
3). 4.87 (brs, IH, exch., OH), 4.69 (s, 2H, H-21), 4.10 (t, IH, H-16), 3.98 (brs, exch., 
OH). 3.16 (dd, IH, J=ll,5 Hz, H-11), 1.82 (OC(CH3)2, 6H ), 1.6-1.8 (m, 5H), 1.2-1.5 
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(m, 6H), 1.16 (s,3H, H-19), 1.08 (s, IH, H-1), 0.95 (s, 3H, H-18); '^C-NMR (DMSO)-
4) 5 21 1.4 (C-20), 193.2 (C-2), 132.5 (C-3), 158.1 (C-4), 109.2 (OC(CH3)2), 98.7 (C-
17), 81.4 (C-:i6), 65.2 (C-11), 64.6 (C-21), 58.2 (C-9), 47.4 (C-1), 48.2 (C-14), 40.4 (C-
12), 36.6 (C-13), 35.1 (C-6), 32.1 (C-5), 29.9 (C-10), 27.4 (C-8), 26.0 (C-15), 25.3 (C-
7), 20.8(C-19), 14.4 (C-18). 
A solution of De (210 mg, 0.5 mM) in argon-saturated acetonitrile (400 ml) was 
irradiated for 2 h at 310 nm. After following the steps described in general 
photoirradiation procedure, compound 3 was obtained as the main product along with a 
trace amount of 2 as detected on TLC. 
11/3'ffyclfoxy~16a,17a-(l-methyIetltylidenedioxy) androsta-l,4-diene-3-one (3): yield: 
105 mg (50%); HRMS calcd. for (M^) C22H30O4 358.4712, found 358.4718; IR (KBr) 
3500,1670, 1625, 1610; ' H - N M R (DMSO-de) 5 7.52 (d, J=8 Hz, IH, H-l), 6.14 (d, IH, 
.1=8 Hz, H-2). 6.03 (s, IH, H-4), 3.92 (m, IH, H-l6), 3.87 (d, J-5Hz, IH, H-l7), 3.40 
(brs.lll. exch., OH), 3.26(m, IH, H-11), 1.6-2.0 (m, 6H), 1.4-1.6 (m, 5H), 1.37 (s,3H, 
H-19). 1.31 (s, 6H), 1.16 (s, 3H, H-18); '^C-NMR (DMSO-dfe) 5 185.8 (C-3), 168.3 (C-
5). 155.4 (C-1), 128.4 (C-2), 124.2 (C-4), 113.3 (OC(CI-l3)2), 80.4 C-16), 103.3 (C-17), 
66.7 (C-11), 59.0 (C-9), 46.7 (C-14), 43.1 (C-12), 34.4 (C-10), 33.6 (C-6), 32.0 (C-7), 
3 1.6 (C-13), 29.9 (C-8), 28.7 (C-15), 26.6 (OC(CH3)2), 25.7 (C-19), 17.3 (C-18). 
Irradiation ofDe in oxygen saturated acetonitrile 
A solution of De (210 mg, 0.5 niM) in oxygen-saturated acetonitrile (400 ml) was 
irradiated for 2.5 h at 254 nm and 310 nm. After following the steps described in 
131 
general photoirradiation procedure, compound 2 (140 mg, 67%) was obtained as 
product at 254 nm whereas a complex mixtures of products was obtained at 310 nm. 
Irradiation ofDe in argon-saturated 2-propanol 
A solution of De (210 mg, 0.5 mM) in argon-saturated 2-propanol (400 ml) was 
irradiated for 2 h at 254 nm and at 310 nm. After following the steps described in 
general photoirradiation procedure, compound 2 (130 mg, 62%) was obtained as major 
product at 254 nm. Whereas at 310 nm both the compounds 2 and 3 were obtained as 
products. 
Irradiation of De in oxygen-saturated 2-propanol 
A solution of De (210 mg, 0.5 mM) in acetonitrile (400 ml) was irradiated for 2.5 h at 
254 nm and 310 nm. After following the steps described in general photoirradiation 
procedure compound 2 (135 mg, 64%) was obtained as product at 254 nm. At 310 nm 2 
(55 mg, 26%) and 4 (110 mg, 52%) were obtained as products. 
17p-Hydroperoxy-lIf5- hydroxy-16a, I7a-(I-methyletltylidenedioxy) androsta-1,4-
diene-3-one (4): Yield: 110 mg (52%); HRMS calcd. for (M"") C22H30O6 390.4700, 
found 390.4694; IR (KBr) 3400, 1655, 1620, 1600; ' H - N M R (DMSO-dt) 5 8.9 (brs, 
e.xch., OOH). 7.56 (d, J=8 Hz, IH, H-1), 6.18 (d, IH, J=8 Hz, H-2), 6.08 (s, IH, H-4), 
4.12 (m, IH. H-16), 4.82(brs, IH, exch., OH), 2.2-2.6 (m, 4H), 1.2-1.9 (m, 6H), 1.4 (s, 
3H), 1.3(s, 3H), 1.2(s,3H); '^C-NMR (DMSO-de) 5 192.0 (C-3), 167.1 (C-5), 156.4 (C-
1). 125.7 (C-2), 124.4 (C-4), 121.5 (C-17), 105.4 (OC(CH3)2), 73.8 (C-16), 67.1 (C-11), 
58.6 (C-9), 40.8 (C-14), 37.1 (C-10), 36.2 (C-12), 33.1 (C-6), 31.9 (C-7), 30.4 (C-13), 
29.6 (C-8), 22.8 (C-15), 26.4 (OC(CH3)2), 25.4 (C-19), 17.5 (C-18). 
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Triphenylphosphine (26 mg) was added to a solution of hydroperoxide 4 (20 mg) in 
dichloromethane (20 ml) and stirring was pursued for 2 h, when the starting material 
was consumed, extraction with water and evaporation gave 15 mg of Compound 5. 
11 l3,16a-Dihydwxyandrosta-l,4-diene-3,l7-dione (5): HRMS calcd. for (M"^ ) 
CmH2404 316.3915, found 316.3920; IR (KBr) 3450, 1745, 1660, 1600; ' H - N M R 
(DMSO-dfi) 5 7.31 (d, J=8 Hz, IH, H-I), 6.42 (d, IH, J=8 Hz, H-2), 6.01 (s, J=].5Hz, 
IH, H-4), 4.98 (brs, IH, exch., OH), 4.10 (m, IH, H-16), 4.01 (brs, IH, exch., OH), 2.5-
2.8 (m. 3H), 1.7-2.4 (m, 5H), 1.3-1.7 (m, 4H ), 1.41 (s, 3H), 0.98 (s, 3H); '^C-NMR 
(DMS0-d6) 5 205.4 (C-17), 181.3 (C-3), 165.2 (C-5), 152.5 (C-1), 130.1 (C-2), 127.2 
(C-4). 75.2 (C-16), 67.4 (C-11), 58.3 (C-9), 40.8 (C-10), 40.4 (C-19), 39.7 (C-13), 36.7 
(C-14). 32.0 (C-6), 31.5 (C-8), 30.5 (C-12), 29.6 (C-7), 27.7 (C-15), 21.2 (C-18). 
Results and discussion 
Irradiation of De at 254 nm in argon flushed acetonitrile or in oxygen-saturated solution 
gave compound 2 as product. The photoreaction of De in 2-propanol at 254 nm 
followed a similar course of reaction under aerobic as well as anaerobic conditions. 
When argon flushed De solution (acetonitrile or 2-propanol) was irradiated at 310 nm 
two products were obtained in both the solvents, which were identified as 2 and 3. At 
the same irradiation wavelength (310 nm) saturation of the solution with oxygen 
affected the product distribution: in 2-propanol 3 was not formed, instead 
hydroperoxide 4 was obtained as main product along with trace amount of 2. Whereas 
in acetonitrile a complex mixture of products was obtained (Scheme 3.2). 
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These results can be rationalized on the basis of different mechanism of photochemical 
reaction of the two-separated chromophores present in this drug. At 254 nm, cross-
conjugated ketone absorbs predominantly or exclusively, which causes the well known 
lumiketone rearrangement^ ' ^ of this chromophore and leads to the formation of 
compound 2 (Scheme 3.3). The rearrangement leading to 2 is a concerted process and 
therefore not affected by the medium. On the contrary at 310 nm, where isolated ketone 
at €,2(1 absorbs a large fraction of light, compound 3 was obtained as product which 
arises via Norrish Type 1 homolytic photocleavage of C17-C20 bond followed by 
hydrogen atom abstraction by alkyl radical from solvent or from HOCH2CO radical. In 
oxygen saturated solution trapping of alkyl radical by oxygen is quite efficient to yield 
peroxy radical. This peroxy radical abstracts hydrogen from protic solvent (2-propanol) 
to give the isolated hydroperoxy derivative 4 (Scheme 3.4). 
All the products obtained were characterized on the basis of the following spectral 
evidences. The IR spectrum of 2 showed absorption bands at 1355, 1160, 1022 
(cyclopropyl), 1565 (C=C), 1680 (C=0). In the NMR spectrum of 2, signals due to the 
rings B, C and D were found to be unaffected while signals due to ring A was strongly 
modified since only two of the olefinic CH were conserved and third was substituted by 
a sp' carbon. In addition two doublets centered at 5 7.24 and 5.98 with J=6.0 Hz in the 
' H - N M R spectrum and the IR band values indicated the presence of an a,(3-unsaturated 
ketone in ring A. A proton singlet at 5 1.08 and '"C-NMR signals at 47.4, 32.1 and 29.9 
indicated a cyclopropyl carbonyl system in ring A. Proof of the stereochemistry came 
from a comparison of its circular dichroism spectra with those of other lumiketones that 
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showed positive and negative cotton effects of similar magnitude and position to those 
reported in Htrature^*''^ ^ (Table 3.1). 
Spectroscopic study of compound 3, particularly NMR data indicated that the steroidal 
skeleton was unaffected while the side chain at C17 has been lost. In the ' H - N M R 
spectrum of 3 the three deshielded olefmic protons at 5 7.52 (d, J=8 Hz, IH), 6.14 (d, 
J=8 Hz, IH) and 6.03 (s, IH) confirmed that the dienone system was intact, and on the 
basis of chemical shifts and spin-spin coupling constants these signals were assigned to 
the C'-l, C-2 and C-4 protons respectively. Signals due to ring B, C and D were also 
unaffected while no signal was observed due to side chain at C17 in its NMR spectrum. 
Its IR spectrum with absorption bands at 3500 (OH), 1670 (a,p-C=0), 1625, 1610 
(C=C) cm"', further support the assigned structure 3 for this compound. 
The NMR spectra of 4 suggested that the structural features in ring A, B and C were 
again conserved while side chain at Cn had been lost. In addition a strongly deshielded 
signal at 5 8.9 (brs, exch., IH) in the ' H - N M R and a new signal at 5 121.5 (C-17) in 
''C-NMR suggested the presence of hydroperoxy group in 4. This compound could be 
reduced by triphenylphosphine and gave 16-hydroxy-17-keto derivative 5 as product 
(Scheme 3.5), This chemical evidence along with the spectroscopic indications (in the 
experimental section) allowed assignment of the hydroperoxide structure 4 for the 
product. 
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hv{254nm) 
MeCN/ 2-propanol 
Argon or oxygen 
(3) 
(major) 
(4) 
(major) 
Scheme 3.2 
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Scheme 3.3 
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hydrogen transfer 
hydrogen transfer 
.0 
,.0 
H 
(3) 
OOH 
.0 
H 
(4) 
Scheme 3.4 
Scheme 3.5 
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•OH 
(4) (5) 
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Compel. 
2 
Related 
lumiproducls" 
^max (As) 
357 (-3.71) 
^max (Ae) 
343 (-4.71) 
344.5 (-3.77) 
Crossover X 
313 
309 
^max (As ) 
278 (+12.22) 
272 (+10.3) 
Crossover X 
253 
250 
^max (As) 
225 (-11.71) 
Short 
wavelength 
-veCD 
'see rets. [26. 27] 
Table 3.1 Circular dichroism spectra of 2 and other related lumiproducts 
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[B| Photochemical studies on clobetasol propionate 
Clobetasol propionate (6) is a dihalogenated highly potent glucocorticoid. It is an 
analogue of prednisolone. It is used only topically on the skin and its effects are limited 
to the local anti-inflammatory activity. Clobetasol is indicated for the treatment of 
psoriasis,'** dry hyperkeratotic dermatoses, initial control of all forms of hyperacute 
eczema, chronic hyperkeratotic eczema, contact dermatitis, atopic dermatitis, lichen 
planus associated with severe pruritis, discoid lumps erythema and granulomatous 
disorders. 
Clobetasol is also very interesting from photochemical point of view because it also 
bears two spatially separated chromophores i.e. cyclohexadienone moiety in ring A and 
carbonyl group at C20. Hence, in an extensive study of photochemistry of steroidal anti-
inflammatory drugs, we have investigated the photochemistry of clobetasol under 
different combinations of solvents and irradiation wavelengths. 
Experimental 
Same as in section [A] 
Irradiation of clobetasol in argon- saturated acetonitrile 
A solution of 6 (234 mg, 0.5 mM) in argon-saturated acetonitrile (400 ml) was 
irradiated for 2.5 h at 254 nm. After following the steps described in general 
photoirradiation procedure (section A), 7 (110 mg) was obtained as product. 
21-Cliloro-9-fluoro-ll-hydroxy-16-metliyl-17(l-oxopropoxy)-J,5-cyclopregn-3-ene-
2,20-dione (7): Yield: 110 mg (47%); HRMS calcd. for (M^) C25H32O5CIF 466.9771, 
found 466.9780; IR (KBr) 3400, 1675 (C=0), 1570 (C=C), 1350, 1161, 1030 cm"' 
141 
(cyclopropyl); ' H - N M R (DMS0)-d6) 5 6.66 (d,lH, J=6.2 Hz, H-4), 5.68 (d, IH, J=6.2 
Hz, H-3), 4.42 (s, 2H, H-21), 4.32 (brs, exch., OH), 2.53 (m, IH, H-16), 3.43 (dd, IH, 
.1=1 1.5 Hz, H-11), 2.29 (m, 2H, H-23), 1.74 (m, IH, H-8), 1.5-1.7 (m, 6H), 1.42 (dd, 
IH, .1=11, 2 Hz, H-14), 1.32 (m,2H, H-15), 1.21 (6H, 2XCH3), 1.11 (6H, 2XCH3) 1.06 
(s, IH, H-1); '^C-NMR (DMS0)-d6) 5 201.3 (C-20), 192.5 (C-2), 174.4 (C-22), 159.7 
(C-4), 130.8 (C-3), 114.1 (C-9), 93.9 (C-17), 71.1 (C-11), 41.3 (C-21), 40.4 (C-1), 39.3 
(C-14), 38.1 {C-8), 37.4 (C-6), 37.0 (C-13), 32.9 (C-12), 31.8 (C-15), 31.2 (C-16), 27.8 
(C-23). 27.1 (C-10), 25.2 (C-5), 18.7 (C-7), 14.6 (C-18) 9.4 (C-19). 
A solution of 6 (234 mg, 0.5 mM) in argon-saturated acetonitrile (400 ml) was 
irradiated for 2 h at 310 nm. After following the steps described in general 
photoirradiation procedure (section A), 8 (90 mg) was obtained as main product along 
with trace amount of 7, as detected on TLC. 
2l-Chl()ro-9-fluoro-ll-hydroxy-16-methyl-17(l-oxopr()poxy)-18,20-cydopregn-l,4-
diene-3-one (8): Yield: 90 mg (39%); HRMS calcd. for (M^) C25H32O5CIF 466.9771, 
found 466.9765; IR (KBr) 3410,1680, 1630, 1615; ' H - N M R (DMS0)-d6) 5 7.34 (d, 
,1=9 1 Iz, IH. H-2), 6.28 (d, .1=9 Hz, IH, H-1), 6.09 (s, IH, H-4), 3.77 (s, 2H, H-21), 3.51 
(brs. c.\ch.. OH). 3.34 (m, 1 H. H-11), 2.37 (m, IH, H-16), 2.21 (m, 2H, H-22), 2.11 (s, 
2H. H-18), 2.09 (d, 2H, H-6), 1.74 (m, IH, H-8), 1.59 (m, 2H, H-15), 1.52 (m, 2H, H-
7), 1.36 (3H, CH3), 1.14 (3H, CH3), 1.06 (3H, CH3); '^C-NMR (DMS0)-d6) 5 185.8 (C-
3). 173.4 (COOR), 167.2 (C-5), 154.7 (C-1), 129.2 (C-2), 125.4 (C-4), 102.2 (C-17), 
99,8 (C-9), 98.1 (C-20), 72.2 (C-11), 55.3 (C-10), 46.9 (C-21), 42.1 (C-14), 39.4 (C-8), 
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37.0 (C-13), 35.2 (C-12), 34.9 (C-18), 33.6 (C-6), 28.7 (C-16), 25.8 (C-7), 19.2 (CH3), 
I7.4(CH3). 16.1 (CH3). 
I net (Hat ion of clohetasol in oxygen saturated acetonitrile 
A solution of 6 (234 mg, 0.5 niM) in oxygen-saturated acetonitrile (400 ml) was 
irradiated for 2.5 h at 254 nm and 310 nm. After following the steps described in 
general photoirradiation procedure (section A), compound 7 (112 mg, 48%) was 
obtained as product at 254 nm where as a complex mixtures of products was obtained at 
310nm. 
Irradiation of dobetasol in argon-saturated 2-propanol 
A solution of 6 (234 mg, 0.5 mM) in argon-saturated 2-propanol (400 ml) was irradiated 
for 2 h at 254 nm and at 310 nm. After following the steps described in general 
photoirradiation procedure (section A), compound 7 (120 mg, 52%) was obtained as 
major product at 254 nm. Whereas at 310 nm both the compounds 7 and 8 were 
obtained as products. 
Irradiation of dobetasol in oxygen-saturated 2-propanol 
A solution of 6 (234 mg, 0.5 mM) in oxygen-saturated acetonitrile (400 ml) was 
irradiated for 2.5 h at 254 nm and 310 nm. After following the steps described in 
general photoirradiation procedure (section A), compound 7 (130 mg, 56%) was 
obtained as product at 254 nm. At 310 nm 7 (42 mg, 18%) and 9 (100 mg, 43%) were 
obtained as products. 
9-Fluoro-l 7-hydroperoxy-16-methyl-17(I-oxopropoxy) androsta-l,4-diene-3-one (9): 
Yield: 100 mg (43%); HRMS calcd. for (M^) C23H31O6F 422.6939, found 422.6930; IR 
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(KBr) 3410, 1660, 1615, 1610; ' H - N M R (DMS0)-d6) 5 8.7 (brs, exch., OOH), 7.14 (d, 
IH. ,1=9 Hz, H-2), 6.30 (d, J=9 Hz, IH, H-1), 6.09 (s, IH, H-4), 3.43 (m, IH, H-11), 
2.29 ( (m, 2H, -OOCCH2CH3), 2.35 (m, IH, H-16), 2.1 (brs, exch., OH), 1.5-1.7 (m, 
5H, H-8, H-12, H-15), 1.36 (s, 3H, H-19), 1.16 (s, 3H, H-18), 2.0 (m, 2H, H-6), 1.52 
(m. 2H. H-7). 1.40 (s, I H, H-14), 1. 11 (3H, CH3), i .02 (3H, CH3); '"C-NMR (DMSO)-
d,0 6 185.8 (C-3), 173.1(-OCOCH2CH3), 168.3 (C-5), 155.4 (C-1), 128.4 (C-2), 124.2 
(C-4). 100.3(C-9), 70.8 (C-11), 54.7 (C-10), 43.6 (C-16), 39.1 (C-8), 37.6 (C-14), 33.0 
(C-6), 33.7 (C-13), 30.3 (C-12), 29.6 (C-15), 28.2 (-OCOCH2CH3), 25.2 (C-7), 24.8 (C-
17). 18.9 (C-19), 11.3(C-18), 9.4(-OCOCH2CH3). 
Results and discussion 
When clobetasol was irradiated at 254 nm in argon flushed acetonitrile or in oxygen 
saturated solution it gave compound 7 as product. The photoreactions of 6 in 2-propanol 
at 254 nm followed a similar course of reaction under aerobic as well as anaerobic 
conditions. Irradiation at 310 nm either in argon saturated acetonitrile or 2-propanol 
gave product 7 along with a new compound 8. At the same irradiation wavelength (310 
nm) saturation of the solution with oxygen affected the product distribution: in 2-
propanol 8 was not formed instead hydroperoxide 9 was obtained as main product along 
with 7. Where as in acetonitrile a complex mixture of products was obtained (Scheme 
3.6). 
These results can be rationalized on the basis of different mechanism of photochemical 
reaction of the two-separated chromophores present in this drug. At 254 nm, cross-
conjugated ketone absorbs predominantly or exclusively, which causes the well known 
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I urn i ketone rearrangement" "^ of this chromophore and leads to the formation of 
compound 7 (Scheme 3.3). The rearrangement leading to 7 is a concerted process and 
therefore not affected by the solvent medium. On the contrary at 310 nm, where isolated 
ketone at C2() absorbs a large fraction of light, compound 8 was obtained as product, 
which arises via hydrogen atom abstraction from the close lying 18-methyl group 
followed by cyclization (Scheme 3.7). In oxygen saturated solution trapping of alkyl 
radical by oxygen is quite efficient to yield peroxy radical. This peroxy radical abstracts 
hydrogen from protic solvent (2-propanol) and gives the isolated hydroperoxy 
derivative 9 (Scheme 3.8). 
All the products obtained were characterized on the basis of the following spectral 
evidences. The IR spectrum of 7 showed absorption bands at 1350, 1161, 1030 
(cyclopropyl), 1570 (C=C), 1675 (C=0). In the NMR spectrum of 7, signals due to the 
rings B,C and D were found to be unaffected while signals due to ring A was strongly 
modified since only two of the olefinic CH were conserved and third was substituted by 
a sp' carbon. Two doublets centered at 5 6.66 and 5.68 with J=6.2 Hz in the ' H - N M R 
spectrum and the IR band values indicated the presence of an a,p-unsaturated ketone in 
ring A. A proton singlet at 5 1.06 and '^C-NMR signals at 40.4, 25.2 and 27.1 indicated 
a cyclopropyl carbonyl system in ring A. Proof of the stereochemistry came from a 
comparison of its circular dichroism spectra with those of other lumiketones that 
showed positive and negative cotton effects of similar magnitude and position to those 
reported in litrature^ '^^ ^ (Table 3.2). 
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Spectroscopic analysis of 8, particularly NMR data indicated that the steroidal skeleton 
was unaffected but both the C20 ketone and 18-methyl signals were lacking. The 
presence of three deshielded olefinic protons at 5 7.34 (d, J=9 Hz, IH), 6.28 (d, J =9 Hz, 
I H) and 6.09 (s, IH) confirmed that the dienone system was intact, and on the basis of 
chemical shifts and spin-spin coupling constants these signals were assigned to the C-2, 
C-1 and C-4 protons respectively. Moreover, signals due to ring B, C and D were also 
unaffected. These data along with the appearance of a new methylene carbon and the IR 
absorption bands at 3410 (OH), 1680 (a,p-unsaturated C=0), 1630, 1615 (C=C) cm"', 
supported the assigned structure . 
The NMR spectra of 9 suggested that the structural features in ring A, B and C were 
again conserved, while one of the side chains at C17 had been lost. In addition a strongly 
deshielded signal at 5 8.7 (brs, exch., IH) in the ' H - N M R and a new signal at 5 124.8 
(C-17) in ''C-NMR suggested the presence of hydroperoxy group in 9. The 
spectroscopic indications (in the experimental section) allowed assignment of the 
hydroperoxide structure to 9. 
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Compd. 
7 
Related 
luiiiiproducts" 
K,x (As) 
355 (-3.71) 
'^ max (As) 
345 (-4.08) 
344.5 (-3.77) 
Crossover X 
315 
311 
'^ max (As) 
280 (+12.22) 
275 (+10.3) 
Crossover X 
253 
252 
^ a x (As) 
225 (-
11.70) 
Short 
wavelength 
-veCD 
''see rets. [26, 27] 
Table .3.2 Circular dichroism spectra of 7 and other related lumiproducts 
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Chapter 4 
Photochemical Studies on Flutamide 
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Introduction 
Flutamide (2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide), 1, FM) is a 
non-steroidal androgen drug which bloclcs androgen receptor sites and is used in 
advanced prostate cancer.'"^ Recent reports have shown that use of this drug is 
associated with photosensitivity reaction and can induce adverse biological effects such 
as siin-exposed eruption in patients after drug treatment."""'^  The photochemistry of FM 
in homogeneous media has been characterized by low photoreactivity as well as by very 
low efficiency in photosensitizing singlet oxygen formation.' "'"^  The photoreactivity of 
free molecule has been rationalized on the basis of an intermolecular nitro to nitrite 
rearrangement followed by cleavage of nitrite intermediate leading to phenol derivative 
2 as the main stable product. The out of plane geometry of the nitro group and the 
consequent overlap of the p-orbital of oxygen with the adjacent orbital of the aromatic 
ring is prerequisite to observe such type of intramolecular photorearrangements. The 
photolysis of FM in presence of biological mimic systems such as cyclodextrin, 
micelles and phospholipid bilayers has been shown to dramatically increase the 
photodecomposition and the different photodegradation pathways were observed.' ' " 
(Scheme 4.1) 
Herein we have investigated; 
[AJ Photolysis of flutamide adsorbed on silica on the silica gel TLC plates. 
[B] Photostability determination of commercially available flutamide oral dosage 
formulations. 
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H N ^ V O H + H N ^ V-NO + HzN^f VNO2 
CF, CF, 
(3) (4) 
Scheme 4.1 
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|A| Photolysis of flutamide adsorbed on silica on the silica gel TLC plates. 
Photochemical investigation of phototoxic drugs in biologically mimicking systems is 
becoming an active area in research, because real life processes occur at surfaces, 
interfaces and multiphase heterogeneous systems. Therefore, to present a model for a 
close correlation between phototoxic and photochemical behaviour of the drug in vivo, 
it is significant to investigate drug photobehaviour in biologically mimicking systems. 
Interface chemistry has played an important role in industrial and natural processes, a 
common feature of this chemistry is the existence of an interface that provides an 
extensive surface whose chemical and geometrical features lead to optimum reaction 
rates and the high chemical selectivity. With this interest, herein, we have investigated 
photolysis of tlutamide adsorbed on silica on the silica gel TLC plates, a biologically 
mimic system, similar to situation in liposomes. ^  
Experimental 
Instrumentation 
The photochemical irradiation was carried out by using a medium pressure mercury 
vapour lamp (125 W). The light was passed through a pyrex glass filter. H-NMR and 
'•'C-NMR spectra were recorded on a Bruker DRX-300 spectrometer using SiMe4 as 
internal standard. FAB-mass spectra were recorded on a Jeol SX 102/DA-6000 
spectrometer at 10 KV accelerating voltage using m-nitrobenzyl alcohol (NBA) matrix 
and argons as FAB gas. Merck silica gel 60 F254 was used for preparing photoirradiation 
plates and column chromatography was performed on Merck silica gel 60 (70-230 
mesh). 
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Chemicals and reagents 
All chemicals used were of analytical grade. Flutamide was extracted from commercial 
medicinal product Cytomid-250 (Cipla Ltd., Mumbai, India) with a soxhlet extractor 
using benzene as a solvent and recrystallized from the same solvent. The purity of the 
crystallized drug was checked by TLC. 
Photohradiation procedure 
Flutamide solution in methanol was misted on silica gel TLC plates by using a TLC 
reagent sprayer and then irradiation of these TLC plates was carried out with UV lamp 
under a stream of nitrogen. After the photolysis, the plates were scarped and adsorbate 
was extracted with methanol and fdtered. The analysis of product was performed by the 
thin layer chromatography (TLC), on a precoated silica gel TLC plates using 
dichloromethane: cyclohexane 80:20 (vol/vol), which showed the photoproduct 3 (Rf = 
0.30) and the starting compound (Rf = 0.20). The solvent was removed in a rotary 
evaporator at room temperature (30° C) and the crude product so obtained, was purified 
by silica gel column chromatography, which yielded 2-methyl-N-[4-nitroso-3-
(tritluoromethyl) phenyl] propanamide (3) as product. 
Characterization of products 
2-Methyl-N-f4-nitroso-3-(tri/Iuoromethyl) phenyl] propanamide (3): H-NMR 
(CD3OD) 5 8.32 (d, J= 2.4 Hz, IH, H-2), 7.94 (dd, J= 8.5 Hz, IH, H-6), 6.28 (d, J=8.5 
Hz, IH, H-5). 2.58 (m, IH, CH(CH3)2), 1.18 (6H, CH(CH3)2); '^C-NMR (CD3OD) 5 
181.0 (CONH). 162.2 (C-4), 138.5 (C-1), 131.9 (C-3), 124.0 (CF3), 122.6 (C-6), 112.7 
(C-2). 110.4 (C-5), 31.3 (CH(CH3)2), 18.6 (CH(CH3)2); FAB-MS: m/z (rel. int.): 261 
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([C,,H|,F3N202+Hf, 9), 230 (CnHnFsNO^ 15), 217 (C8H4F3N202^ 10), 189 
(C7H4F3N2O , 18), 174 (C7H3F3NO^ 100), 145 (C7H4F3^ 20), 86 (C4H8NO^ 25). 
Results and discussion 
Irradiation ol silica gel TLC plates misted with flutamide under UV light and a stream 
of nitrogen afforded the photoproduct 3 as the only major isolated product (Scheme 
4.2). The structure of photoproduct 3 was confirmed on the basis of IR, NMR and mass 
spectral studies (experimental section). A similar photobehaviour of FM, after its 
incorporation to P-cyclodextrin cavities and in unilamillar phospholipid bilayer vesicles 
has been well characterized by Sortino et al.'' The photoreactivity of this drug in 
homogenous media is exclusively characterized by nitro to nitrite rearrangement leading 
to phenol derivative 2 as the main stable photoproduct (Scheme 4.1). The photolysis of 
FM after its incorporation into (B-cyclodextrin cavities increases the 
photodecomposition with the photogeneration of photoproduct 2 along with 3 and 4, 
whereas in phospholipid bilayers photoproduct 3 was noticed as the sole stable 
photoproduct. In this study, for the photolysis of FM on silica gel we have also isolated 
photoproduct 3 as the only product. A possible hypothesis to explain the 
photogeneration of 3 and inhibition of 2 may be due to the structural changes of FM 
occurring upon its incorporation in silica gel cavities. 
It is generally accepted that the structure of the surface of silica consists of 
interconnected network of silanol (SiOH) and siloxane (SiOSi) linkage.'^  Silanol 
linkage are generally classified as (1) the isolated or free (non-hydrogen bonded silanols 
that are characteristic of crystalline silica) (2) the vicinal or hydrogen bonded or active 
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silanols that are characteristic of amorphous silica and (3) hydrated silanols that may be 
the result of water binding to either free or vicinal silanols (Figure 4.1). The active 
silanols are so positioned on the silica surface so as to permit hydrogen bonding. In this 
regard, perpendicular geometry of nitro group with respect to aromatic ring, which is 
necessary for the formation of 2, may be lost due to weak interactions involving active 
silanol and CF3/NO2 groups present in flutamide, and would account well for the 
obtained results. 
Our results concerning to photobehaviour of FM on silica gel further support the fact 
that the drug photochemical behaviour in homogeneous media is the first step for 
understanding of molecular basis of the drug but alone can not be used to understand in 
vivo photochemistry. For a correlation between photobehaviour and phototoxicity of the 
drugs, its photoreactivity should also be investigated in heterogeneous systems of 
increasing complexicity, specific interactions and steric constraints. 
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|B| Photostability determination of commercially available flutamide oral dosage 
formulations. 
Some drugs on exposure to light undergo important chemical changes accompanied by 
alternation in their activities, and in some cases there may be a total loss of the 
therapeutic activity. Manufacturers of pharmaceutical products use light resistant 
coating/or packing to minimize their photodegradation. Long term exposure to sunlight 
or artificial light may result in photodamage, if pharmaceutical formulations are 
improperly stored, and thus poor storage conditions may potentially decrease clinical 
efllciency of these products. Differences in the degree of light protection may also exist 
between different formulation types. Consequently, if differences in photostability 
between these formulations are present, product substitution may not be warranted. 
With this interest, herein, we have investigated the photostability of commercially 
available flutamide oral dosage formulations (tablets) available in India. We have also 
compared the photodegradation of FM powder and methanol solution of three 
commercially available FM oral dosage formulations. 
Experimental 
Chemicals and reagents 
All chemicals used were of analytical or HPLC grade. Pure flutamide powder was 
extracted from commercial medicament Cytomid-250 (Cipla ltd., Mumbai, India) with a 
soxhiet extractor using benzene as a solvent and recrystallized from the same solvent. 
The purity of the crystallized drug was checked by TLC. Three FM tablets (250 mg) 
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[Cytomid-250 (Cipla Ltd.), Plutamide (Torrent Pharm. Ltd.), Prostamid (BDH 
Industries Ltd.)] obtained from local market in India were studied. 2-hydroxy-5-
nitrobenzaldehyde was used as internal standard (IS). 
The FM stock solution was prepared in methanol (10 mg/ml) and standard solutions 
were obtained by serial dilution. The Internal standard solution (IS) was prepared (40 
|.ig/ml) in methanol. I ml of IS solution was mixed with 1 ml of the tested 
concentrations of FM (12.5-150 |Jg/ml) and 20 |il of the mixed solution was injected to 
HPLC. 
Imtdiation test 
For artificial light irradiation, a 40 W tungsten lamp was used. FM samples were placed 
50 cm from the lamp in a cabinet. Protected samples from extraneous light were placed 
in aluminum foils. Exposure to indirect sunlight was also used to compare the efficacy 
of artificial light and natural room daylight in photodecomposition of FM. Samples 
were irradiated from 0-12 weeks in artificial light and indirect sunlight. Samples were 
collected at 0, I, 2, 4, 6, 8, 10 and 12 weeks intervals (n=3). FM powder samples (10 
mg) were placed in 10 ml clean glass vials, irradiated from 0-12 days and samples were 
collected at 0, 1, 2, 3, 7, 10 and 12 days. Also a total of 11 x ] ml methanolic FM 
solution samples (10 fig/ml) were placed in 5 ml clear glass vials and irradiated for a 
period of 0-360 min. Samples were taken at 0, 5, 10, 15, 20, 30, 45, 60, 120, 240, 360 
mins. 
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Sample preparation 
Fluianiick tablets: Five irradiated FM tablets were crushed into fine particles and a 
quantity equivalent to 10 mg of FM was placed in a centrifuge tube and 2 ml of 
chloroform was added. The mixture was vortexed for 30 s and centrifuged for 5 min. 
Twenty f.il of supernatant was drawn by Hamiltonian syringe and added to a tube 
containing 100 fil of IS solution (40 ^ig/ml). This solution was evaporated to a dry 
residue under Nitrogen stream. Two hundred |il of mobile phase was added to the 
residue and vortexed for 10 s. Aliquots of 10 fxl were injected to HPLC. 
Flulamide powder samples: Each of the irradiated FM powder samples were diluted 
with 2 ml of chloroform and vortexed for 20 s. Twenty |il of this solution was mixed 
with 100 |.il of IS solution (40 ng/ml), and dried over nitrogen stream, then 1 ml of 
mobile phase was added and vortexed for 10 s, Finally, 10 \i\ of this solution was 
injected to HPLC. 
Flulamide melhanolic sohilion: One hundred \i\ of IS was added to the vials containing 
I ml of FM (100 |ig/ml) and vortexed, and then 10 i^l of the solution was injected to 
HPLC. 
Identification of the photoproduct 
0.2 mg/ml of FM methanolic solution was exposed to indirect sunlight. At 5 min 
intervals 10 |al of the solution were injected to HPLC until no FM peak was observed in 
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chromatogram (45 min). The solution was then evaporated over nitrogen stream and 
subjected to mass spectrometry after purifying by using column chromatography. 
Chromatography and instrumentation 
FAB-mass spectra were recorded on a Jeol SX 102/DA-6000 spectrometer at 10 KV 
accelerating voltage using w-nitrobenzyl alcohol (NBA) matrix and argons as FAB gas. 
Merck silica gel 60 F254 plates were used for photoirradiation and column 
chromatography was performed on Merck silica gel 60 (70-230 mesh). HPLC was 
performed on a Hewlett-Packard 1100 chromatograph equipped with online photodiode 
array detector. The analysis of FM and its photoproducts was achieved on a 
FiCharoCart FLP-18 column (5 \x.m packing, 4x 250 mm) eluting with a linear gradient 
of CH3CN at a flow rate of 1 ml/min with monitoring at 300 nm. 
Results and discussion 
In the present study photostability of FM formulations available in India was 
determined after exposure to indirect natural light and continuous artificial light. FM, 
its photoproduct 2 and IS were eluted at approximately 8.8, 6.5 and 4.9 min 
respectively. Resolution between FM and 2 was adequate and no buffer and pFI 
adjustment was required with this chromatographic system. Mass spectra of 
photodecomposition product produced major fragments at 248 (M'^  , 4%), 247 (M ' 30 
%), 177 (M^-(CH3)2CHCO, 100%), 157 (50%), 71 (20%) that confirmed the structure 
of photoproduct 2. 
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Figure 4.2 shows a typical chromatogram of (a) commercial 10 mg FM tablet irradiated 
for 12 weeks with indirect natural sunlight (b) a sample of FM methanolic solution 
irradiated with indirect natural sunlight for 6 hours and (c) a sample of FM methanolic 
solution irradiated with artificial light for 6 hours. 
Figure 4.3a shows photodegradation plots of FM powder and figure 4.3b shows 
photodegradation of FM methanolic solution after artificial light irradiation. 
Photodegradation of FM powder, measured as percentage loss of FM powder exceeds 
10% in 30 hours. Photodegradation of FM methanolic solution exceeds 10% in 
approximately 45 min. and was essentially complete within 7 hours. It was also 
observed that the efficacy of artificial light in photodecomposition of FM is more than 
natural indirect sunlight and it can be due to the higher intensity of artificial light than 
natural light. The percentage of FM content (w/w initial FM content) was also 
measured in all three tested formulations irradiated for up to 12 weeks by artificial and 
natural light. 
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Figure 4.2 chromatogram of (a) commercial 10 mg FM tablet irradiated for 12 
weeks with indirect natural sunlight (b) a sample of FM methanolic solution 
irradiated with indirect natural sunlight for 6 hours and (c) a sample of FM 
methanolic solution irradiated with artificial light for 6 hours; 1=IS, 2= photoproduct 
2, 3=FM. 
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Figure 4.3a Photodecomposition of FM powder by 
using artificial liglit 
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Time(h) 
Figure 4.3b Photodecomposition of FM methanolic solution 
using artificial light 
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Table I summarizes photodegradation data for each formulation after 0, 5 and 12-weeic 
exposure to artificial light. The average percentage of photoproduct 2 found in the 
formulations was 1.05, 1.21, 1.49 for 0, 5, and 12 weeks, respectively. Results obtained 
in this study showed that differences between data obtained were not significant and 
none of the tested FM formulations underwent any appreciable decomposition (> 10%), 
even after 12 weeks irradiation. 
Formulation 
Cytomid-250 
Prostamid 
Plutamide 
Percentage of photoproduct 2 (w/w initial FM content) 
0 week 
1.0 
1.0 
1.15 
5 week 
1.14±0.08 
1.10±0.03 
1.40±0.13 
12 week 
1.28±0.11 
1.39±0.24 
l.81±0.19 
Table 1 Flutamide formulations photodegradation data 
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Chapter 5 
Photooxygenation Studies on Furanoterpenes 
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Introduct ion 
For over a century, natural products have served as tools and leads for the 
developments of new drugs, and several natural compounds from plants and 
animals kingdom are now useful drugs. Moreover, plenty of plant materials for 
their biologically active principles have proved to be of potential medicinal 
value. ' ' 'The photoreactivity of synthetic drugs have been intensively studied in 
the recent past for their photosensitizing properties, phototoxicity and 
phototherapeutic values and also for photodegradation studies.^"^ However, a 
significant and related work on photochemistry of medicinally and biologically 
active compounds from plants is sporadic. ' '^ It is of importance to study the 
photoreactivity of biologically active plant metabolite for a correlation to their 
possible in vivo photoreactions and phototoxicity. Several natural plant extracts 
containing terpenoids are widely used in agriculture and medicine.'^'"^ 
Photochemical study is expected to through light on improving the stability of 
these compounds into the biological extracts containing terpenoids. Moreover, 
the significance of generation and reactions of singlet oxygen with 
biomolecules in plants and living systems have been recognized. It is now 
generally accepted that certain secondary plant substances have a defensive 
role, offering protection against predators, pathogens and competitors. It is 
increasingly recognized that certain of these defensive chemicals are capable of 
photosensitizing reactions that involve the transfer of light energy to oxygen, it 
is thus apparent that plants may utilize these activated forms of oxygen, such as 
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singlet oxygen, in their own defense. Other secondary plant products may have 
a physiological role in that they protect the plant against damaging 
photodynamic reactions by quenching the excited singlet state of oxygen. 
Within the context we have investigated photooxidation reactions of the 
following terpenoids: 
|A] Sensitized photooxygenation of tinosponone, a clerodane diterpene from 
Tinaspora cordifolia. 
I B] Photooxidation of 2p-angeloyloxy-10p-H-furanoeremophilane. 
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|A| Sensitized photooxygenation of tinosponone, a clerodane 
diterpene from Tinospora cordifolia 
Tinosponone (1), a clerodane diterpene isolated from Tinospora cordifolia, a 
plant of recognized medicinal values which is widely used as anti-bacterial, 
analgesic, antipyretic and also for the treatment of jaundice, skin diseases, 
diabetes, anaemia etc. " Several compounds containing 3-substituted furan 
moiety have been isolated from this plant species. " In spite of immense 
medicinal use of this plant extract the photochemical sensitivity of their 
bioactive constituents has not been described in the literature. The 3-substituted 
furan moiety is quite susceptible to attack by biological oxygens; we therefore, 
have investigated photooxygenation of tinosponone under different 
combinations of sensitizer dyes and solvents. 
Experimental 
Apparatus and chemicals 
Irradiations were carried out in a photoreactor equipped with medium pressure 
mercury vapour lamp inserted in a water-cooled immersion well with 
continuous supply of water. IR spectra were recorded as KBr discs on a Perkin 
Elmer model spectrum RXl. ' H - N M R and '^C-NMR spectra were recorded on a 
Bruker Avance DRX-300 spectrometer using SiMe4 as internal standard and 
CDCI3 as solvent. FAB-mass spectra were recorded on a Jeol SX I02/DA-6000 
spectrometer at 10 KV accelerating voltage using m-nitrobenzyl alcohol (NBA) 
matrix and argons as FAB gas. Elemental analyses were carried on a Carlo Erba 
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model 1108 Elemental analyzer. High-resolution mass spectra were determined 
with a VG-ZAB-BEQ9 spectrometer. All solvents and chemicals used were of 
analytical grade. Tinosponone was isolated from stem of Tinospora cordifolia 
according to literature procedure.^'* The purity of 1 was determined by 
comparison of its melting point and ' H - N M R with that of literature value. 
Merck silica gel 60 F254 plates were used for analytical TLC; column 
chromatography was performed on Merck silica gel 60 (70-230 mesh). 
Irradiation procedure 
An air-saturated benzene solution of tinosponone (1) (100 mg, 1.5 mM in 
200mL) was irradiated for 8 hr with a medium pressure mercury vapour lamp 
(125 W) in presence of methylene blue (0.01 gm, 10% wt/wt of tinosponone). 
Complete decomposition of 1 was monitored by thin layer chromatography 
(ethyl acetate: hexane; 3 : 7). Removal of the solvent under reduced pressure and 
column chromatography of the resulting photoproduct on silica gel yielded 
compound 2 and 3. This photoreaction was also carried out under nitrogen 
atmosphere by saturating the solution with nitrogen prior to irradiation and with 
continuous bubbling during irradiation. 
Similar experiments were carried out by using different combinations of solvents 
and sensitizers (Table 5.1 and 5.2), Two different sets of reactions were also 
carried out in similar way by using DABCO/sodium azide (10% wt/wt of 
tinosponone) with methylene blue as sensitizer. 
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Ch uracterizatlon of products 
(3S,4aS,4hS,8R,8aR,10aR)-8-Hydroxy-3-(5 '-hydroxy-2 '-oxo-2 ',5'-dihydrofuran 
-3'-yl)-4a,8a-dimethyl-3,4,8,8a,9,10-hexahydro-10aH-benzo[f]isochromene-l,5 
(4aH,4hH)-dione (2): mp 177°C; Rf 0.83; [a]^^D-93.7 (c 0.92, CHCI3); HRMS: 
[M'] calcd for C19H22O7, 362.3738; found, 362.3731; IR (KBr) v 3500, 3390, 
1745, 1715, 1678, 1450 cm"'; ' H - N M R (CDCI3, 5, ppm): 6.94 (d, IH, J=7.1 Hz, 
11-4-), 6.67 (dd, IH, J = ]0.8, 5.2 Hz, H-7), 6.15 (d, IH, J=7.0 Hz, H-5'), 5.91 (d, 
IH, .1=10.8 Hz, H-6), 4.91 (dd, IH, J=12.2, 3.6 Hz, H-3), 4.82 (brs, exch., -OH), 
4.28 (d, IH, J=5.1 Hz, H-8), 2.42 (dd, IH, J=14.8, 3.4 Hz, H-4), 2.38 (brs, IH, 
H-lOa), 2.21 (m, IH, H-9), 2.20 (brs, IH, H-4b), 2.18 (m, IH, H-10), 1.65 (dd, 
IH. J=15.4, 12.2 Hz, H-4), 1.61 (m, IH, H-10), 1.42 (s, -CH3), 1.1 (dt, IH, 
,1=13.8, 4.5 Hz, H-9), 0.80 (s, -CH3); '^C-NMR (CDCI3, 8, ppm): 204.5 (C-5), 
176.2 (C-1), 175.7 (C-3), 141.5 (C-1), 143.1 (C-7), 136.5 (C-2), 127.5 (C-6), 
97.5 (C-10), 74.5 (C-8), 60.5 (C-3), 52.6 (C-4b), 49.2 (C-lOa), 42.9 (C-8a), 40.1 
(C-4), 34.8 (C-4a), 30.9 (CH3), 29.9 (C-9), 26.6 (CH3), 19.2 (C-10); MS m/z 
(relative intensity): 345 (Ci9H2i06^ 14), 318 (C|8H2205^ 100), 303 (C,8H230/, 
15), 274 (C,7H2203^ 10), 263 (CsHigO/ , 17), 261 (C|7H2502^ 9); Anal, calcd. 
for C19H22O7: C 62.97, H 6.12, O 30.91; found C 62.84, H 6.08, O 30.98. 
(3S,4aS,4bS,8R,SaR,10aR)-8-Hydroxy-4a,8a-dimethyl-3-((l 'R)-3 '-oxo-4 ',6'-
dioxa-bicyclo[3.1.0]hexan-r-yl)-3,4,8,8a,9,10-hexahydro-10aH-benzolf] 
isochroinene-l,5(4aH,4bH)-dione (3): mp 164°C; Rf 0.62; [a]^^D -84.6 (c 
0.47, CHCI3); HRMS: [M^] calcd for C19H22O7, 362.3738; found, 362.3751; 
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IR (KBr) v3430, 1750, 1710, 1660, 1210, 950, 745 cm"'; ' H - N M R {CDCI3, 5, 
ppm): 6.52 (dd, 1H, J=10.6, 4.8 Hz, H-7)), 5.75 (d, IH, J=10.4 Hz, H-6), 5.23 
(s, IH, H-4), 4.87 (dd, IH, J=12.4, 3.8 Hz, H-3), 4.30 (d, IH, J=5.1 Hz, H-8), 
4.12 (brs, exch., -OH), 2.28 (dd, IH, J=14.2, 2.9 Hz, H-4), 2.22 (brs, IH, H-
10a), 2.36 (m, IH, H-9), 2.2 (s, IH, H-1), 2.16 (brs, IH, H-4b), 1.98 (m, IH, 
H-10), 1.71 (m, IH, H-10), 1.58 (dd, IH, J=15.3, 11.8 Hz, H-4), 1.38 (s, CH3), 
1.12 (dt, IH, J=13.6, 4.4 Hz, H-9), 0.80 (s, CH3); '^C-NMR (CDCI3, 5, ppm): 
202.6 (C-5), 175.2 (C-1), 171.1 (C-2), 145.2 (C-7), 130.7 (C-6), 120.4 (C-4), 
75.2 (C-8), 59.2 (C-10), 56.8 (C-3), 52.5 (C-4b), 48.1 (C-lOa), 44.2 (C-8a), 
41.7 (C-4), 36.6 (C-4a), 36.2 (C-1), 31.3 (CH3), 25.4 (CH3), 18.8 (C-10), 18.6 
(C-9),; MS m/z (relative intensity): 318 (C|8H2205^ 20), 290 (Ci7H2204^ 100), 
278 (C|5H|805\ 11), 276 (C,7H2403^ 11), 263 ( C j H i g O / , 9), 221 (Ci4H2i02\ 
16), 84 (C4H402^, 19); Anal, calcd. for C19H22O7: C 62.97, H 6.12, O 30.91; 
found C 62.74, H 6.34, 0 31.05. 
(3S,4aS,4hS,8R,8aR,10aR)-8-Hydroxy-3-(5 '-hy draper oxy-2 '-methoxy-2 ',5'-
dihydrofuran-3 '-yl) -4 a, 8a-dimethyl-3,4,8,8a, 9,10-h exahydro-10aH-benzo[f] 
isochromene~l,5(4aH,4bH)-dione (4): mp 169°C; [af\ -77.8 (c 0.34, 
CHCI3); HRMS: [M^] calcd for CjoHjeOs, 394.4156; found, 394.4152; IR 
(KBr) V 3520, 3500, 1670, 1250 cm"'; ' H - N M R (CDCI3, 5, ppm): 8.12 (brs, 
exch., OOH), 6.61 (dd, IH, J=10.7, 5.2 Hz, H-7), 6.21 (d, IH, J=7.4 Hz, H-10), 
5.84 (s, IH, H-3), 5.72 (d, IH, J=7.2 Hz, H-1), 5.62 (d, IH, J=10.8 Hz, H-6), 
4.94 (dd, IH, ,1=12.1, 3.2 Hz, H-3), 4.64 (brs, exch., -OH) 4.26 (d, IH, J=4.8 
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Hz, H-8), 3.22 (s, 3H, -OCH3), 2.48 (dd, IH, J=13.8, 3.2 Hz, H-4), 2.30 (brs, 
IH, H-lOa), 2.22 (m, IH, H-9), 2.20 (brs, IH, H-4b), 2.12 (m, IH, H-10), 1.68 
(dd. IH. J=15.2, 12.8 Hz, H-4), 1.65 (m, IH, H-10), 1.48 (s, 3H, CH3), 1.1 (dt, 
IH. .1=13.8, 4.0 Hz, H-9), 0.82 (s, 3H); '^C-NMR (CDCI3, 8, ppm): 200.5 (C-
5). 173.4 (C-1), 143.7 (C-7), 141.4 (C-2), 129.4 (C-6), 114.7 (C-1), 114.7 (C-
1), 1 12.2 (C-10), 98.4 (C-3), 73.8 (C-8), 58.1 (C-3), 53.8 (OCH3), 51.3 (C-4b), 
47.6 (C-lOa), 43.1 (C-8a), 39.2 (C-4a), 33.7(C-CH3), 26.1 (C-9), 25.2 (CH3), 
18.4 (C-10); MS m/z (relative intensity): 301 ( C s H j i O / , 100), 363 
(C,9H2307", 18), 361 (C20H25O6\ 21), 331 (C,9H2305\ 13), 288 (C,7H2o04\ 
11), 206 (C|4H220^ 15), 84 (C4H402^ 21); Anal, calcd. for C20H26O8: C 60.90, 
H 6.64, O 32.45; found C 60.98, H 6.45, 0 32.52. 
Results and discussion 
Irradiation of air-saturated benzene solution of tinosponone with methylene 
blue as sensitizer in a water-cooled immersion well type photoreactor 
equipped with medium pressure mercury vapour lamp and purification of 
the crude product by silica gel column chromatography afforded two 
compound 2 (epimeric mixture) and 3. When tinosponone was irradiated 
with methylene blue in methanol, the chromatographic analysis (TLC) of 
irradiated mixture did not show the presence of any of the previously 
identified products (2 and 3), rather a new product 4 (epimeric mixture) 
was observed (Scheme 5.1). When these photoreactions were carried out in 
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the absence of sensitizer same products were obtained but the reaction was 
observed to be slow. 
The effect of the nature of solvent on photooxidation was studied by using 
different solvents. The amount of substrate could not be kept same, as the 
solubility of substrate was different in different solvents. Therefore, relative 
yields of products were determined in these cases. For this purpose, different 
reaction mixtures were irradiated under standard condition for the same time 
period. Then 15 ml of each solution was taken out, concentrated and 
subjected to preparative TLC for the isolation of the products, and 
correlation of their yields. Yields of products in. different solvents were 
found to vary v i^th the polarity of the solvent. The yield was higher in polar 
solvents in comparison to non-polar solvents (Table 5.1). This observation 
may be attributed to longer lifetime of 'O2 in polar solvents.^^'^^ Owing to 
the solubility problem, the concentration of 1 was not same in all the 
solutions, as it was in the case of methylene blue therefore, possibility of 
energy transfer for different yields of products cannot be discarded. To 
confirm whether energy transfer or longer lifetime of'O2 is responsible for 
different yields of products, we conducted experiments by varying the 
concentration of sensitizer (5x10 to 2x10 mol L ) to the concentration of 
tinosponone in different solvents. Similar pattern of product formation was 
also obtained in these cases, which supports the fact that lifetime of 'O2 and 
in turn polarity of solvent is responsible for the observed difference in the 
[82 
>ields. The dependence of percentage yields of the products on triplet 
energies of various sensitizers has also been studied. It was observed that 
rose bengal and methylene blue was much more efficient than riboflavin and 
benzophenone in the photosensitized decomposition of 1 (Table 5.2). This 
may be due to the fact that rose bengal and methylene blue, with lower triplet 
energies, produce singlet oxygen in large amount^^'^^ by type II mechanism.^^ 
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Solvent Lifetime of O2 Yields of products 
^ (2+3) 
Benzene 24 32.3(19.6+12.7) 
Acetone 26 31.6(18.9+12.7) 
Acetonitrile 30 35.2(22.8+12.4) 
Chloroform 60 40.4 (27.1 + 13.3) 
Concentration of tinosponone =100 mg/200mL, 1.5 mM. Concentration 
of methylene blue = 10% wt/wt of tinosponone. Time of irradiation = 4 
hours. ^See refs. [25, 26]. Yields of the products were determined after 
isolation according to experimental part. 
Table 5.1 Yields of products, by methylene blue 
photosensitized reaction of tinosponone with different solvents 
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Sensitizer Triplet energy^ Yields of products 
(Kcal/mole) (%)^ 
(2+3) 
Methylene blue 33 .5 -34 .0 31.7(19.1+12.6) 
Rose bengal 39 .2 -42 .2 30.3(17.1 + 13.2) 
Riboflavin 57.8 21.2(11.3+9.9) 
Benzophenone 68 .6-69 .1 19.9(9.9+10.0) 
Concentration of tinosponone =100 mg/200mL, 1.5 mM. Concentration 
of dye = 10% wt/wt of tinosponone. Time of irradiation = 4 hours. ^See 
ref. [35]. ''Yields of the products were determined after isolation 
according to experimental part. Benzene was used as solvent. 
Table 5.2 Effect of triplet energies of different sensitizers on the 
yields of products. 
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On other hand riboflavin and benzophenone (higher triplet energies) act 
mainly by type 1 photosensitized photooxidation, do not produce significant 
amount of '02.^° The participation of 'O2 in the reaction was confirmed by 
studying the effect of some scavengers on the yield of this photooxidation 
reaction. The drastic lowering of the yields of the products in presence of 
scavengers (DABCO-17%; sodium azide-14%) confirms that 'O2 is active 
oxidizing species in this photoreaction. Also no reaction was observed on 
conducting experiments under nitrogen atmosphere. When irradiations were 
carried out by using silica bound rose Bengal/' same products were obtained 
but the reaction was observed to be slow. 
The structure of the photoproducts was assigned on the basis of IR, ' H - N M R , 
'^C-NMR, mass spectral and elemental analysis studies. The spectral data of 
photoproducts 2, 3 and 4 were found to be similar with that of 1 except for 
the furan signals. The furan ring has been site of attack is evident from 
absence of carbon /hydrogen signals due to furan moiety in the spectral data 
of all the identified photoproducts. The spectral studies suggested that 
product 2 posses 5-hydroxy butenolide moiety instead of furan moiety. The 
additional IR bands at 3390 cm"' (hydroxy group), 1670 (a, (3-unsaturated 
ketone) and extra carbonyl '^C- resonance at 5 175.7 suggested an extra 
1 o 
lactone carbonyl compared to that of parent compound. The C-NMR signal 
for C-5' at 5 97.5ppm (attached to proton at a downfield value of 5 6.15 ppm) 
indicated that carbon is attached to two oxygen atoms. This proton is in split 
187 
with the proton of a, P-unsaturated carbon at S 6.94, suggesting that carbon 
attached to two oxygen atoms must be adjacent to a, P-unsaturated carbon. 
The change of furan ring to 5-hydroxy butenolide moiety is also evident from 
the two carbon signals at 5 136.5 and 175.7 instead of the olefmic signals of 
furan at 8 121.5 and 139.7. 
Fhe spectral data for compound 3 was also found to be similar with that of 1 
except for the furan signals. On the basis of following spectral data we 
conclude the presence of epoxy lactone in 3. The '^C-NMR spectrum 
indicated an additional lactone carbonyl resonance at 5 171.1. A signal at 5 
120.4 was assigned to a dioxygenated carbon of the epoxylactone ring, with 
additional support from its H-NMR signal at 5 5.23. Of the other carbons of 
the lactone ring, a carbon resonance value at 5 36.2 along with a proton 
resonance at 8 2.2 was assigned to the methylene carbon and at 5 59.2 
assigned to the quaternary carbon. The formation of lactone ring gets 
additional support from the IR spectrum of 3, which shows characteristic 
absorption for two lactone carbonyl at 1750 and 1710 cm"' and for the 
epoxide ring at 3150, 1210, 950 and 745 cm"'. 
The compound 4 was having a comparably similar spectral data to 1, with a 
basic difference in furan ring values. It was shown to contain a 2,5-
dihydrofuran ring with an allylic hydroperoxy and a methoxy group. The H-
NMR spectrum recorded a highly deshielded signal at 5 8.1 (brs, exch., IH) 
and a three proton singlet at 8 3.32, which were assigned to the allylic -OOH 
group (at C-5') and -OMe group (at C-2') respectively. This regiostructure gets 
support from the ' H - N M R signals as a singlet at a low value of 5 5.84 for C-2' 
proton and a doublet at a high value of 5 6.21 for C-5' proton. Of the olefinic 
carbons, a carbon resonance at 5 114.7 was assigned to C-4' and at 5 141.4 was 
assigned to C-3'. The signals for the protons at C-4' and -OCH3 were 
appropriately observed at 5 5.72 and 3.32, respectively. Additional structural 
information for the compound 4 was inferred from its following chemical 
properties: 1) with Pb(0Ac)4, gas was evolved, which is characteristic of 
compounds containing -OOH group; 2) with potassium iodide-acetic acid 
solution it liberated iodine, indicating presence of 0 - 0 bond.^ 
The formation of photoproducts 2, 3 and 4 can be envisaged to occur from 
unstable cyclic peroxide la , which initially results by a [47I:+27T:] cycloaddition 
of 'O2 to furan ring (Scheme 5.1). This unstable cyclic peroxide (la) 
undergoes homolytic cleavage of 0 - 0 bond to give a diradical which affords 
products 2 and 3 by following two competing processes:"'^ '" '^^  in one way the 
diradical intermediate formed undergos epoxycyclization followed by 1,2-
hydrogn shift gives compound 3. In an alternative competitive path a 1,4-
hydrogen migration in the diradical intermediate gives product 2 (Scheme 5.2). 
In the presence of polar methanol solvent, the solvolysis induced 
transformation of intermediate la leads to the formation of product 4. 
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| B | Photoox idat ion of 2 p - a n g e l o y l o x y - 1 0 p - H - f u r a n o e r e m o p h i l a n e 
Furanoeremophilanes, a novel class of sesquiterpenes is the constituents of 
several medicinal plants^ '^"^ and is well known for their medicinal values^^"*' 
e.g. antioxidant and antiradica! property, toxicity'*^''"^ and antifeedant'*'' activity. 
Herein we have investigated photooxidation of 2p- angeloyloxy-lOp-H-
furanoeremophilane ' (5) m its reaction with singlet oxygen ( O2) using 
different reaction media. 
E x p e r i m e n t a l 
Instrumentation and chemicals 
Same as in section [A] 
Irradiation procedure 
Irradiation of 2/3-angeloyloxy-lOfi-H-furanoeremop/tilane (5) in benzene 
2|3-Angeloyloxy-10p-H-furanoeremophiiane was isolated as described in the 
literature.'*^ Compound 5 (100 mg , 0.316 mM) was dissolved in benzene (250 
ml) and the solution was irradiated, under continuous bubbling of air, with a 
light from a 400W medium pressure mercury lamp housed in a water cooled 
immersion well quartz photo-reactor. The Progress of reaction was monitored 
by thin layer chromatography (TLC), which indicated gradual disappearance of 
starting material. When the rate of product formation became negligible, 
solvent was removed and the residue was purified by TLC on silica gel, eluting 
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with 50% ether-hexane, where it yielded hydroxybutenolide (8) and 
epoxylactone (10) as the products (Scheme 5.3). 
2l3-Angeloyloxy-8-hydroxy-10/3-H-eremophilanolide (8): Yield: 38.48 mg; mp 
210° C; HRMS calcd. for (M^) C20H28O5 348.198 found 348.199; IR v.^ax'"'"': 
3620 (-0H), 1765 (Lactone), 1715, 1650 (C=C-COOR); ' H - N M R (CDCI3) 5 
1.06 (d. J=6.8 Hz, 3H, H-15), 1.16 (s, 3H, H-14), 1.41 (s, IH, H-10), 1.51 (m, 
2H, H-l & H-3), 1.55 (dd, J=17 & 9 Hz, IH, H-9), 1.59 (m, IH, H-4), 1.71 (d, 
.1=1.5 Hz, 3H, H-4'), 1.75 (s, IH, H-6), 1.76 (m, 2H, 1-H & 3-H), 1.80 (d, 
.1 = 1 7& 9 Hz, IH, 9-H), 1.93 (s, 6H, H-5' & H-13), 2.00 (s, IH, H-6), 3.91 (m, 
IH, H-2), 6.03 (m, 1 H, H-3'); '^C-NMR (CDCI3) 5 11.6 (C-13), 12.1 (C -4'), 
16.4 (C-15), 17.5 (C -5'), 20.5 (C-14), 25.4 (C-10), 26.5 (C-6), 31.1 (C-4), 35.1 
(C-1), 37.3 (C-3), 40.6 (C-9), 50.8 (C-5), 71.8 (C-2), 110.9 (C-8), 125 (C-11), 
128.3 (C-2'), 138.6 (C-3'), 156.3 (C-7), 167.2 (C-1') 176.0 (C-12); El-MS m/z 
(rel. int.%): 349 ( M+1, 25), 245 (M+1-RCOOH, 42), 218(100). 
2fi-Aiigel<)yIoxy-7,8-epoxy-10/3-H-eremophilanolide (10): Yield: 19.75 mg; mp 
206 °C: HRN4S calcd. for (M^) C20H28O5 348.198 found 348.197; IR Vmax'™"' : 
1765 (Lactone), 1715, 1650 (C=C-COOR) 1420, 1380, 1330, 1293, 1171, 964, 
816, 733, 562; ' H - N M R (CDCI3) 5 1.06 (d, J=6.8 Hz, 3H, H-15), 1.16 (s, 3H, 
H-14), 1.24 (d, J=7 Hz, 3H, H-13), 1.33 (dd, J= 15 & 7 Hz, IH, H-6), 1.41 (s, 
IH, H-IO), 1.51 (m, 2H, H-l & H-3), 1.58 (dd, J= 15 & 7 Hz, IH, H-6), 1.59 ( 
m, IH, H-4), 1.64 (dd, J=15 & 7 Hz, IH, H-9), 1.71 (d, J=1.5 Hz, 3H, H-4'), 
1.76 (m, 2H, H-l & H-3), 1.89 (dd, J=15 & 7, IH, H-9) 1.93 (s, 3H, H-5'), 2.78 
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(q, J=7 Hz, IH, H-11), 3.91 (m, IH, H-2), 6.03 (m, IH, H-3'); '^C-NMR 
(CDCI3) 6 10.3 (C-13), 12.1 (C-4'), 16.3 (C-15), 17.5 (C -5'), 20.1 (C-5), 
27.4(C-10), 30.5 (C-9), 30.7(C-4), 34.4 (C-1), 36.7 (C-6), 37.2 (C-3), 71.8 (C-
2), 93.3 (C-8), 128.3 (C-2'), 138.6 (C-3'), 167.2 (C-1'), 177.4 (C-12); EI-MS 
m/z (rel. int.%): 347 ( M^ 1), 329 (M^-HiO, 2), 247 ( M ' " - C 4 H 7 C 0 0 H , 12), 83 
(C4H7CO^ 100), 55 (83-CO, 44). 
Photosensitized oxygenation of 2P-angeloyloxy-10p-H-furanoeremophilane 
(5) in methanol 
Compound 5 (100 mg, 0.316 mM), was dissolved in 250 ml MeOH containing 
100 mg of rose bengal. The solution was irradiated with a 400W medium 
pressure mercury lamp in a water-cooled immersion well type quartz photo 
reactor with continuous supply of O2. The progress of the reaction was 
monitored by TLC (silica gel, ether-hexane). When the rate of product 
formation became negligible solvent was evaporated in a rotary evaporator, and 
the residue taken up in ether, the ether was washed with water, treated with 
activated charcoal, dried and evaporated to yield 11 as colorless oil (Scheme 
5.4). 
2p-Angeloyloxy-10P-H-8-methoxy-12-hydroperoxy 
dihydrofuranoeremophilane (11): Yield: 37.20 mg; mp 198° C; HRMS calcd. 
for (M"") C21H32O6 380.219 found 380.220; IR v.^ax'"'"': 3514, 2130, 1830, 
1715, 1650, 1250; ' H - N M R (CDCI3) 5 1.06 (d, J=6.8 Hz, 3H, H-15), 1.16 (s, 
3H, H-14), 1.41 (m, IH, H-10), 1.42 (dd, J= 15 & 7 Hz, iH, H-9), 1.57 (m, 2H, 
193 
H-1), 1.51 (m, 2H, H-3), 1.59 (m, IH, H-4), 1.67 (dd, J= 15 & 7 Hz, 3H, H-9), 
1.71 (d. .1 = 1.5 Hz, 3H, H-4'), 1.75 (dd, .1=15 & 7 Hz, IH, H-6), 1.76 (m, 2H, H-
3). 1.81 (d, .1 = 1.5 Hz, 3H, H-13), 1.93 (s, 3H, H-5'), 3.24 (s, -OCH3), 3.91 (m, 
IH. H-2), 6.03 (m, IH, H-3'), 8.16 (s, IH, H-12); '^C-NMR (CDCI3) 8 7.6 (C-
13), 12.1 (C-4'), 16.3 (C-15), 17.5 (C-5'), 20.5 (C-14), 21.2 (C-6), 25.8 (C-10), 
35.4 (C-l), 37.3 (C-3), 39.5 (C-9), 51.4 (C-5), 51.6 (-OCH3), 71.8 (C-2), 110.3 
(C-12), 112.0 (C-8), 128.3 (C-2'), 130.8 (C-11), 138.6 (C-3'), 141.7 (C-7), 
167.2 (C-r ) ; EI-MS m/z (rel. int.%): 381 (M^ 7), 363 (M-H2O, 13), 209 (15), 
180.15 (3), 83 (100). 
Reanangement of 11 under acidic condition 
Compound 11 (0.2 mM) was taken in MeOH to which 5% HCl was added until 
ihc solution became cloudy. The mixture was refluxed for 2 hr, cooled, diluted 
with water, and extracted with ether to yield a compound identified as 8. All the 
spectral values in IR, ' H - N M R , ' ^ C - N M R and mass spectra were found to 
correspond to that of 8 (Scheme 5.5). 
Pyrolysis of Pliotoproduct 11 
A sample of 11 (0.2 mM) was taken in benzene and injected into the gas 
chromatograph (column, 200°, injection block 250°). A single product as 12 
was formed. The product was collected from the gas chromatograph (Scheme 
5.5). 
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2p-Angeloyloxy -10f3-H-8-methoxy-eremophilanolide (12): Yield: 31.15 mg; UV 
Xniax 216 nm; mp 200° C; HRMS calcd. for (M^) C21H30O5 362.208 found 
362.209; IR Vi^ax'""': 1779, 1760, 1698, 1650, 1533; ' H - N M R (CDCI3) 5 1.06 
(d, .1=6.8 Hz, 3H, H-15), 1.16 (s, 3H, H-14), 1.41 (m, IH, H-10), 1.51 (m, 2H, 
H-1 & H-3), 1.53 (dd, J=15 & 7 Hz, IH, H-9), 1.59 (m, IH, H-4), 1.71 (d, J= 15 
Hz. 3H. H-4'), 1.75 (dd, J=15 & 7 Hz, IH, H-6), 1.76 (m, 2H, H-1 & H-3), 1.78 
(dd. ,1=15 & 7 Hz, IH, H-9), 2.00 (dd, J=15 & 7, IH, H-6), 3.24 (s, -OCH3), 
3.91 (m, IH, H-2), 6.03 (m, IH, H-3'); '^C-NMR (CDCI3) 5 7.6 (C-13), 12.1 
(4'-C), 16.4 (C-15), 17.5 (C-5'), 20.5 (C-14), 21.2 (C-6), 25.8 (C-10), 31.1 (C-
4), 35.4 (C-1), 39.5 (C-9), 51.4 (C-5), 51.6 (-OCH3), 71.8 (C-2), 110.3 (C-12), 
112.0 (C-8), 128.3 (C-2'), 130.8 (C-11), 138.6 (C-3'), 141.7 (C-7), 167.2 (C-1'); 
El-MS m/z (rel. int.%): 363 (M+, 34), 332 (M^-0CH3, 13), 263 (M^-
C4H7COOH, 1 1), 83 (C4H7CO^ 93), 55 (C4H7CO^-CO, 40). 
Reduction of N with triphenylphosp/iine 
A solution of 11 (0.2 mM) in ether was added drop wise to a refluxing solution 
of triphenylphosphine in 30 ml ether during 1.5 h. The solution was refluxed 1 
h. chilled to -5 ''C and filtered to remove the triphenylphosphine oxide. The 
ether was removed with a rotary evaporator, and the residue was 
chromatographed on silica gel column to give 16 (Scheme 5.5). 
2/3-Angeloyfoxy -10/3-H-eremophilanolide (16): Yield: 31.85 mg; UV Xmax 217 
nm; mp 195° C; HRMS calcd. for (M^) C20H28O4 332.198 found 332.199; IR 
v„K,x"""': 1808, 1800. 1765, 1715, 1650, 1000; ' H - N M R (CDCI3): 5 1.06 (dd, 
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.1=15 & 7 Hz, 3H, H-15), 1.16 (s, 3H, H-14), 1.40 (dd, J=15 &7 Hz, IH, H-9), 
1.41 (m, IH, H-iO), 1.51 (m, 2H, H-1 & H-3), 1.59 (m, IH, H-4), 1.65 (dd, 
J=I5 & 7 Hz, IH, H-9), 1.75 (d, J=17 Hz, IH, H-6), 1.76 (m, 2H, IH & H-3), 
1.93 (s, 3H, H-5'), 1.93 (s, 3H, H-13), 3.91 (m, IH, H-2), 4.91 (dd br, J=6.5 & 
10 Hz, IH, H-8), 6.03 (m, IH, H-3'); '^C-NMR (CDCI3): 5 11.3 (C-13), 12.1 
(C-4'), 16.4 (C-15), 17.5 (C-5'), 20.5 (C-14), 31.1 (C-4), 31.6 (C-10), 32.7 (C-
6), 34.0 (C-9), 34.8 (C-1), 37.3 (C-3), 50.5 (C-5), 71.8 (C-2), 81.2 (C-8), 125.9 
(C-l 1), 128.3 (C-2'), 138.6 (C-3'), 164.6 (C-7), 167.2 (C-T), 176.0 (C-12); EI-
MS m/z (rel. int.%): 333 (M^ 37), 277 (M^-C4H7, 24), 233 (M^-C4H7COOH, 
31), 83 (C4H7CO^ 91), 55 (C4H7CO^-CO, 13). 
Irradiation of 5 in Silica gel bound Rose bengal 
Compound 5 (100 mg, 0.316 mM), [Psi]-rose bengal^' (200 mg, 6.5 mg/g) and 
100 ml of methanol were placed in the photochemical reactor and irradiated at 
10" C in the presence of bubbling oxygen. The progress of reaction was 
monitored by TLC. After 10 h of irradiation, the reaction mixture was removed, 
washed with methanol and chromatographed on silica gel to give two products, 
identified to be same as 8 and 10 by comparison of their spectral data. It was 
found that upon standing the reaction mixture and so also on addition of dil HCI 
in the reaction mixture, the product 10 (epoxy lactone) converted into hydroxy 
butenolide 8 (Scheme 5.4). 
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Result and Discussion 
Irradiation of furanoeremophilane (5) in benzene under continuous air bubbling 
with quartz filtered light from a medium pressure mercury lamp, and 
purification of the crude product by silica gel column chromatography afforded 
compound 8 and 10, identified as 2p-angeloyloxy-8-hydroxy-10p-H-
eremophilanolide and 2p-angeloyloxy-7,8-epoxy-l OP-H-eremophilanolide, 
respectively. Both the 2p-angeloyloxy-10p-H-furanoeremophilane (5) and 
hydroxybutenolide (8) have been isolated from the same plant species and it has 
been indicated that 5 is probable natural artefact of S."*^  
The mechanism of formation of y-hydroxybutenolide (8) and epoxylactone (10) 
is depicted in Scheme 5.3. [4TI:+27I:] Cycloaddition of O2 to furan moiety of 5 gives 
an unstable ozonide peroxide intermediate (6), which by hemolytic cleavage of 0 -0 
bond produces diradical intermediate 7. Intermediate 7 on epoxycyclization followed by 
1,2 - hydrogen shift gives compound 10. In an alternative competitive path a 1,4-
hydrogen migration in the intermediate 7 gives product 8 (Scheme 5.3). Cyclic 
peroxides are generally unstable, however in some cases stable peroxides have 
been isolated.'*'' The participation of 'O2 in this reaction was confirmed by 
studying the effect of DABCO (singlet oxygen scavenger) on the yields of 
photooxidation products. The drastic lowering of the yield of products in 
presence of DABCO confirms that 'O2 is active oxidizing species in this 
photoreaction. Also no reaction was observed on conducting experiments under 
nitrogen atmosphere. 
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The ' H - N M R and ^C-NMR spectrum of compound 8 were similar to those of 5 
except for the furan signals. The extra carbonyl resonance at 5 177.4 ppm 
indicated an additional lactone carbonyl compared to that of parent compound. 
This was confirmed by the presence of IR bands at 1765, 1715 and 1650 cm"'. 
The absence of C/H NMR signals due to furan moiety indicated that the furan 
ring had been the site of attack. '^C-NMR signals at 5 110. ppm (carbon having 
no proton), indicated that the carbon must be attached to two oxygen atoms. 
Further, 5 2.48 and 2.23, the H-9 signal in compound 5 changes to 5 1.80 and 
1.55 ppm, suggesting that double bond between Cv-Cg in 5 is shifted to Cy-Cn 
in 8, and the carbon connected to two oxygen atoms must be adjacent to p 
carbon of the a, (B-unsaturated ketone system. The presence of other carbon 
signals at 1 77.4, 156.3, 125.9 and 1 1.6 ppm along with an IR band at 3620 cm"' 
indicated that the furan ring has been modified to a y-hydroxybutenolide 
moiety. The compound was thus assigned structure as 8 with a molecular 
formula C20I-I28O5 (M^ 349). 
The spectral data of photoproduct 10 was almost identical to that of starting 
compound 5, except for the values corresponding to an epoxide at Cy-Cg and an 
epoxylactone in place of furan ring. This is evidenced by the following changes 
in the methylene carbon signals: S 2.60, 2.35 ppm (C-6) and 5 2.48, 2.23 ppm 
(C-9). changed to 5 1.58, 133 ppm (C-6) and 5 1.89, 1.64 ppm (C-9) suggesting 
that the chan«e has occurred at Cy-Cs. Further '•'C-NMR value at 5 59.3 ppm 
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(C-7) and 93.3 ppm (C-8), suggested that initially sp^ hybridized carbon 
changed to quaternary carbon. The compound 10 showed a proton singlet at 5 
2.78 ppm, attached to C-11 (5 47.8 ppm), which was not present in the in 
starting compound. This suggested that both the double bonds of furan ring 
were utilized in epoxide and lactone formation. '^C-NMR exhibited signal due 
to lactone carbonyl at 5 177.4 ppm which is supported by the IR bands at 1765 
cm"' (lactone) and 1715 cm-l (a, P-unsaturated ester). 
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Scheme 5.3 
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Photooxygenation of 5 in methanol gave a compound identified as a crystalline 
hydroperoxide whose properties require that it should have structure 11. The 
compound has absorption bands at 3514 cm'' ( -00H) and 1250 cm"' (C-0) but 
none in - C = 0 region indicating it to be a hydroperoxide. Its ' H - N M R spectrum 
has significant signals at 5 8.16 (IH, OOH, exch.) and 5 3.24 (3H, OCH3) 
consistent with structure 11. A quantitative Zeisel determination indicated the 
presence of one OMe group and the result of quantitative peroxide and active 
hydrogen determinations were consistent with the presence of one 0 - 0 and one 
OH group. When 5 was irradiated in presence of [Psi]-rose bengal^' in methanol 
under bubbling oxygen a mixture of products 8 and 10 was obtained. It was 
found that upon standing the reaction mixture and so also on addition of dil HCI 
in the reaction mixture, the product 10 (epoxy lactone) converted into hydroxy 
butenolide 8 (Scheme 5.4). 
Treatment of methoxy hydroperoxide 11 with methanolic HCI gave a product 
identified as 8. Whereas pyrolysis of 11 produced 12 (Scheme 5.5). The 
structure of 12 was readily established by its spectral and chemical properties. 
In the IR, the compound absorbs at 1779 cm"', characteristics of y-oxygenated 
a.p-unsaturated-y-lactone functionality. In the UV as well, the absorption 
characteristics of this chromophore occurred at Xmax 216 nm. The NMR 
spectrum clearly showed the presence of a -OMe group 5 3.24 (3H) and an 
all\lic Mc 5 1.71 (3H). The presence of the OMe group was confirmed by a 
quantitative zeisel determination. Reduction of 11 with triphenylphosphine in 
201 
ether gave a product which was identified as 16. Its formation could be realized 
via unstable hemiacetal 14 (Scheme 5.5). Its IR absorption at 1779 cm"' and UV 
Aniax 217 nm are characteristic of an a, P-unsaturated y-lactone. The NMR 
spectrum showed the presence of an allylic Me group, 6 1.93 (3H, t); the single 
proton in the lactone ring appears as the quartet centered at 5 4.91 (IH, J=6 and 
1 1 Hz). The compound was identified as 2p-angeloyIoxy -lOP-H-
eremophilanolide (16). 
202 
RO O2, hv 
// Sens/CH^OhT 
O2. [Psil -Rose bengal 
/iW Methanol 
OOH 
On standing or 
treatment with acid 
Scheme 5.4 
203 
RO^ / \ i H OH 
Scheme 5.5 
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